Nature's Miracle Holding Inc. Common Stock (NMHI) S-13 Oct 24IPO registrationFinancial data

Company Profile

Document And Entity Information

Document And Entity Information	6 Months Ended
Document And Entity Information	Jun. 30, 2024
Document Information Line Items
Entity Registrant Name	Nature’s Miracle Holding Inc.
Document Type	S-1
Amendment Flag	false
Entity Central Index Key	0001947861
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	DE

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Balance Sheets - USD ($)		Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash and cash equivalent		$ 30,532	$ 221,760	$ 810,371
Accounts receivable, net		2,053,678	1,236,248	3,555,332
Inventories, net		4,169,333	5,046,084	8,802,062
Prepayments and other current assets		347,465	139,734	133,650
Loans receivable				132,913
Total Current Assets		7,318,843	7,409,495	13,447,632
NON-CURRENT ASSETS
Accounts receivable, net of current portion				138,613
Security deposit		27,633	47,633	66,720
Right-of-use assets, net		578,179	503,089	973,147
Cost method investment		1,000,000	1,000,000
Property and equipment, net		4,326,552	4,406,272	4,588,433
Deferred offering costs			833,932	395,000
Deferred tax asset, net				215,937
Goodwill				1,023,533
Total Assets		13,251,207	14,200,421	20,849,015
CURRENT LIABILITIES
Short-term loans		2,928,183	509,443	1,453,464
Current portion of long-term debts		284,493	268,805	110,810
Accounts payable		8,875,916	8,034,044	2,335,069
Other payables and accrued liabilities		3,385,079	1,351,951	604,972
Operating lease liabilities - current		460,311	359,459	468,425
Tax accrual		452,725	340,628	399,187
Deferred income - Contract liabilities		64,069	118,909	808,118
Total Current Liabilities		20,364,262	14,782,522	16,721,642
NON-CURRENT LIABILITIES
Long-term debts, net of current portion		5,833,562	5,979,939	2,967,218
Operating lease liabilities, net of current portion		184,147	157,897	542,709
Total Non-Current Liabilities		6,017,709	6,137,836	3,509,927
Total Liabilities		26,381,971	20,920,358	20,231,569
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY (DEFICIT)
Preferred Stock Value
Common Stock Value	[1]	2,645	2,227	2,227
Additional paid-in capital		1,894,563	1,526,773	1,526,773
Accumulated deficit		(15,026,864)	(8,247,862)	(909,691)
Accumulated other comprehensive loss		(1,108)	(1,075)	(1,863)
Total Stockholders’ Deficit		(13,130,764)	(6,719,937)	617,446
Total Liabilities and Stockholders’ Deficit		13,251,207	14,200,421	20,849,015
Related Party
CURRENT ASSETS
Accounts receivable - related parties, net		717,835	305,669
Prepayments and other current assets				13,304
Loans receivable			460,000
CURRENT LIABILITIES
Short-term loans - related parties		908,255	783,255	710,000
Accounts payable - related parties		2,713,074	2,758,074	9,605,523
Other payables - related parties		$ 292,157	$ 257,954	$ 226,074

[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares		Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred Stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized		1,000,000	1,000,000	1,000,000
Preferred Stock, shares issued
Preferred Stock shares outstanding
Common Stock, par value (in Dollars per share)	[1]	$ 0.0001	$ 0.0001	$ 0.0001
Common Stock, shares authorized	[1]	100,000,000	100,000,000	100,000,000
Common Stock, shares issued	[1]	26,456,764	22,272,478	22,272,478
Common Stock, shares outstanding	[1]	26,456,764	22,272,478	22,272,478

[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
REVENUE		$ 3,404,967	$ 1,943,528	$ 5,609,687	$ 4,910,200	$ 8,932,751	$ 18,621,344
COST OF REVENUE		2,952,747	1,843,257	4,845,150	4,512,669	9,881,622	16,952,201
GROSS PROFIT		452,220	100,271	764,537	397,531	(948,871)	1,669,143
OPERATING EXPENSES:
Selling, general and administrative		1,540,983	458,037	2,684,120	1,015,046	4,066,016	3,442,257
Stock compensation expenses		195,908		367,805
Goodwill impairment loss						1,023,533
Total operating expenses		1,736,891	458,037	3,051,925	1,015,046	5,089,549	3,442,257
LOSS FROM OPERATIONS		(1,284,671)	(357,766)	(2,287,388)	(617,515)	(6,038,420)	(1,773,114)
OTHER INCOME (EXPENSE)
Interest (expense) income, net		(486,586)	38,890	(788,975)	(360,020)	(847,191)	(742,715)
Non cash finance expense				(1,000,000)
Loss on loan extinguishment			(233,450)		(233,450)	(233,450)
Loss from short-term investment							(41,143)
Other expenses		3,738	6,716	3,738	6,346	(752)	27,403
Total other expense, net		(482,848)	(187,844)	(1,785,237)	(587,124)	(1,081,393)	(756,455)
LOSS BEFORE INCOME TAXES		(1,767,519)	(545,610)	(4,072,625)	(1,204,639)	(7,119,813)	(2,529,569)
PROVISION FOR (BENEFIT OF) INCOME TAXES
Current						2,421	76,287
Deferred					(242,908)	215,937	(144,731)
Total provision for (benefit of) income taxes		800	(139,040)	2,500	(230,690)	218,358	(68,444)
NET LOSS		(1,768,319)	(406,570)	(4,075,125)	(973,949)	(7,338,171)	(2,461,125)
OTHER COMPREHENSIVE LOSS
Foreign currency translation adjustment		(83)	(65)	(33)	791	788	(1,863)
COMPREHENSIVE LOSS		$ (1,768,402)	$ (406,635)	$ (4,075,158)	$ (973,158)	$ (7,337,383)	$ (2,462,988)
WEIGHTED AVERAGE NUMBER OF COMMON STOCK*
Basic (in Shares)	[1]	26,414,009	22,272,478	24,793,466	22,272,478	22,272,478	16,707,410
LOSS PER SHARE
Basic (in Dollars per share)		$ (0.07)	$ (0.02)	$ (0.16)	$ (0.04)	$ (0.33)	$ (0.15)

[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024

Unaudited Condensed Consolida_4

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Parentheticals) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Related party revenue		$ 588,720	$ 25,097	$ 994,098	$ 25,097	$ 300,053
Diluted	[1]	26,414,009	22,272,478	24,793,466	22,272,478	22,272,478	16,707,410
Diluted		$ (0.07)	$ (0.02)	$ (0.16)	$ (0.04)	$ (0.33)	$ (0.15)

[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024

Unaudited Condensed Consolida_5

Unaudited Condensed Consolidated Statements of Change in Stockholders’ Deficit - USD ($)		Preferred stock	Common stock	Additional paid in capital	Accumulated deficit	Accumulated other comprehensive loss	Total
Balance at Dec. 31, 2021			$ 891	$ 209,109	$ 1,560,487		$ 1,770,487
Balance (in Shares) at Dec. 31, 2021	[1]		8,908,991
Reverse recapitalization of Visiontech and Nature’s Miracle (Issuance of shares)			$ 690	393,310			394,000
Reverse recapitalization of Visiontech and Nature’s Miracle (Issuance of shares) (in Shares)	[1]		6,904,468
Acquisition of Hydroman			$ 646	924,354			925,000
Acquisition of Hydroman (in Shares)	[1]		6,459,019
VIE consolidation					(9,053)		(9,053)
Foreign currency translation adjustments						(1,863)	(1,863)
Net loss					(2,461,125)		(2,461,125)
Balance at Dec. 31, 2022			$ 2,227	1,526,773	(909,691)	(1,863)	617,446
Balance (in Shares) at Dec. 31, 2022	[1]		22,272,478
Foreign currency translation adjustments						856	856
Net loss					(567,379)		(567,379)
Balance at Mar. 31, 2023			$ 2,227	1,526,773	(1,477,070)	(1,007)	50,923
Balance (in Shares) at Mar. 31, 2023	[1]		22,272,478
Balance at Dec. 31, 2022			$ 2,227	1,526,773	(909,691)	(1,863)	617,446
Balance (in Shares) at Dec. 31, 2022	[1]		22,272,478
Net loss							(973,949)
Balance at Jun. 30, 2023			$ 2,227	1,526,773	(1,883,640)	(1,072)	(355,712)
Balance (in Shares) at Jun. 30, 2023	[1]		22,272,478
Balance at Dec. 31, 2022			$ 2,227	1,526,773	(909,691)	(1,863)	617,446
Balance (in Shares) at Dec. 31, 2022	[1]		22,272,478
Foreign currency translation adjustments						788	788
Net loss					(7,338,171)		(7,338,171)
Balance at Dec. 31, 2023			$ 2,227	1,526,773	(8,247,862)	(1,075)	(6,719,937)
Balance (in Shares) at Dec. 31, 2023	[1]		22,272,478
Balance at Mar. 31, 2023			$ 2,227	1,526,773	(1,477,070)	(1,007)	50,923
Balance (in Shares) at Mar. 31, 2023	[1]		22,272,478
Foreign currency translation adjustments						(65)	(65)
Net loss					(406,570)		(406,570)
Balance at Jun. 30, 2023			$ 2,227	1,526,773	(1,883,640)	(1,072)	(355,712)
Balance (in Shares) at Jun. 30, 2023	[1]		22,272,478
Balance at Dec. 31, 2023			$ 2,227	1,526,773	(8,247,862)	(1,075)	(6,719,937)
Balance (in Shares) at Dec. 31, 2023	[1]		22,272,478
Issuance of shares upon the reverse recapitalization			$ 403		(2,703,877)		(2,703,474)
Issuance of shares upon the reverse recapitalization (in Shares)	[1]		4,034,286
Stock compensation expense			$ 6	171,891			171,897
Stock compensation expense (in Shares)	[1]		62,740
Shares to be issued for stock compensation			$ (6)	6
Shares to be issued for stock compensation (in Shares)	[1]		(62,740)
Foreign currency translation adjustments						50	50
Net loss					(2,306,806)		(2,306,806)
Balance at Mar. 31, 2024			$ 2,630	1,698,670	(13,258,545)	(1,025)	(11,558,270)
Balance (in Shares) at Mar. 31, 2024	[1]		26,306,764
Balance at Dec. 31, 2023			$ 2,227	1,526,773	(8,247,862)	(1,075)	$ (6,719,937)
Balance (in Shares) at Dec. 31, 2023	[1]		22,272,478
Stock compensation expense (in Shares)							26,306,764
Net loss							$ (4,075,125)
Balance at Jun. 30, 2024			$ 2,645	1,894,563	(15,026,864)	(1,108)	(13,130,764)
Balance (in Shares) at Jun. 30, 2024	[1]		26,456,764
Balance at Mar. 31, 2024			$ 2,630	1,698,670	(13,258,545)	(1,025)	(11,558,270)
Balance (in Shares) at Mar. 31, 2024	[1]		26,306,764
Stock compensation expense			$ 16	195,892			195,908
Stock compensation expense (in Shares)	[1]		162,465
Shares to be issued for stock compensation			$ (1)	1
Shares to be issued for stock compensation (in Shares)	[1]		(12,465)
Foreign currency translation adjustments						(83)	(83)
Net loss					(1,768,319)		(1,768,319)
Balance at Jun. 30, 2024			$ 2,645	$ 1,894,563	$ (15,026,864)	$ (1,108)	$ (13,130,764)
Balance (in Shares) at Jun. 30, 2024	[1]		26,456,764

[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024

Unaudited Condensed Consolida_6

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,075,125)	$ (973,949)	$ (7,338,171)	$ (2,461,125)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation expense	79,720	83,388	164,942	141,342
Allowance for credit losses	24,391	789	907,021	322,395
Amortization of operating right-of-use asset	155,295	204,732	371,739	283,444
Amortization of debt issuance cost		73,782	72,807	52,693
Deferred taxes expenses (benefits)		(242,908)	215,937	(144,731)
Loss from short-term investment				41,143
Loss on loan extinguishment		233,450	233,450
Loss on early termination of right-of-use asset		33,423	33,423
Stock compensation expenses	367,805
Non cash finance expense	1,000,000
Loss on disposal of fixed assets			17,219
Goodwill impairment loss			1,023,533
Inventory impairment loss			1,269,469
Change in operating assets and liabilities
Accounts receivable	(1,253,986)	(105,364)	245,007	(3,528,434)
Inventories	876,751	2,242,101	2,486,509	3,094,723
Prepayments and other current assets	(207,731)	89,676	(6,084)	192,033
Prepayments - related parties			13,304
Security deposit	20,000	49,960	19,088
Accounts payable	796,876	(1,775,240)	(1,148,473)	79,818
Other payables and accrued liabilities	485,314	(68,251)	852,662	326,087
Accrued interest payable – related parties	34,203	26,033	63,141	4,317
Operating lease liabilities	(103,284)	(260,484)	(428,883)	(285,949)
Tax accrual	112,097	12,597	(58,559)	(338,002)
Deferred income - Contract liabilities	(54,841)	(121,006)	(689,209)	(232,593)
Net cash used in operating activities	(1,742,515)	(497,271)	(1,680,128)	(2,452,839)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment				(52,894)
Proceeds from the reverse recapitalization	1,120,177
Payments of transaction costs incurred by Lakeshore	(1,044,980)
Repayments of promissory note – related party of Lakeshore	(75,000)
Loan to related parties		(150,000)	(570,000)	(410,000)
Loan to Lakeshore	(40,000)
Loan repayment from related parties				6,000
Loan repayment from third parties		132,913	132,913	130,614
Short-term investment				(300,000)
Sale of short-term investment				258,855
Cash acquired through business combination				97,650
Net cash used in investing activities	(39,803)	(17,087)	(437,087)	(269,775)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceed from issuance of shares				394,000
Payments of deferred offering costs	(266,925)	(533,929)	(438,932)	(395,000)
Long-term loan borrowing		3,338,546	3,338,546
Repayments on long-term loan	(130,689)	(54,999)	(167,830)	(85,469)
Short-term loan borrowing from third parties	2,487,500	4,812	608,312	2,225,887
Repayments on short-term loan from third parties	(498,760)	(1,763,814)	(1,858,591)	(825,116)
Short-term loan borrowing from related parties		773,255	773,255	710,000
Repayments on short-term loan from related parties		(700,000)	(700,000)
Borrowings from other payables - related parties		1,000	1,558	372,944
Payments on other payables - related parties			(28,501)	(175,000)
Net cash provided by financing activities	1,591,126	1,064,871	1,527,817	2,222,246
EFFECT OF FOREIGN EXCAHANGE ON CASH	(36)	792	787	(1,858)
CHANGES IN CASH	(191,228)	551,305	(588,611)	(502,226)
CASH AND CASH EQUIVALENT, beginning of year	221,760	810,371	810,371	1,312,597
CASH AND CASH EQUIVALENT, end of year	30,532	1,361,676	221,760	810,371
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income tax	3,315	5,379	4,221	405,956
Cash paid for interest	604,512	185,981	768,221	692,187
SUPPLEMENTAL DISCLOSURE OF NON-CASH TRANSACTIONS:
Acquisition of Photon				45,500
Right of use assets acquired under new operating leases	285,185	46,284	46,284
Long term investment converted from accounts receivable		1,000,000
Loan receivables converted from accounts receivable				263,527
Vehicles purchased through auto loan				56,440
Cost method investment converted from accounts receivable			1,000,000
Derecognition of early termination of right-of-use asset		144,602	144,602
Derecognition of early termination of operating lease liabilities		152,179	152,179
Reduce of right-of-use asset and operating lease liabilities based on modification	54,800
Accumulated deficit acquired upon the reverse recapitalization	1,603,020
Deferred offering cost converted to APIC upon the reverse recapitalization	$ 1,100,857
Building acquired through consolidation of Upland				4,395,230
Mortgage acquired through consolidation of Upland				3,000,000
Shares issued to acquire net assets of Hydroman				925,000
Loan to related parties offset with other payables per agreement			$ 110,000

Nature of Business and Organiza

Nature of Business and Organization	6 Months Ended	12 Months Ended
Nature of Business and Organization	Jun. 30, 2024	Dec. 31, 2023
Nature of Business and Organization [Abstract]
Nature of business and organization	Note 1 — Nature of business and organization Nature’s Miracle Holding Inc., which until March 11, 2024 was known as LBBB Merger Corp. (the “Company”, “Nature’s Miracle”) is a company incorporated on August 1, 2022 under Delaware law as a wholly owned subsidiary of the Lakeshore Acquisition II Corp., a Cayman Islands exempted company (“Lakeshore”). On March 11, 2024, Lakeshore merged with and into the Company for the sole purpose of reincorporating Lakeshore into the State of Delaware (“Reincorporation”). Immediately after the Reincorporation, the Company consummated the merger contemplated by the Merger Agreement between the Company and Nature’s Miracle, Inc., a Delaware corporation (“NMI”), resulting in the stockholders of NMI becoming 84.7% stockholders of the Company and the Company becoming the 100% stockholder of NMI. (“the Merger”). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of NMI common stock issued and outstanding immediately prior to the effective time was canceled and automatically converted into the right to receive the applicable pro rata portion of shares of the Company common stock, the aggregate value of which was equal to: (a) $230,000,000 minus (b) the estimated Closing Net Indebtedness (as defined in the Merger Agreement) (the “Merger Consideration”). The Merger is considered as a reverse recapitalization in accordance with Accounting Standards Codification (“ASC”) 805-40. Under this method of accounting, Lakeshore will be treated as the “acquired” company for financial reporting purposes. This determination is primarily based on NMI’s stockholders comprise 84.7% of the voting power of the Company, directors appointed by NMI constituting three of the five members of the Company’s board of directors, NMI’s operations prior to the Merger comprising the only ongoing operations of the Company, and NMI’s senior management comprising all of the senior management of the Company. Accordingly, for accounting purposes, the financial statements of the Company will represent a continuation of the financial statements of NMI with the Merger treated as the equivalent of NMI issuing stock for the net assets of Lakeshore, accompanied by a recapitalization. The net assets of Lakeshore will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger will be presented as those of NMI in financial statements of the Company. The consolidation of the Company and its subsidiaries have been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying consolidated financial statements in accordance with ASC 805-50-45-5. All share and per share data has been retroactively restated to reflect the current capital structure of the Company. The Company is a growing agriculture technology company focusing on the greenhouse and cultivation industry and providing products to indoor growers in a CEA (Controlled Environment Agriculture) setting in North America. Reorganization under NMI NMI is a holding company incorporated on March 31, 2022 in Delaware. NMI has no substantial operations other than holding all the outstanding share capital of its subsidiaries. NMI, its subsidiaries and variable interest entity (“VIE”). On June 1, 2022, NMI entered into the Share Exchange Agreements with the stockholders of Visiontech Group, Inc. (“Visiontech”, a California Company), resulting in the stockholders of Visiontech becoming 56.3% stockholders of NMI and NMI becoming the 100% stockholder of Visiontech. The transaction was accounted as a reverse recapitalization in accordance with ASC 805. The process of identifying the accounting acquirer began with a consideration of the guidance in ASC 810-10 related to determining the existence of a controlling financial interest. The general rule provided by ASC 810-10 is that the party that holds directly or indirectly greater than 50% of the voting shares has a controlling financial interest. As such, NMI is treated as the “acquired” company for financial reporting purposes. This determination was primarily based on the stockholders of Visiontech to have a majority of the voting power of the post-combination company, Zhiyi (Jonathan) Zhang, former president of Visiontech, became the President of NMI, the relative size of Visiontech compared to NMI. Accordingly, for accounting purposes and the combination was treated as the equivalent of Visiontech issuing shares for the net assets of NMI, accompanied by a recapitalization. The net assets of NMI is stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the business combination would be those of Visiontech. On June 1, 2022, NMI also entered into the Share Exchange Agreements with the stockholders of Hydroman, Inc. (“Hydroman”, a California Company) to acquire 100% of Hydroman by issuing 6,844,000 shares of NMI’s common stock to the stockholders of Hydroman. The transaction was accounted for as a business combination according with ASC 805 where NMI (post combination with Visiontech) is both the legal and accounting acquirer. On July 28, 2022, Nature’s Miracle (California), Inc., (“NMCA”), a California corporation wholly owned by NMI was incorporated. NMCA focuses on greenhouse development services and started provide container grow sales in first quarter of 2024. On August 18, 2022, NMI acquired 100% interest of Photon Technology (Canada) Ltd, a Canadian company (“Photon”) for a total consideration of CAD $62,571 that was equivalent to $45,500. The purchase was accounted for as an asset purchase. Wei Yang, stockholder of NMI, was the sole stockholder of Photon prior to the acquisition. Upon completion of the acquisition, NMI has 100% of the equity interest of Photon, and Photon became a wholly-owned subsidiary of NMI. Photon will focus on manufacturing greenhouse and cultivation- related products. There was no material operation as of June 30, 2024. On August 27, 2021, Visiontech and Upland 858 LLC (“Upland”), who share common stockholders with Visiontech, entered into a promissory note agreement. Upland is a special purchase entity set up to purchase and hold a warehouse located in California. Upland promised to pay to Visiontech the sum of $1,574,079, together with simple interest thereon at the rate of 4.9% per annum. All sums of principal and unpaid interest thereon shall be due and payable in full to Visiontech on August 28, 2026. On January 10, 2022, Upland entered into a $3,000,000 commercial loan at a fixed rate of 3.79% with Bank of the West. With the funding from Visiontech and the bank, Upland purchased a warehouse located in California at the price of $4,395,230. On February 1, 2022, Upland leased the warehouse to Visiontech through a single lease agreement. As such, Visiontech is exposed to the variability of the building owned by Upland and Upland is a VIE of Visiontech. Visiontech is the primary beneficiary of Upland since Visiontech has a controlling financial interest in Upland and it has both (1) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE. On August 27, 2022, Upland entered into an assignment and assumption of unsecured promissory note with Zhiyi (Jonathan) Zhang, Vartor Vahe Doudakian and Yang Wei (collectively “Assignees”). Upland transferred to Assignees all of its right, title, duties, liabilities and obligation under the promissory note signed by and among Visiontech and Upland on August 27, 2021 in the original principal amount of $1,574,079. Visiontech also provided the consent to surrender its right to collect from Upland. As the stockholders are de facto agents of Visiontech, Visiontech and its de facto agents continue to bear the risk of losses or the rights to receive benefits from Upland. As such, in accordance with ASC 810, Upland is considered variable interest entity(“VIE”) of Visiontech and the financial statements of Upland was consolidated from the date of control and variable interest existed. See Note 4 for details.	Note 1 — Nature of business and organization Nature’s Miracle Holding Inc., which until March 11, 2024 was known as LBBB Merger Corp. (the “Company”) is a company incorporated on August 1, 2022 under Delaware law as a wholly owned subsidiary of the Lakeshore Acquisition II Corp., a Cayman Islands exempted company (“Lakeshore”). On March 11, 2024, Lakeshore merged with and into the Company for the sole purpose of reincorporating Lakeshore into the State of Delaware (“Reincorporation”). Immediately after the Reincorporation, the Company consummated the merger contemplated by the Merger Agreement between the Company and Nature’s Miracle, Inc., a Delaware corporation (“Nature’s Miracle”), resulting in the stockholders of Nature’s Miracle becoming 84.7% stockholders of the Company and the Company becoming the 100% stockholder of Nature’s Miracle.(“the Merger”) Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Nature’s Miracle common stock issued and outstanding immediately prior to the effective time was canceled and automatically converted into the right to receive the applicable pro rata portion of shares of the Company common stock, the aggregate value of which was equal to: (a) $230,000,000 minus (b) the estimated Closing Net Indebtedness (as defined in the Merger Agreement) (the “Merger Consideration”). The Merger is considered as a reverse recapitalization in accordance with Accounting Standards Codification (“ASC”) 805-40. Under this method of accounting, Lakeshore will be treated as the “acquired” company for financial reporting purposes. This determination is primarily based on Nature’s Miracle’s stockholders comprise 84.7% of the voting power of the Company, directors appointed by Nature’s Miracle constituting three of the five members of the Company’s board of directors, Nature’s Miracle’s operations prior to the Merger comprising the only ongoing operations of the Company, and Nature’s Miracle’s senior management comprising all of the senior management of the Company. Accordingly, for accounting purposes, the financial statements of the Company will represent a continuation of the financial statements of Nature’s Miracle with the Merger treated as the equivalent of Nature’s Miracle issuing stock for the net assets of Lakeshore, accompanied by a recapitalization. The net assets of Lakeshore will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger will be presented as those of Nature’s Miracle in financial statements of the Company. The consolidation of the Company and its subsidiaries have been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying consolidated financial statements in accordance with ASC 805-50-45-5. All share and per share data has been retroactively restated to reflect the current capital structure of the Company. The Company is a growing agriculture technology company focusing on the greenhouse and cultivation industry and providing products to indoor growers in a CEA (Controlled Environment Agriculture) setting in North America. Reorganization under Nature’s Miracle Nature’s Miracle is a holding company incorporated on March 31, 2022 in Delaware. Nature’s Miracle has no substantial operations other than holding all the outstanding share capital of its subsidiaries. Nature’s Miracle, its subsidiaries and variable interest entity (“VIE”). On June 1, 2022, Nature’s Miracle entered into the Share Exchange Agreements with the stockholders of Visiontech Group, Inc. (“Visiontech”, a California Company), resulting in the stockholders of Visiontech becoming 56.3% stockholders of Nature’s Miracle and Nature’s Miracle becoming the 100% stockholder of Visiontech. The transaction was accounted as a reverse recapitalization in accordance with ASC 805. The process of identifying the accounting acquirer began with a consideration of the guidance in ASC 810-10 related to determining the existence of a controlling financial interest. The general rule provided by ASC 810-10 is that the party that holds directly or indirectly greater than 50% of the voting shares has a controlling financial interest. As such, Nature’s Miracle is treated as the “acquired” company for financial reporting purposes. This determination was primarily based on the stockholders of Visiontech to have a majority of the voting power of the post-combination company, Zhiyi Zhang, former president of Visiontech, became the President of Nature’s Miracle, the relative size of Visiontech compared to Nature’s Miracle. Accordingly, for accounting purposes and the combination was treated as the equivalent of Visiontech issuing shares for the net assets of Nature’s Miracle, accompanied by a recapitalization. The net assets of Nature’s Miracle is stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the business combination would be those of Visiontech. On June 1, 2022, Nature’s Miracle also entered into the Share Exchange Agreements with the stockholders of Hydroman, Inc. (“Hydroman”, a California Company) to acquire 100% of Hydroman by issuing 6,844,000 shares of Nature’s Miracle’s common stock to the stockholders of Hydroman. The transaction was accounted for as a business combination according with ASC 805 where Nature’s Miracle (post combination with Visiontech) is both the legal and accounting acquirer. See Note 5 for details. On July 28, 2022, Nature’s Miracle (California), Inc., a California corporation wholly owned by Nature’s Miracle was incorporated. Nature’s Miracle (California), Inc. focuses on greenhouse development services. There was no material operation for the year ended December 31, 2023. On August 18, 2022, Nature’s Miracle acquired 100% interest of Photon Technology (Canada) Ltd, a Canadian company (“Photon”) for a total consideration of CAD $62,571 that was equivalent to $45,500. The purchase was accounted for as an asset purchase. Wei Yang, stockholder of Nature’s Miracle, was the sole stockholder of Photon prior to the acquisition. Upon completion of the acquisition, Nature’s Miracle has 100% of the equity interest of Photon, and Photon became a wholly-owned subsidiary of Nature’s Miracle. Photon will focus on manufacturing greenhouse and cultivation- related products. There was no material operation for the year ended December 31, 2023. On August 27, 2021, Visiontech and Upland 858 LLC (“Upland”), who share common stockholders with Visiontech, entered into a promissory note agreement. Upland is a special purchase entity set up to purchase and hold a warehouse located in California. Upland promised to pay to Visiontech the sum of $1,574,079, together with simple interest thereon at the rate of 4.9% per annum. All sums of principal and unpaid interest thereon shall be due and payable in full to Visiontech on August 28, 2026. On January 10, 2022, Upland entered into a $3,000,000 commercial loan at a fixed rate of 3.79% with Bank of the West. With the funding from Visiontech and the bank, Upland purchased a warehouse located in California at the price of $4,395,230. On February 1, 2022, Upland leased the warehouse to Visiontech through a single lease agreement. As such, Visiontech is exposed to the variability of the building owned by Upland and Upland is a VIE of Visiontech. Visiontech is the primary beneficiary of Upland since Visiontech has a controlling financial interest in Upland and it has both (1) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE (benefits). On August 27, 2022, Upland entered into an assignment and assumption of unsecured promissory note with Zhiyi Zhang, Vartor Vahe Doudakian and Yang Wei (collectively “Assignees”). Upland transferred to Assignees all of its right, title, duties, liabilities and obligation under the promissory note signed by and among Visiontech and Upland on August 27, 2021 in the original principal amount of $1,574,079. Visiontech also provided the consent to surrender its right to collect from Upland. As the stockholders are de facto agents of Visiontech, Visiontech and its de facto agents continue to bear the risk of losses or the rights to receive benefits from Upland. As such, in accordance with ASC 810, Upland is considered variable interest entity(“VIE”) of Visiontech and the financial statements of Upland was consolidated from the date of control and variable interest existed. See Note 4 for details.

Going Concern

Going Concern	6 Months Ended	12 Months Ended
Going Concern	Jun. 30, 2024	Dec. 31, 2023
Going Concern [Abstract]
Going concern	Note 2 — Going concern In assessing liquidity, the Company monitors and analyzes cash on-hand and operating expenditure commitments. The Company’s liquidity needs are to meet working capital requirements and operating expense obligations. To date, the Company financed its operations primarily through cash flows from operations, debt financing from financial institution and related parties. As of June 30, 2024 and December 31, 2023, the Company had approximately $31,000 and $0.2 million in cash which primarily consists of bank deposits, which are unrestricted as to withdrawal and use. The Company’s working capital deficit was approximately $13.0 million and $7.4 million as of June 30, 2024 and December 31, 2023. On July 3, 2024, the Company signed four convertible note investment agreements total of $410,000 from four investors. Each note bears 12% interest per annum and matures in 6 months. The Company shall repay the principal and accumulated interest after six months. If the investors choose to convert, the number of shares will be calculated by dividing the principal plus accumulated interest by $0.442. $410,000 had been deposited into the Company’s bank account in July 2024. On July 16, 2024, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a certain investor (the “Purchaser”) pursuant to which the Company sold, in a private placement (the “July 2024 Offering”), a $180,000 convertible note (the “July 2024 Note” and, the shares underlying the July 2024 Note, the “July 2024 Note Shares”) with an original issue discount of $27,500 and warrant (the “July 2024 Warrant”) to purchase up to 217,500 shares of common stock (the “July 2024 Warrant Shares”) at an exercise price of $0.87 per share. As consideration for entering into the Securities Purchase Agreement, the Company issued a total of 180,000 shares (the “Commitment Shares”) to the Purchaser on July 19, 2024. The July 2024 Warrant is exercisable on July 17, 2024 until five years from July 17, 2024. On July 30, 2024, the note was terminated as a result of the Company’s full payment of the note’s principal amount and accrued interest and other fees in the total amount of $212,400. As a result, all obligations under the note have been satisfied, and the note is no longer outstanding. On July 25, 2024, the Company entered into an underwriting agreement with EF Hutton LLC as the underwriter, relating to a firm commitment underwritten public offering of 5,000,000 units (the “Units”) consisting of (i) one share of common stock, par value $ 0.0001 per share (“Common Stock”) and (ii) one Series A Warrant to purchase one share of Common Stock (“Warrant”) at a public offering price of $0.24 per Unit, for aggregate gross proceeds of $1.2 million, prior to deducting underwriting discounts and other offering expenses. The closing of the offering occurred on July 29, 2024. On August 13, 2024, the Company entered a securities purchase agreement with 1800 Diagonal Lending LLC (“Diagonal”), in connection with the issuance of a promissory note in the aggregate principal amount of $181,700, including an original issue discount of $23,700, closing expenses of $8,000 deducted from funding amount; with additional tranches of financing of up to $1.0 million in the aggregate during the next twelve months subject to further agreement by and between Diagonal and the Company. The initial funding shall be payable in 10 equal monthly installments of $20,350. In the event of default, the note has convertibility provisions. The Company has experienced recurring losses from operations and negative cash flows from operating activities since 2022. In addition, the Company had, and may potentially continue to have, an ongoing need to raise additional cash from outside sources to fund its expansion plan and related operations. Successful transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support the Company’s cost structure. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued. If the Company is unable to realize its assets within the normal operating cycle of a twelve (12) month period, the Company may have to consider supplementing its available sources of funds through the following sources: ● financial support from the Company’s related parties and stockholders; ● other available sources of financing from banks and other financial institutions; ● equity financing through capital market. The Company can make no assurances that required financings will be available for the amounts needed, or on terms commercially acceptable to the Company, if at all. If one or all of these events does not occur or subsequent capital raises are insufficient to bridge financial and liquidity shortfall, there would likely be a material adverse effect on the Company and would materially adversely affect its ability to continue as a going concern. The unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern and, accordingly, do not include any adjustments that might result from the outcome of this uncertainty.	Note 2 — Going concern In assessing liquidity, the Company monitors and analyzes cash on-hand and operating expenditure commitments. The Company’s liquidity needs are to meet working capital requirements and operating expense obligations. To date, the Company financed its operations primarily through cash flows from operations, debt financing from financial institution and related parties. As of December 31, 2023 and 2022, the Company had approximately $0.2 million and $0.8 million in cash which primarily consists of bank deposits, which are unrestricted as to withdrawal and use. The Company’s working capital deficit was approximately $7.4 million and $3.3 million as of December 31, 2023 and 2022. On March 7, 2024 the Company’s subsidiary Nature’s Miracle obtained a loan in the amount of $1,405,000 with 10% interest which is due on March 7, 2025. The Company has experienced recurring losses from operations and negative cash flows from operating activities since 2022. In addition, the Company had, and may potentially continue to have, an ongoing need to raise additional cash from outside sources to fund its expansion plan and related operations. Successful transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support the Company’s cost structure. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued. If the Company is unable to realize its assets within the normal operating cycle of a twelve (12) month period, the Company may have to consider supplementing its available sources of funds through the following sources: ● financial support from the Company’s related parties and stockholders; ● other available sources of financing from banks and other financial institutions; ● equity financing through capital market. The Company can make no assurances that required financings will be available for the amounts needed, or on terms commercially acceptable to the Company, if at all. If one or all of these events does not occur or subsequent capital raises are insufficient to bridge financial and liquidity shortfall, there would likely be a material adverse effect on the Company and would materially adversely affect its ability to continue as a going concern. The consolidated financial statements have been prepared assuming that the Company will continue as a going concern and, accordingly, do not include any adjustments that might result from the outcome of this uncertainty.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Basis of Presentation and Summary of Significant Accounting Policies [Abstract]
Basis of presentation and summary of significant accounting policies	Note 3 — Basis of presentation and summary of significant accounting policies Basis of presentation The unaudited condensed consolidated financial statements include the accounts of the Company and its variable interest entities and have been prepared in accordance with U.S. GAAP and the requirements of the U.S. Securities and Exchange Commission (“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These unaudited condensed consolidated financial statements have been prepared on the same basis as its annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2024, or for any other interim period or for any other future year. All intercompany balances and transactions have been eliminated in consolidation. Principles of consolidation The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiaries, which include its wholly owned subsidiaries and VIE over which the Company exercises control and, when applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company and its subsidiaries and VIE have been eliminated upon consolidation. Use of estimates and assumptions The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities reported and disclosures of contingent assets and liabilities as of the date of the unaudited financial statements and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Cash and cash equivalents Cash and cash equivalents consist of amounts held as cash on hand and bank deposits. From time to time, the Company may maintain bank balances in interest bearing accounts in excess of the $250,000 currently insured by the Federal Deposit Insurance Corporation for interest bearing accounts (there is currently no insurance limit for deposits in noninterest bearing accounts). The Company has not experienced any losses with respect to cash. Management believes our Company is not exposed to any significant credit risk with respect to its cash. Prepayments and other current assets Prepaid expenses and other current assets primarily include prepaid expenses paid to product providers, and other deposits. Management regularly reviews the aging of such balances and changes in payment and realization trends and records allowances when management believes collection or realization of amounts due are at risk. Accounts considered uncollectable are written off against allowances after exhaustive efforts at collection are made. As of June 30, 2024 and December 31, 2023, no allowance for doubtful account was recorded. Accounts receivable, net During the ordinary course of business, the Company extends unsecured credit to its customers. Accounts receivable are stated at the amount the Company expects to collect from customers. Management reviews its accounts receivable balances each reporting period to determine if an allowance for doubtful accounts is required. An allowance for doubtful accounts is recorded in the period in which loss is determined to be probable based on assessment of specific evidence indicating likelihood of collection, historical experience, account balance aging and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased. Starting from January 1, 2023, the Company adopted ASU No.2016-13 “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASC Topic 326”). The Company used a modified retrospective approach, and the adoption does not have an impact on our unaudited condensed consolidated financial statements. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. Inventory Inventory consists of finished goods ready for sale and is stated at the lower of cost or market. The Company values its inventory using the weighted average costing method. The Company’s policy is to include as a part of cost of goods sold any freight incurred to ship the product from its vendors to warehouses. Outbound freight costs related to shipping costs to customers are considered periodic costs and are reflected in cost of revenue. The Company regularly reviews inventory and considers forecasts of future demand, market conditions and product obsolescence. If the estimated realizable value of the inventory is less than cost, the Company makes provisions in order to reduce its carrying value to its estimated market value. The Company also reviews inventory for slow moving inventory and obsolescence and records impairment for obsolescence. During the three and six months ended June 30, 2024, there was no inventory impairment loss recorded. During the three and six months ended June 30, 2023, there was no inventory impairment loss recorded. Cost method investment The Company accounts for investments with less than 20% of the voting shares and does not have the ability to exercise significant influence over operating and financial policies of the investee using the cost method. The Company records cost method investment at the historical cost in its unaudited condensed consolidated financial statements and subsequently records any dividends received from the net accumulated earrings of the investee as income. Dividends received in excess of earnings are considered a return of investment and are recorded as reduction in the cost of the investments. Cost method investment is evaluated for impairment when facts or circumstances indicate that the fair value of the long-term investments is less than its carrying value. An impairment is recognized when a decline in fair value is determined to be other-than-temporary. The Company reviews several factors to determine whether a loss is other-than-temporary. These factors include, but are not limited to, the: (i) nature of the investment; (ii) cause and duration of the impairment; (iii) extent to which fair value is less than cost; (iv) financial condition and near-term prospects of the investments; and (v) ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. No event had occurred and indicated that other-than-temporary impairment existed and therefore during the three and six months ended June 30, 2024, the Company did not record any impairment charges for its investments. During the three and six months ended June 30, 2023, the Company did not record any impairment charges for its investments. Security deposits To maintain a stable supply for goods and build a long-term relationship, the Company may pay certain amount of funds to its vendors as security deposits which are recorded as non-current assets on the balance sheet depending on its return date. Property and equipment Property and equipment are stated at historical cost. Depreciation is provided over the estimated useful life of each class of depreciable assets and is computed using the straight-line method over the useful lives of the assets are as follows: Useful Life Machinery and equipment 5 years Computer and peripherals 3 years Trucks and automobiles 5 years Buildings 39 years The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statements of operations. Expenditures for maintenance and repairs are expensed as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. Deferred offering costs Deferred offering costs consist primarily of expenses paid to attorneys, consultants, underwriters, and etc. related to its merger transaction. The balance has been offset with the proceeds received after the close of the offering. Fair value measurement The Company adopted ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability. ASC Topic 820 specifies a hierarchy of valuation techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows: Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. When available, the Company uses quoted market prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest rates and currency rates. Fair values of financial instruments Financial instruments include cash and cash equivalents, accounts receivable, prepayments, loan receivable, and other current assets, other payable and accrued liabilities, accounts payable — related parties, short term loans and taxes payable. The Company considers the carrying amount of short-term financial instruments to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization. The Company’s long-term debts are measured at amortized cost, no fair value option is elected. Revenue recognition The Company follows Accounting Standards Codification (“ASC”) 606 Revenue Recognition and recognizes revenue from product sales revenues, net of promotional discounts and return allowances, when the following revenue recognition criteria are met: a contract has been identified, separate performance obligations are identified, the transaction price is determined, the transaction price is allocated to separate performance obligations and revenue is recognized upon satisfying each performance obligation. The Company is a growing agriculture technology company providing CEA hardware products to growers in the controlled environment agriculture industry setting in North America. Majority of the Company’s products were grow lights and related products for the indoor growing settings. Starting from first quarter of 2024, the Company also provides indoor grow containers to its customers. The Company’s contracts with customers where the amounts charged per product is fixed and determinable, the specific terms of the contracts were agreed on by the Company including payment terms which are typically 30 to 60 days for existing customers and prepaid for most new customers. In certain contracts involving customers that entered into rebate programs with utility companies for using LED lighting, payment term ranges from 60 to 120 days. The Company’s performance obligation is to deliver the products to customers. For indoor grow container products, the Company also involved in customization of the products to suit customer’s specific needs. The provision of customization and configuration to meet certain technical specification per US market and delivery of product is considered one performance obligation as the as the services provided are not distinct within the context of the contract whereas the customers can only obtain benefit when the services and products are provided together. Transaction prices are mostly fixed. In some contracts, when determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customers and the transfer of the promised goods or services to the licensees will be one year or less. The Company had one contract with customer with installment payment terms of up to 16 months. The difference between the contract price and the Company’s cash selling price of the same products are recognized as interest income over the term of the payments. Interest income amounted to $44,239 and $78,385 during the three and six months ended June 30, 2023, respectively. This contract was terminated on July 12, 2023. The Company transfers the risk of loss or damage upon shipment, therefore, revenue from product sales is recognized at a point in time when control of product transfer to customer and the Company has no further obligation to provide services related to such product evidenced by customer signing acceptances upon receipt of goods. Return allowances, which reduce product revenue by the Company’s best estimate of expected product returns, are estimated using historical experience. The Company evaluates the criteria of ASC 606 — Revenue Recognition Principal-Agent Considerations in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Company ships the products according to shipping terms on the purchase order or sales order. Once delivery is complete, the Company then sends an invoice to the customer according to the quantity and price of shipment. The Company evaluates the indicators of control in accordance with ASU 2016-08: 1) the Company is the most visible entity to customers and assumes fulfilment risk and risks related to the acceptability of products, including addressing customer inquiries directly and handling of product returns or refunds directly if any. For grow light products, the Company has its own brand for marketing. For indoor grow containers products, the Company is also involved in the design and technical specification of the products to meet requirement in the US market 2) The Company assumes inventory risk either through storing the products in its own warehouses; or for drop shipments directly from vendors, the Company takes the title from vendors through inspection and acceptance and is responsible for product damage during shipment period prior to acceptance of its customers and is also responsible for product return if the customer is not satisfied with the products. 3) The Company determines the resale price of the products. 4) The Company is the party that directs the use of the inventory and can prevent the vendor from transferring the product to a customer or to redirect the products to a different customer, after evaluating the above scenario, the Company considers itself the principal of these arrangements and records revenue on a gross basis. The Company’s disaggregate revenue stream by products are summarized below: For the For the June 30, June 30, June 30, June 30, (Unaudited) (Unaudited) (Unaudited) (Unaudited) Grow light $ 3,404,967 $ 1,943,528 $ 5,465,906 $ 4,910,200 Indoor grow containers - - 143,781 - Total revenues $ 3,404,967 $ 1,943,528 $ 5,609,687 $ 4,910,200 Prepayments received from customers prior to the delivery of goods to customers or picked up by the customers are recorded as contract liability under the account Deferred income — contract liabilities. Movements of Deferred income — contract liabilities consisted of the following as of the date indicated: As of As of Beginning balance $ 118,909 $ 808,118 Prepayments from customers 470,967 1,370,836 Recognized as revenues (525,807 ) (2,060,045 ) Ending balance $ 64,069 $ 118,909 The Company periodically provides incentive offers to its customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases and other similar offers. Current discount offers, when accepted by the Company’s customers, are treated as a reduction to the transaction price of the related transaction. Sales discounts are recorded in the period in which the related sale is recognized. Sales return allowances are recorded and estimated based on historical returns which were generally immaterial to the Company. Estimated warranty are immaterial because suppliers provide a warranty period of 1-5 years for all products, varying depending on the product type. After customers provide their purchase invoices and serial numbers for the return products, the factories will issue the replacement products. Additionally, the factories will also bear the corresponding shipping costs, making the company’s warranty expenses negligible. Cost of revenue Cost of revenue mainly consist of costs for purchases of products and related storage, warehouse rent, outbound freight, delivery fees and payroll related expenses. Segment reporting The Company follows ASC 280, Segment Reporting. The Company’s chief operating decision maker, the Chief Executive Officer, reviews the results of operations when making decisions about allocating resources and assessing the performance of the Company as a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. The Company’s long-lived assets are all located in California, United States, and substantially all the Company’s revenues are derived from within the USA. Therefore, no geographical segments are presented. Leases The Company follows ASC 842 — Leases (“ASC 842”), which requires lessees to record right-of-use (“ROU”) assets and related lease obligations on the balance sheet, as well as disclose key information regarding leasing arrangements. ROU assets represent our right to use an underlying asset for the lease terms and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Income taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their perspective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized. As a result of the implementation of certain provisions of ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting and disclosure for uncertainty in tax position, as defined, ASC 740 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes. The Company follows the provisions of ASC 740 and has analyzed filing positions in each of the federal and state jurisdictions where the Company is required to file income tax returns, as well as open tax years in such jurisdictions. The Company has identified the U.S. federal jurisdiction, and the states of Delaware, as its “major” tax jurisdictions. The Company believes that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. The Company’s policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes. Stock-based compensation The Company accounts for stock-based compensation awards to employees in accordance with FASB ASC Topic 718, “Compensation – Stock Compensation”, which requires that stock-based payment transactions with employees be measured based on the grant-date fair value of the equity instrument issued and recognized as compensation expense over the requisite service period. The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 718 amended by ASU 2018-07. Under FASB ASC Topic 718, stock compensation granted to non-employees has been determined as the fair value of the consideration received or the fair value of equity instrument issued, whichever is more reliably measured and is recognized as an expense as the goods or services are received. Warrants The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity. Commitments and Contingencies In the ordinary course of business, the Company is subject to certain contingencies, including legal proceedings and claims arising out of the business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable that a loss has occurred, and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and specific facts and circumstances of each matter. Loss per share Basic loss per share is computed by dividing net loss attributable to holders of common stock by the weighted average number of common stock outstanding during the year. During the three and six months ended June 30, 2024, basic and diluted loss per share are the same because the Company had net loss for the periods. During the three and six months ended June 30, 2023, basic and diluted loss per share are the same because the Company had net loss for the periods. Recently issued accounting pronouncements In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its unaudited condensed consolidated financial statements and related disclosures. Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated balance sheets, statements of income and comprehensive income and statements of cash flows.	Note 3 — Basis of presentation and summary of significant accounting policies Basis of presentation The accompanying financial statements have been prepared in accordance with the generally accepted accounting principles in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”). The Company’s fiscal year end date is December 31. Principles of consolidation The consolidated financial statements include the financial statements of the Company and its subsidiaries, which include its wholly owned subsidiaries and VIE over which the Company exercises control and, when applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company and its subsidiaries and VIE have been eliminated upon consolidation. Use of estimates and assumptions The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities reported and disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Cash and cash equivalents Cash and cash equivalents consist of amounts held as cash on hand and bank deposits. From time to time, the Company may maintain bank balances in interest bearing accounts in excess of the $250,000 currently insured by the Federal Deposit Insurance Corporation for interest bearing accounts (there is currently no insurance limit for deposits in noninterest bearing accounts). The Company has not experienced any losses with respect to cash. Management believes our Company is not exposed to any significant credit risk with respect to its cash. Short-term investments Short-term investments are investment in marketable equity securities that are measured and recorded at fair value based on quoted prices in active markets on reporting dates with changes in fair value, whether realized or unrealized, recorded through the income statement. Prepayments and other current assets Prepaid expenses and other current assets primarily include prepaid expenses paid to product providers, and other deposits. Management regularly reviews the aging of such balances and changes in payment and realization trends and records allowances when management believes collection or realization of amounts due are at risk. Accounts considered uncollectable are written off against allowances after exhaustive efforts at collection are made. As of December 31, 2023 and 2022, no allowance for doubtful account was recorded. Accounts receivable During the ordinary course of business, the Company extends unsecured credit to its customers. Accounts receivable are stated at the amount the Company expects to collect from customers. Management reviews its accounts receivable balances each reporting period to determine if an allowance for doubtful accounts is required. An allowance for doubtful accounts is recorded in the period in which loss is determined to be probable based on assessment of specific evidence indicating likelihood of collection, historical experience, account balance aging and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased. Starting from January 1, 2023, the Company adopted ASU No.2016-13 “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASC Topic 326”). The Company used a modified retrospective approach, and the adoption does not have an impact on our consolidated financial statements. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. Inventory Inventory consists of finished goods ready for sale and is stated at the lower of cost or market. The Company values its inventory using the weighted average costing method. The Company’s policy is to include as a part of cost of goods sold any freight incurred to ship the product from its vendors to warehouses. Outbound freight costs related to shipping costs to customers are considered periodic costs and are reflected in cost of revenue. The Company regularly reviews inventory and considers forecasts of future demand, market conditions and product obsolescence. If the estimated realizable value of the inventory is less than cost, the Company makes provisions in order to reduce its carrying value to its estimated market value. The Company also reviews inventory for slow moving inventory and obsolescence and records impairment for obsolescence. For the year ended December 31, 2023 and 2022, inventory impairment loss amounted to $1,269,469 and $0, respectively. Cost method investment The Company accounts for investments with less than 20% of the voting shares and does not have the ability to exercise significant influence over operating and financial policies of the investee using the cost method. The Company records cost method investment at the historical cost in its consolidated financial statements and subsequently records any dividends received from the net accumulated earrings of the investee as income. Dividends received in excess of earnings are considered a return of investment and are recorded as reduction in the cost of the investments. Cost method investment is evaluated for impairment when facts or circumstances indicate that the fair value of the long-term investments is less than its carrying value. An impairment is recognized when a decline in fair value is determined to be other-than-temporary. The Company reviews several factors to determine whether a loss is other-than-temporary. These factors include, but are not limited to, the: (i) nature of the investment; (ii) cause and duration of the impairment; (iii) extent to which fair value is less than cost; (iv) financial condition and near term prospects of the investments; and (v) ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. No event had occurred and indicated that other-than-temporary impairment existed and therefore the Company did not record any impairment charges for its investments for the years ended December 31, 2023 and 2022. Security deposits To maintain a stable supply for goods and build a long-term relationship, the Company may pay certain amount of funds to its vendors as security deposits which are recorded as non-current assets on the balance sheet depending on its return date. Property and equipment Property and equipment are stated at historical cost. Depreciation is provided over the estimated useful life of each class of depreciable assets and is computed using the straight-line method over the useful lives of the assets are as follows: Useful Life Machinery and equipment 5 years Computer and peripherals 3 years Trucks and automobiles 5 years Buildings 39 years The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statements of operations. Expenditures for maintenance and repairs are expensed as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. Deferred offering costs Deferred offering costs consist primarily of expenses paid to attorneys, consultants, underwriters, and etc. related to its merger transaction. The balance will be offset with the proceeds received after the close of the offering. Business combination The purchase price of an acquired company is allocated between tangible and intangible assets acquired and liabilities assumed from the acquired business based on their estimated fair values, with the residual of the purchase price recorded as goodwill. Transaction costs associated with business combinations are expensed as incurred and are included in general and administrative expenses in the Company’s consolidated statements of operations. The results of operations of the acquired business are included in the Company’s operating results from the date of acquisition. Goodwill Goodwill represents the excess of the consideration paid of an acquisition over the fair value of the net identifiable assets of the acquired subsidiaries at the date of acquisition. Goodwill is not amortized and is tested for impairment at least annually, more often when circumstances indicate impairment may have occurred. Goodwill is carried at cost less accumulated impairment losses. If impairment exists, goodwill is immediately written off to its fair value and the loss is recognized in the consolidated statements of operations and comprehensive loss. Impairment losses on goodwill are not reversed. The Company reviews the carrying value of intangible assets not subject to amortization, including goodwill, to determine whether impairment may exist annually or more frequently if events and circumstances indicate that it is more likely than not that an impairment has occurred. The Company has the option to assess qualitative factors to determine whether it is necessary to perform further impairment testing in accordance with ASC 350-20, as amended by ASU 2017-04. If the Company believes, as a result of the qualitative assessment, that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, then the impairment test described below is required. The Company compares the fair values of each reporting unit to its carrying amount, including goodwill. If the fair value of each reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. If the carrying amount of a reporting unit exceeds its fair value, impairment is recognized for the difference, limited to the amount of goodwill recognized for the reporting unit. Estimating fair value is performed by utilizing various valuation techniques, with the primary technique being a discounted cash flow. For the year ended December 31, 2023 and 2022, goodwill impairment loss amounted $1,023,533 and $0 Fair value measurement The Company adopted ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability. ASC Topic 820 specifies a hierarchy of valuation techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows: Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. When available, the Company uses quoted market prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest rates and currency rates. Fair values of financial instruments Financial instruments include cash and cash equivalents, accounts receivable, prepayments, loan receivable, and other current assets, other payable and accrued liabilities, accounts payable — related parties, short term loans and taxes payable. The Company considers the carrying amount of short-term financial instrument to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization. The Company’s long term debts are measured at amortized cost, no fair value option is elected. Revenue recognition The Company follows Accounting Standards Codification (“ASC”) 606 Revenue Recognition and recognizes revenue from product sales revenues, net of promotional discounts and return allowances, when the following revenue recognition criteria are met: a contract has been identified, separate performance obligations are identified, the transaction price is determined, the transaction price is allocated to separate performance obligations and revenue is recognized upon satisfying each performance obligation. The Company’s contracts with customers where the amounts charged per product is fixed and determinable, the specific terms of the contracts were agreed on by the Company including payment terms which are typically 30 to 60 days. In certain contracts involving customers that entered into rebate programs with Utility companies for using LED lighting, payment term ranges from 60 to 120 days. In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customers and the transfer of the promised goods or services to the licensees will be one year or less. The Company had one contract with customer with installment payment terms of up to 16 months. The difference between the contract price and the Company’s cash selling price of the same products are recognized as interest income over the term of the payments. Interest income amounted to $78,385 and $22,764 for the years ended December 31, 2023 and 2022, respectively. This contract was terminated on July 12, 2023 and the Company recognized provision for credit loss of approximately $0.2 million. The Company transfers the risk of loss or damage upon shipment, therefore, revenue from product sales is recognized at a point in time when control of product transfer to customer and the Company has no further obligation to provide services related to such product evidenced by customer signing acceptances upon receipt of goods. Return allowances, which reduce product revenue by the Company’s best estimate of expected product returns, are estimated using historical experience. The Company evaluates the criteria of ASC 606 — Revenue Recognition Principal Agent Considerations in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Company has only one performance obligation which is the delivery of products. The Company ships the products according to shipping terms on the purchase order or sales order. Once delivery is complete, the Company then sends an invoice to the customer according to the quantity and price of shipment. If the timing of payments agreed to by the parties to the contract (either explicitly or implicitly) provides the customer or the entity with a significant benefit of financing the transfer of goods or services to the customer, the entity will need to adjust the promised amount of consideration for the effects of the time value of money when determining the transaction price. Generally, when the Company is primarily responsible for fulfilling the promise to provide a specified good or service, the Company is subject to inventory risk before control of the good or service has been transferred to a customer and the Company has discretion in establishing the price, revenue is recorded at gross. Prepayments received from customers prior to the delivery of goods to customers or picked up by the customers are recorded as contract liability under the account Deferred income — contract liabilities. Movements of Deferred income — contract liabilities consisted of the following as of the date indicated: As of As of Beginning balance $ 808,118 $ 997,732 Prepayments from customers 1,370,836 1,352,698 Recognized as revenues (2,060,045 ) (1,542,312 ) Ending balance $ 118,909 $ 808,118 The Company periodically provides incentive offers to its customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases and other similar offers. Current discount offers, when accepted by the Company’s customers, are treated as a reduction to the transaction price of the related transaction. Sales discounts are recorded in the period in which the related sale is recognized. Sales return allowances are recorded and estimated based on historical returns which were generally immaterial to the Company. Estimated warranty are immaterial because suppliers provide a warranty period of 1-5 years for all products, varying depending on the product type. After customers provide their purchase invoices and serial numbers for the return products, the factories will issue the replacement products. Additionally, the factories will also bear the corresponding shipping costs, making the company’s warranty expenses negligible. Cost of revenue Cost of revenue mainly consist of costs for purchases of products and related storage, warehouse rent, outbound freight, delivery fees and payroll related expenses. Segment reporting The Company follows ASC 280, Segment Reporting. The Company’s chief operating decision maker, the Chief Executive Officer, reviews the results of operations when making decisions about allocating resources and assessing the performance of the Company as a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. The Company’s long-lived assets are all located in California, United States, and substantially all of the Company’s revenues are derived from within the USA. Therefore, no geographical segments are presented. Leases The Company follows ASC 842 — Leases (“ASC 842”), which requires lessees to record right-of-use (“ROU”) assets and related lease obligations on the balance sheet, as well as disclose key information regarding leasing arrangements. ROU assets represent our right to use an underlying asset for the lease terms and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Income taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their perspective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized. As a result of the implementation of certain provisions of ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting and disclosure for uncertainty in tax position, as defined, ASC 740 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes. The Company follows the provisions of ASC 740, and has analyzed filing positions in each of the federal and state jurisdictions where the Company is required to file income tax returns, as well as open tax years in such jurisdictions. The Company has identified the U.S. federal jurisdiction, and the states of Delaware, as its “major” tax jurisdictions. The Company believes that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. The Company’s policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes. Commitments and Contingencies In the ordinary course of business, the Company is subject to certain contingencies, including legal proceedings and claims arising out of the business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable that a loss has occurred and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and specific facts and circumstances of each matter. Loss per share Basic loss per share is computed by dividing net loss attributable to holders of common stock by the weighted average number of common stock outstanding during the year. For the years ended December 31, 2023 and 2022, basic and diluted earnings/ (loss) per share are the same because the Company has no common stock equivalents outstanding during these periods. Recently adopted accounting pronouncements In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments — Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments — Credit Losses — Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-02 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. The Company adopted the ASU on January 1, 2023 and the adoption of this ASU did not have a material effect on the Company’s consolidated financial statements. Recently issued accounting pronouncements In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures. Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s consolidated balance sheets, statements of income and comprehensive income and statements of cash flows.

Variable Interest Entity

Variable Interest Entity	6 Months Ended	12 Months Ended
Variable Interest Entity	Jun. 30, 2024	Dec. 31, 2023
Variable Interest Entity [Abstract]
Variable interest entity	Note 4 — Variable interest entity The Company does not have direct ownership in Upland but has been actively involved in their operations and has the power to direct the activities and significantly impact Upland’s economic performance. The Company also bears the risk of losses from Upland. As such, in accordance with ASC 810, Upland is considered variable interest entity (“VIE”) of the Company and the financial statements of Upland was consolidated from the date of control and variable interest existed. Based on the loan agreement between its creditor and Upland 858 LLC, the loan is a non-recourse debt secured by the assets owned by Upland 858 LLC only and guaranteed by the stockholders of Upland 858 LLC only. Upland 858 LLC’s creditor will have no-recourse to Visiontech which is considered to be the primary beneficiary of the VIE structure but not the legal owner of Upland 858 LLC: Accordingly, the accounts of Upland were consolidated in the accompanying financial statements as VIE of Visiontech from January 2022 when Upland acquired the warehouse in California. The carrying amount of the assets and liabilities are as follows: As of Cash $ 1,046 Prepaid expense 1,800 Property and equipment, net 4,180,504 Total assets $ 4,183,350 Current portion of long-term debt $ 82,374 Long-term debt, net of current portion 2,730,266 Accrued expenses 398 Intercompany payable to Visiontech 1,367,078 Total liabilities $ 4,180,116 The operating results of VIE included in the unaudited condensed consolidated statements of operations are as follows for the period indicated: For the For the Revenue * $ 83,211 $ 166,421 Selling, general and administrative (27,840 ) (82,450 ) Interest expense (25,414 ) (51,034 ) Income tax - (1,700 ) Net income $ 29,957 $ 31,237 * Upland generated its revenue from leasing the warehouse to Visiontech. Revenue of Upland was fully eliminated on the unaudited condensed consolidated statements of operations.	Note 4 — Variable interest entity The Company does not have direct ownership in Upland but has been actively involved in their operations and has the power to direct the activities and significantly impact Upland’s economic performance. The Company also bears the risk of losses from Upland. As such, in accordance with ASC 810, Upland is considered variable interest entity (“VIE”) of the Company and the financial statements of Upland was consolidated from the date of control and variable interest existed. Based on the loan agreement between its creditor and Upland 858 LLC, the loan is a non-recourse debt secured by the assets owned by Upland 858 LLC only and guaranteed by the stockholders of Upland 858 LLC only. Upland 858 LLC’s creditor will have no-recourse to Visiontech which is considered to be the primary beneficiary of the VIE structure but not the legal owner of Upland 858 LLC: Accordingly, the accounts of Upland were consolidated in the accompanying financial statements as VIE of Visiontech from January 2022 when Upland acquired the warehouse in California. The carrying amount of the assets and liabilities are as follows: As of Cash $ 8,889 Prepaid expense 1,800 Property and equipment, net 4,224,930 Total assets $ 4,235,619 Current portion of long-term debt $ 80,638 Long-term debt, net of current portion 2,771,959 Intercompany payable to Visiontech (2) 1,411,025 Total liabilities $ 4,263,622 The operating results of VIE included in the consolidated statements of operations are as follows for the period indicated: For the Revenue (1) $ 332,842 Selling, general and administrative (169,563.00 ) Interest expense (2) (259,713.00 ) Income tax (800.00 ) Net loss $ (97,234.00 ) (1) Upland generated its revenue from leasing the warehouse to Visiontech. Revenue of Upland was fully eliminated on the consolidated statements of operations. (2) Upland generated interest expense of $155,806 from the intercompany payable to Visiontech of $1,411,025, both amounts were eliminated on the consolidated statements of operations.

Business Combination

Business Combination	12 Months Ended
Business Combination	Dec. 31, 2023
Business Combination [Abstract]
Business combination	Note 5 — Business combination On June 1, 2022, Nature’s Miracle also entered into the Share Exchange Agreements with the stockholders of Hydroman, to acquire 100% of Hydroman by issuing 6,844,000 shares of Nature’s Miracle’s common stock with the purpose of increasing capacity and expanding the Company’s market. The transaction was accounted as business combination according with ASC 805 where Nature’s Miracle (post combination with Visiontech) is both the legal and accounting acquirer. The common stock issued as consideration for the purchase of Hydroman was valued using the net book value on a per-share-basis of the common stock of Nature’s Miracle multiplied by the number of shares issued; after considering a variety of approaches and valuation techniques management believes the use of the net book value of Nature’s Miracle’s common stock is the most fair depiction and approximation of the fair value the transaction price and at the time of the acquisition. The Company then allocated the fair value of consideration of Hydroman based upon the fair value of the identifiable assets acquired and liabilities assumed on the acquisition date. The Company estimated the fair values of the assets acquired and liabilities assumed at the acquisition date in accordance with the Business Combination standard issued by the FASB with the valuation methodologies using level 3 inputs, except for other current assets and current liabilities were valued using the cost approach. Management of the Company is responsible for determining the fair value of assets acquired and liabilities assumed as of the acquisition date. Acquisition-related costs incurred for the acquisition are not material and have been expensed as incurred in general and administrative expense. The following table summarizes the fair value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of Hydroman on June 1, 2022. Fair value Cash $ 97,650 Inventories, net 3,538,989 Other current assets 163,009 Right-of-use assets 1,227,673 Deferred tax assets 115,562 Other non-current assets 120,538 Accounts payable – related parties (3,752,571 ) Other current liabilities (780,423 ) Other non-current liabilities (828,960 ) Net assets acquired (98,533 ) Goodwill on acquisition 1,023,533 Total consideration $ 925,000 Approximately USD 1.0 million of goodwill arising from the acquisition is mainly attributable to the excess of the consideration paid over the fair value of the net assets acquired that cannot be recognized separately as identifiable assets under U.S. GAAP, and comprise (a) the assembled work force and (b) the expected but unidentifiable business growth as a result of the synergy resulting from the acquisition.

Goodwill

Goodwill	12 Months Ended
Goodwill	Dec. 31, 2023
Goodwill [Abstract]
Goodwill	Note 6 — Goodwill Changes in the carrying amount pf goodwill for the year ended December 31, 2023 and 2022 were as follows: December 31, December 31, Beginning balance $ 1,023,533 $ - Acquisitions - 1,023,533 Goodwill impairment (1,023,533 ) - Ending balance $ - $ 1,023,533 The Company reviews the carrying value of goodwill and determine that the carrying value of the reporting unit exceeds its fair value and recognized the impairment for goodwill. Due to key management turnover resulted in lack of synergy for the business combination, for the year ended December 31, 2023 and 2022, goodwill impairment loss amounted to $1,023,533 and $0, respectively.

Accounts Receivable, Net

Accounts Receivable, Net	6 Months Ended	12 Months Ended
Accounts Receivable, Net	Jun. 30, 2024	Dec. 31, 2023
Accounts Receivable, Net [Abstract]
Accounts receivable, net	Note 6 — Accounts receivable, net Accounts receivable consisted of the following as of the date indicated: As of As of Accounts receivable $ 2,737,042 $ 1,906,222 Less: allowance for credit losses (683,364 ) (669,974 ) Subtotal accounts receivable, net 2,053,678 1,236,248 Accounts receivable - related parties 717,835 305,669 Total accounts receivable, net $ 2,771,513 $ 1,541,917 Provision for credit losses were $14,176 and $24,391 during the three and six months ended June 30, 2024, respectively. (Recovery) provision for credit losses were $(23,401) and $789 during the three and six months ended June 30, 2023, respectively. Movement of allowance: Movement of allowance for credit losses consisted of the following as of the date indicated: June 30, December 31, Beginning balance $ 669,974 $ 259,690 Addition 24,391 907,021 Recovery/write-off (11,001 ) (496,737 ) Ending balance $ 683,364 $ 669,974	Note 7 — Accounts receivable, net Accounts receivable consisted of the following as of the date indicated: As of As of Accounts receivable $ 1,906,222 $ 3,953,635 Accounts receivable - related parties 305,669 - Less: allowance for credit losses (669,974 ) (259,690 ) Total accounts receivable, net 1,541,917 3,693,945 Accounts receivable – non-current * — 138,613 Accounts receivable – current $ 1,541,917 $ 3,555,332 * On November 11, 2022, the Company had one contract with customer with installment payment terms of up to 16 months. The difference between the contract price and the Company’s cash selling price of the same products are recognized as interest income over the term of the payments. As of December 31, 2023 and 2022, the account receivable of this client was $0 and $462,114, of which account receivable -non-current was $0 Provision for credit losses were $907,021 and $322,395 for the years ended December 31, 2023 and 2022, respectively. Movement of allowance: Movement of allowance for credit losses consisted of the following as of the date indicated: December 31, December 31, Beginning balance $ 259,690 $ 15,898 Allowance from acquisition of Hydroman — 4,964 Addition 907,021 322,395 Write-off (496,737 ) (83,567 ) Ending balance $ 669,974 $ 259,690

Loans Receivable

Loans Receivable	6 Months Ended	12 Months Ended
Loans Receivable	Jun. 30, 2024	Dec. 31, 2023
Loans Receivable [Abstract]
Loans Receivable	Note 7 — Loans Receivable In September 2022, Visiontech and CGGP, LLC (“CGGP”), a customer who purchased industrial light fixtures, entered into three promissory note agreements with terms of six months. The total amount of the notes was $123,688. The notes bear interest thereon at the annual rate of 7% and requires monthly installment payments totaled $21,038. For the three and six months ended June 30, 2023, the Company paid $0 and $62,383, respectively. This loan has been paid off on March 17, 2023. In September 2022, Visiontech and NewCo Vision, LLC (“NewCo”), a customer who purchased industrial light fixtures, entered into three promissory note agreements with terms of six months. The total amount of the notes was $139,840. The notes bear interest thereon at the annual rate of 7% and requires monthly installment payments totaled $23,785. For the three and six months ended June 30, 2023, the Company paid $0 and $70,530, respectively. This loan has been paid off on March 17, 2023.	Note 8 — Loans Receivable Loans receivable consisted of the following as of the date indicated: As of As of Loan to CGGP, LLC $ — $ 62,383 Loan to NewCo Vision, LLC — 70,530 Total loan receivable $ — $ 132,913 In September 2022, Visiontech and CGGP, LLC (“CGGP”), a customer who purchased industrial light fixtures, entered into three promissory note agreements with terms of six months. The total amount of the notes was $123,688. The notes bear interest thereon at the annual rate of 7% and requires monthly installment payments totaled $21,038. As of December 31, 2022, the total outstanding amount due from CGGP was $62,383. This loan has been paid off on March 17, 2023. In September 2022, Visiontech and NewCo Vision, LLC (“NewCo”), a customer who purchased industrial light fixtures, entered into three promissory note agreements with terms of six months. The total amount of the notes was $139,840. The notes bear interest thereon at the annual rate of 7% and requires monthly installment payments totalled $23,785. As of December 31, 2022, the total outstanding amount due from NewCo was $70,530. This loan has been paid off on March 17, 2023.

Cost Method Investment

Cost Method Investment	6 Months Ended	12 Months Ended
Cost Method Investment	Jun. 30, 2024	Dec. 31, 2023
Cost Method Investment [Abstract]
Cost method investment	Note 8 — Cost method investment Cost method investment consist of the following: As of As of 10% Investment of Iluminar $ 1,000,000 $ 1,000,000 Total $ 1,000,000 $ 1,000,000 On April 11, 2023, one of the Company’s customers, Iluminar Lighting LLC (“Iluminar”) entered into Debt Conversion Agreement with the Company pursuant to which it will convert $1,000,000 of accounts receivable to 1,033,333 shares of Iluminar which is 10% of Iluminar’s outstanding shares. As of June 30, 2024, the shares were issued to the Company. No identified event or change in circumstances that would have a significant adverse effect on the value of investment and the Company determined no impairment was deemed necessary as of June 30, 2024.	Note 9 — Cost method investment Cost method investment consist of the following: As of As of 10% Investment of Iluminar $ 1,000,000 $ — Total $ 1,000,000 $ — On April 11, 2023, one of the Company’s customers, Iluminar Lighting LLC (“Iluminar”) entered into Debt Conversion Agreement with the Company pursuant to which it will convert $1,000,000 of accounts receivable to 1,033,333 shares of Iluminar which is 10% of Iluminar’s outstanding shares. As of December 31, 2023, the shares were issued to the Company. The Company reviewed financial condition and estimated fair value of Illuminar and determined no impairment was deemed necessary for the year ended December 31, 2023.

Property and Equipment, Net

Property and Equipment, Net	6 Months Ended	12 Months Ended
Property and Equipment, Net	Jun. 30, 2024	Dec. 31, 2023
Property and Equipment, Net [Abstract]
Property and equipment, net	Note 9 — Property and equipment, net Property and equipment, net consist of the following: As of As of Trucks & Automobiles $ 285,099 $ 285,099 Machinery & Equipment 67,847 67,847 Building 3,465,230 3,465,230 Land 930,000 930,000 Subtotal 4,748,176 4,748,176 Less: accumulated depreciation (421,624 ) (341,904 ) Total $ 4,326,552 $ 4,406,272 Depreciation expense during the three and six months ended June 30, 2024 amounted to $39,860 and $79,720, respectively. Depreciation expense during the three and six months ended June 30, 2023 amounted to $41,694 and $83,388, respectively.	Note 10 — Property and equipment, net Property and equipment, net consist of the following: As of As of Computers & Peripherals $ — $ 7,167 Trucks & Automobiles 285,099 293,599 Machinery & Equipment 67,847 84,085 Building 3,465,230 3,465,230 Land 930,000 930,000 Subtotal 4,748,176 4,780,081 Less: accumulated depreciation (341,904 ) (191,648 ) Total $ 4,406,272 $ 4,588,433 Depreciation expense for the years ended December 31, 2023 and 2022 amounted to $164,942 and $141,342, respectively. For the years ended on December 31, 2023 and 2022, the company recognized a loss of $17,219 and $0, respectively, in relation to the disposal of equipment at its carrying value.

Loans Payable

Loans Payable	6 Months Ended	12 Months Ended
Loans Payable	Jun. 30, 2024	Dec. 31, 2023
Loans Payable [Abstract]
Loans payable	Note 10 — Loans payable Short-term loans: Short-term loans consist of one account receivable factoring agreement, one subordinated business loan, three third parties loans as of June 30, 2024. Short-term loans consist of one account receivable factoring agreement and one individual loan as of December 31, 2023. On October 23, 2023, NMI, Visiontech and Hydroman (collectively “Merchants”) entered into a standard merchant cash advance agreement with Factor H. The Company sold $768,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $503,500 was remitted to the Company, after the deduction of the total fees of $26,500. The Company agreed to pay a weekly installment of $22,814.84 for 32 weeks with a final extra payment of $38,500. The effective interest rate of this agreement was 85.36%. For the three and six months ended June 30, 2024, the Company paid $227,493 and $409,443 principal of the loan. On May 2, 2024, the Merchants entered into another standard merchant cash advance agreement with Factor H. The Company sold $1,240,150 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $807,500 was remitted to the Company, after the deduction of the total fees of $42,500. The Company agreed to pay a weekly installment of $41,000 for 31 weeks. The effective interest rate of this agreement was 93.05%. The Company use this loan to pay off $175,315 previous loan with Factor H that dated on October 23, 2023. For the three and six months ended June 30, 2024, the Company paid $70,125 and $70,125 principal of the loan. These receivable purchase agreements were accounted for as secured borrowing under ASC 860 since there is no legal, actual, effective transfer of the receivables to the Factors. Rather, the Factors only have generally claim against the receivable pools not a particular receivable. As of June 30, 2024 and December 31, 2023, outstanding balance amounted to $737,375 and $409,443, respectively. On October 30, 2023, NMI entered into a loan agreement with an independent third party pursuant to which the Company borrowed a principal amount of $100,000 with an annual interest rate of 12% for a term of one year. The loan balance as of June 30, 2024 and December 31, 2023 was $100,000 and $100,000, respectively. On March 7, 2024, the Company’s subsidiary Nature’s Miracles entered into a loan agreement with Peng Zhang, a shareholder of the Company. The amount of the loan is $1,405,000 with 10% interest and is due on March 7, 2025. On February 10, March 28, June 5, June 27, September 22, December 22, 2023 and February 20, 2024, Lakeshore entered into seven promissory notes with RedOne Investment Limited (“Redone”) to which Lakeshore borrowed an aggregate principal amount of $380,000 with zero interest rate. On July 11, 2023, Lakeshore entered into a loan agreement with Deyin Chen (Bill) to which Lakeshore borrowed a principal amount of $125,000 with an annual interest rate of 8%. This loan was extended to March 11, 2024 with interest waived pursuant to a Side Letter to the loan agreements dated December 8, 2023. A payment of $75,000 was made upon close of the Merger on March 11, 2024 and the loan balance was $50,000 after the payment. On March 11, 2024, NMI, Redone and Deyin Chen (Bill) entered into agreement that $50,000 owed to Deyin Chen (Bill) will be assigned to Redone and the Company will assume the outstanding balance of the loan of $430,000, The loan shall bear interest of 8% per annum. $50,000 initially shall be paid by the Company no later than first month anniversary of March 11, 2024, further extended to May 31, 2024 and had been paid on July 29, 2024. Second payment of $150,000 shall be paid by September 11, 2024 and the last payment of $230,000 shall be paid by December 11, 2024, Interest expenses of approximately $5,695 and $7,595 was accrued during the three and six months ended June 30, 2024, respectively. On June 6, 2024, the Merchants entered into a subordinated business loan and security agreement with Agile Capital Funding, LLC and Agile Lending, LLC for the principal amount of $288,750, including the administrative agent fee of $13,750. The Company agreed to pay a weekly installment of $15,056 for 28 weeks. The effective interest rate of this agreement was 99.88%. The collateral consists of the Company’s right, title and interest in and to including the Company’s financial assets, goods, accounts, equipment, inventory, contract rights or rights to payment of money. The Company received the net proceeds on June 7, 2024. For the three and six months ended June 30, 2024, the Company paid $19,192 and $19,192 principal of the loan. The Company also make the following principal payments for the below loans for the period ended June 30, 2023: On August 31, 2022, the Merchants entered into a standard merchant cash advance agreement with Factor A. Merchants sells to Factor A $1,065,000 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor A remitted the net purchase price of $712,500 to Merchants, after deducting the total fees of $37,500. Merchants agreed to pay a weekly installment of $26,625 for 40 weeks to Factor A until Factor A received the total purchased amount of receipts. The effective interest rate of this agreement was 105.19%. During the three and six months ended June 30, 2023, the Company paid $181,461 and $326,233 principal of the loan, respectively. On September 1, 2022, Visiontech entered into a receivables purchase agreement with another Factor B. Visiontech sold to Factor B $458,500 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor B disbursed the net purchase price of $339,465 to Visiontech, after deducting the origination fees of $10,500. Visiontech agreed to pay a weekly installment of $8,817.31 for 52 weeks to Factor B until Factor B received the total purchased amount of receipts. The effective interest rate of this agreement was 55.79%. During the three and six months ended June 30, 2023, the Company paid $178,874 and $262,157 principal of the loan, respectively. On October 31, 2022, Hydroman entered into a receivables purchase agreement with Factor C. Hydroman sold to Factor C $675,000 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor C remitted the net purchase price of $485,000 to Hydroman, after the deduction of the origination fees of $15,000. Hydroman agreed to pay a weekly installment of $16,071 for 42 weeks to Factor C until Factor C receive the total purchased amount of receipts. The effective interest rate of this agreement was 106.56%. During the three and six months ended June 30, 2023, the Company paid $247,619 and $367,632 principal of the loan, respectively. On October 31, 2022, Visiontech entered into a future receivable sale and purchase agreement with a capital management institution D at a sale price of $100,000, after the deduction of the origination fees of $10,000. According to the agreement, the amount of receivables being sold was $149,000 with 20% purchased percentage and the estimated daily payment amount is $1,490 for 20 weeks. The effective interest rate of this agreement was 85.25%. During the three and six months ended June 30, 2023, the Company paid $0 and $68,868 principal of the loan, respectively. On November 2, 2022, Hydroman entered into a receivables purchase agreement with Factor E. Hydroman sold to Factor E $374,750 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor E remitted the net purchase price of $225,000 to Hydroman, after the deduction of the total closing costs of $25,000. Hydroman agreed to pay a weekly installment of $15,615 for 24 weeks to Factor E until Factor E receive the total purchased amount of receipts. The effective interest rate of this agreement was 84.67%. During the three and six months ended June 30, 2023, the Company paid $129,673 and $188,441 principal of the loan, respectively. On November 18, 2022, the “Merchants” entered into a standard merchant cash advance agreement with Factor F. The Company sold to Factor F $206,113 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor F remitted the net purchase price of $123,750 to the Company, after the deduction of the total fees of $13,750. The Company agreed to pay a weekly installment of no more than $8,588 for 24 weeks to Factor F until Factor F receive the total purchased amount of receipts. The effective interest rate of this agreement was 89.96%. During the three and six months ended June 30, 2023, the Company paid $75,112 and $110,977 principal of the loan, respectively. On November 18, 2022, the “Merchants” entered into a standard merchant cash advance agreement with Factor G. The Company sold to Factor G $206,113 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor G remitted the net purchase price of $123,750 to the Company, after the deduction of the total fees of $13,750. The Company agreed to pay a weekly installment of no more than $8,588 for 24 weeks to Factor G until Factor G receive the total purchased amount of receipts. The effective interest rate of this agreement was 89.96%. During the three and six months ended June 30, 2023, the Company paid $$69,112 and $110,977 principal of the loan, respectively. On September 21, 2022, Hydroman signed a commercial loan with WebBank for the principal amount of $100,000. This loan requires a weekly installment payment of $2,244.38 for 52 weeks. The effective interest rate of this loan was 31.22%. The Company paid off this loan on June 14, 2023. During the three and six months ended June 30, 2023, the Company paid $57,696 and $76,064 principal of the loan, respectively. On September 18, 2022, Hydroman and ClassicPlan Premium Financing, Inc., entered into a premium financing agreement with a total gross policy premium and related fees of $35,508 and financed $26,387 of it. Hydroman needs to pay a monthly installment of $3,065 for six months with the last installment due on May 19, 2023. The effective interest rate of this loan was 10.80%. The Company paid off this loan on May 16, 2023. During the three and six months ended June 30, 2023, the Company paid $11,965 and $14,922 principal of the loan, respectively. On February 13, 2023, Hydroman and First Insurance Funding entered into a premium financing agreement with a total gross policy premium and related fees of $4,812 and financed $4,461 of it. Hydroman needs to pay a monthly installment of $481 for ten months with the last installment due on December 13, 2023. The effective interest rate of this loan was 16.85%. The Company terminated the insurance policy and this loan on June 15, 2023. During the three and six months ended June 30, 2023, the Company paid $4,393 and $4,812 principal of the loan, respectively. Short-term loans — related parties: refer to Note 11 Related Party transactions. Interest expenses for short term loans amounted to $304,302 and $428,215 during the three and six months ended June 30, 2024, respectively. Interest expenses for short term loans amounted to $5,364 and $381,814 during the three and six months ended June 30, 2023, respectively. Long-term debts: Long-term debts consist of three auto loans, one building loan, and one secured business loan as of June 30, 2024 and December 31, 2023. The outstanding amount of the auto loans were $97,641 and $114,621 as of June 30, 2024 and December 31, 2023, respectively. On February 27, 2021, the Company purchased a vehicle for $68,802 and financed $55,202 of the purchase price through an auto loan. The loan requires monthly installment payment of $1,014 with the last installment due on February 28, 2026. On June 8, 2021, the Company purchased the second vehicle for $86,114 and financed $73,814 of the purchase price through auto loan. The loan requires monthly installment payment of $1,172 with the last installment due on June 23, 2027. On September 28, 2022, the Company purchased the third vehicle for $62,230 and financed $56,440 of the purchase price through auto loan. The loan requires a monthly installment payment of $1,107 with the last installment due on September 28, 2027. During the three and six months ended June 30, 2024, the Company made total payments of $8,541 and $16,980 towards the auto loans, respectively. During the three and six months ended June 30, 2023, the Company made total payments of $8,130 and $16,168 towards the auto loans, respectively. Minimum required principal payments towards the Company’s auto loans as of June 30, 2024 are as follows: Twelve months ended June 30, Repayment 2025 $ 35,240 2026 32,944 2027 26,172 Thereafter 3,285 Total $ 97,641 The outstanding amount of the building loan was $2,812,641 and $2,852,597 as of June 30, 2024 and December 31, 2023, respectively. On January 10, 2022, the Company purchased one building and land for $4,395,230 and financed $3,000,000 of the purchase price through Bank of the west. The loan requires monthly installment payment of $15,165 with the last installment due on January 10, 2032. During the three and six months ended June 30, 2024, the Company made total payments of $19,930 and $39,957 towards the loan, respectively. During the three and six months ended June 30, 2023, the Company made total payments of $19,218 and $38,831 towards the loan, respectively. Minimum required principal payments towards the Company’s building loan as of June 30, 2024 are as follows: Twelve months ended June 30, Repayment 2025 $ 82,374 2026 85,380 2027 88,495 Thereafter 2,556,392 Total $ 2,812,641 The outstanding amount of the secured business loan was $3,207,773 and $3,281,526 as of June 30, 2024 and December 31, 2023, respectively. On June 14, 2023, the Company’s subsidiaries Visiontech and Hydroman entered into a secured business loan agreement with Newtek Business Services Holdco 6, Inc. for a principal sum of up to $3,700,000 with a maturity date of July 1, 2033. The loan is secured by the Company’s building and guaranteed by the Company’s major stockholders. During the three and six months ended June 30, 2024, the Company made total payments of $37,629 and $73,752 towards the loan, respectively. During the three and six months ended June 30, 2023, the Company made total payments of $0 and $0 towards the loan, respectively. Minimum required principal payments towards the Company’s secured business loan as of June 30, 2024 are as follows: Twelve months ended June 30, Repayment 2025 $ 166,879 2026 196,507 2027 231,396 Thereafter 2,612,991 Total $ 3,207,773 Interest expenses for long term loans amounted to $159,385 and $320,304 during the three and six months ended June 30, 2024, respectively. Interest expenses for long term loans amounted to $28,870 and $56,594 during the three and six months ended June 30, 2023, respectively.	Note 11 — Loans payable Short-term loans: Short-term loans consist of one account receivable factoring agreement and one individual loan as of December 31, 2023. The Company paid off all other third party short-term loans by the Newtek Business loan (refer to Long-term loan) on June 14, 2023. The principal amount of short-term loans paid amounted to approximately $1.9 million resulting loss from debt extinguishment of approximately $0.2 million. Short-term loans consist of seven accounts receivable factoring agreements, one bank loan and an insurance premium financing loan as of December 31, 2022. On August 31, 2022, Nature’s Miracle, Visiontech and Hydroman (collectively “Merchants”) entered into a standard merchant cash advance agreement with Factor A. Merchants sells to Factor A $1,065,000 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor A remitted the net purchase price of $712,500 to Merchants, after deducting the total fees of $37,500. Merchants agreed to pay a weekly installment of $26,625 for 40 weeks to Factor A until Factor A received the total purchased amount of receipts. The effective interest rate of this agreement was 105.19%. On September 1, 2022, Visiontech entered into a receivables purchase agreement with another Factor B. Visiontech sold to Factor B $458,500 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor B disbursed the net purchase price of $339,465 to Visiontech, after deducting the origination fees of $10,500. Visiontech agreed to pay a weekly installment of $8,817.31 for 52 weeks to Factor B until Factor B received the total purchased amount of receipts. The effective interest rate of this agreement was 55.79%. On October 31, 2022, Hydroman entered into a receivables purchase agreement with Factor C. Hydroman sold to Factor C $675,000 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor C remitted the net purchase price of $485,000 to Hydroman, after the deduction of the origination fees of $15,000. Hydroman agreed to pay a weekly installment of $16,071 for 42 weeks to Factor C until Factor C receive the total purchased amount of receipts. The effective interest rate of this agreement was 106.56%. On October 31, 2022, Visiontech entered into a future receivable sale and purchase agreement with a capital management institution D at a sale price of $100,000, after the deduction of the origination fees of $10,000. According to the agreement, the amount of receivables being sold was $149,000 with 20% purchased percentage and the estimated daily payment amount is $1,490 for 20 weeks. The effective interest rate of this agreement was 85.25%. On November 2, 2022, Hydroman entered into a receivables purchase agreement with Factor E. Hydroman sold to Factor E $374,750 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor E remitted the net purchase price of $225,000 to Hydroman, after the deduction of the total closing costs of $25,000. Hydroman agreed to pay a weekly installment of $15,615 for 24 weeks to Factor E until Factor E receive the total purchased amount of receipts. The effective interest rate of this agreement was 84.67%. On November 18, 2022, the “Merchants” entered into a standard merchant cash advance agreement with Factor F. The Company sold to Factor F $206,113 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor F remitted the net purchase price of $123,750 to the Company, after the deduction of the total fees of $13,750. The Company agreed to pay a weekly installment of no more than $8,588 for 24 weeks to Factor F until Factor F receive the total purchased amount of receipts. The effective interest rate of this agreement was 89.96%. On November 18, 2022, the “Merchants” entered into a standard merchant cash advance agreement with Factor G. The Company sold to Factor G $206,113 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor G remitted the net purchase price of $123,750 to the Company, after the deduction of the total fees of $13,750. The Company agreed to pay a weekly installment of no more than $8,588 for 24 weeks to Factor G until Factor G receive the total purchased amount of receipts. The effective interest rate of this agreement was 89.96%. On October 23, 2023, the “Merchants” entered into a standard merchant cash advance agreement with Factor H. The Company sold $768,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $503,500 was remitted to the Company, after the deduction of the total fees of $26,500. The Company agreed to pay a weekly installment of $22,814.84 for 32 weeks with a final extra payment of $38,500. The effective interest rate of this agreement was 85.36%. These receivable purchase agreements were accounted for as secured borrowing under ASC 860 since there is no legal, actual, effective transfer of the receivables to the Factors. Rather, the Factors only have generally claim against the receivable pools not a particular receivable. The average dollar amount of the borrowings for the years ended December 31, 2023 and 2022 were $503,500 and $317,857. The weighted average effective interest rate for the years ended December 31, 2023 and 2022 were 85.36% and 92.64%. The Company paid off all third party short-term loans except the one with Factor H by the Newtek Business loan (refer to Long-term loan) on June 14, 2023. As of December 31, 2023 and 2022, outstanding balance amounted to $409,443 and $1,435,285. On September 21, 2022, Hydroman signed a commercial loan with WebBank for the principal amount of $100,000. This loan requires a weekly installment payment of $2,244.38 for 52 weeks. The effective interest rate of this loan was 31.22%. The bank loan balance as of December 31, 2023 and 2022 was $0 and $76,064, respectively. The Company paid off this loan on June 14, 2023. On September 18, 2022, Hydroman and ClassicPlan Premium Financing, Inc., entered into a premium financing agreement with a total gross policy premium and related fees of $35,508 and financed $26,387 of it. Hydroman needs to pay a monthly installment of $3,065 for six months with the last installment due on May 19, 2023. The effective interest rate of this loan was 10.80%. The outstanding amount of the premium financing loan was $0 and $14,922 as of December 31, 2023 and 2022, respectively. The Company paid off this loan on May 16, 2023. On February 13, 2023, Hydroman and First Insurance Funding entered into a premium financing agreement with a total gross policy premium and related fees of $4,812 and financed $4,461 of it. Hydroman needs to pay a monthly installment of $481 for ten months with the last installment due on December 13, 2023. The effective interest rate of this loan was 16.85%. The Company terminated the insurance policy and this loan on June 15, 2023. On October 30, 2023, Nature’s Miracle entered into a loan agreement with an independent third party pursuant to which the Company borrowed a principal amount of $100,000 with an annual interest rate of 12% for a term of one year. The loan balance as of December 31, 2023 was $100,000. Short-term loans — related parties: refer to Note 12 Related Party transactions. Interest expenses for short term loans amounted to $428,159 and $635,296 for the years ended December 31, 2023 and 2022, respectively, Long-term debts: Long-term debts consist of three auto loans, one building loan, and one secured business loan as of December 31, 2023. Long-term debts consist of three auto loans and one building loan as of December 31, 2022. The outstanding amount of the auto loans were $114,621 and $147,354 as of December 31, 2023 and 2022, respectively. On February 27, 2021, the Company purchased a vehicle for $68,802 and financed $55,202 of the purchase price through an auto loan. The loan requires monthly installment payment of $1,014 with the last installment due on February 28, 2026. On June 8, 2021, the Company purchased the second vehicle for $86,114 and financed $73,814 of the purchase price through auto loan. The loan requires monthly installment payment of $1,172 with the last installment due on June 23, 2027. On September 28, 2022, the Company purchased the third vehicle for $62,230 and financed $56,440 of the purchase price through auto loan. The loan requires a monthly installment payment of $1,107 with the last installment due on September 28, 2027. During the year ended December 31, 2023 and 2022, the Company made total payments of $32,733 and $24,333 towards the auto loans, respectively. Minimum required principal payments towards the Company’s auto loans as of December 31, 2023 are as follows: Twelve months ended December 31, Repayment 2024 $ 34,383 2025 36,120 2026 27,656 2027 16,462 Total $ 114,621 The outstanding amount of the building loan was $2,852,597 and $2,930,674 as of December 31, 2023 and 2022, respectively. On January 10, 2022, the Company purchased one building and land for $4,395,230 and financed $3,000,000 of the purchase price through Bank of the west. The loan requires monthly installment payment of $15,165 with the last installment due on January 10, 2032. During the year ended December 31, 2023 and 2022, the Company made total payments of $78,077 and $69,326 towards the loan, respectively. Minimum required principal payments towards the Company’s building loan as of December 31, 2023 are as follows: Twelve months ended December 31, Repayment 2024 $ 80,638 2025 83,868 2026 86,928 2027 90,100 Thereafter 2,511,063 Total $ 2,852,597 The outstanding amount of the secured business loan was $3,281,526 and $0 as of December 31, 2023 and 2022, respectively. On June 14, 2023, the Company’s subsidiaries Visiontech and Hydroman entered into a secured business loan agreement with Newtek Business Services Holdco 6, Inc. for a principal sum of up to $3,700,000 with a maturity date of July 1, 2033. The loan is secured by the Company’s building and guaranteed by the Company’s major stockholders. During the year ended of December 31, 2023, net proceed to the Company amounted to approximately $3,300,000 with approximately $360,000 of debt issuance cost. The company paid off $822,610 third party short-term loans. Minimum required principal payments towards the Company’s secured business loan as of December 31, 2023 are as follows: Twelve months ended December 31, Repayment 2024 $ 153,784 2025 181,088 2026 213,239 2027 251,099 Thereafter 2,482,316 Total $ 3,281,526 Interest expenses for long term loans amounted to $406,442 and $102,854 for the years ended December 31, 2023 and 2022, respectively.

Related Party Transactions

Related Party Transactions	6 Months Ended	12 Months Ended
Related Party Transactions	Jun. 30, 2024	Dec. 31, 2023
Related Party Transactions [Abstract]
Related party transactions	Note 11 — Related party transactions Purchases and accounts payable – related parties: UniNet Global Inc., a vendor whose stockholder is Zhiyi (Jonathan) Zhang who is also one of the stockholders and management of the Company, sold certain products to Visiontech. As of June 30, 2024 and December 31, 2023, the outstanding accounts payable amount due to UniNet Global Inc. was $2,713,074 and $2,758,074, respectively. From 2022 to April 2023, Jinlong (David) Du, the CEO of Megaphoton, was also the Director of NMI and will serve as Director of the Company following the Merger with Lakeshore. On April 17, 2023, Jinlong Du resigned from his position as a member of the NMI’s board of director and will not serve as the Company’s director post merger. During the three and six months ended June 30, 2023, the purchases Visiontech made from Megaphoton was $137,974 and $230,390. During the three and six months ended June 30, 2023, the purchases Hydroman made from Megaphoton was $0 and $0. Hydroman and Megaphoton ended the exclusive supplier agreement on May 4, 2023. On April 11, 2023, one of the Company’s customers and vendors, Iluminar Lighting LLC (“Iluminar”) entered into Debt Conversion Agreement with the Company pursuant to which it will convert $1,000,000 of accounts receivable to 1,033,333 shares of Iluminar which is 10% of Iluminar’s outstanding shares. During the three and six months ended June 30, 2024, the purchases made from Iluminar was $1,160 and $1,160, respectively. During the three and six months ended June 30, 2023, the purchases made from Iluminar was $0 and $0, respectively. Revenue and accounts receivable - related party: During the three and six months ended June 30, 2024, the sales revenue from Iluminar was $588,720 and $994,098, respectively. During the three and six months ended June 30, 2023, the sales revenue from Iluminar was $25,097 and $25,097, respectively. As of June 30, 2024 and December 31, 2023, the account receivable from Iluminar was $717,835 and $305,669, respectively. Other payables — related parties For the year ended December 31, 2022, Nature’s Miracle Inc. (Cayman) (“NMCayman”), former stockholders of NMI, currently under common control of Mr. Tie (James) Li, the Company’s CEO, paid a total amount of $345,000 of legal and audit fee for the Company. As of June 30, 2024 and December 31, 2023, the outstanding amount due to NMCayman was $170,000 and $170,000, respectively. For the year ended December 31, 2021, Yang Wei, former shareholder of the Visiontech and current shareholder of the Company, paid a total amount of $23,813 of normal business operating fee for the Company. As of June 30, 2024 and December 31, 2023, the outstanding amount due to Yang Wei was $23,813 and $23,813, respectively. For the year ended December 31, 2022, Zhiyi (Jonathan) Zhang, paid a total amount of $27,944 of normal business operating fee for the Company. On May 19, 2023 and September 4, 2023, Zhiyi (Jonathan) Zhang paid another $1,000 and $557 for normal business operating expenses, respectively. On October 11, 2023, the Company paid off $28,501 of the balance. As of June 30, 2024 and December 31, 2023, the outstanding amount due to Zhiyi (Jonathan) Zhang was $1,000 and $1,000. As of June 30, 2024 and December 31, 2023, accrued interest expense from related parties, were $97,344 and $63,141, respectively, which were included in other payable related parties on the Company’s balance sheets. (see Short-term loans — related parties for detail). Loan receivable — related parties: As of As of December 31, Loan to Lakeshore Acquisition II Corp. $ - $ 460,000 Total loan receivable – related parties $ - $ 460,000 On June 8, 2023, the Company and Lakeshore entered into a promissory note for the principal amount of $40,000 with zero interest rate. On July 7, 2023, August 10, 2023, September 11, 2023, October 11, 2023 and November 9, 2023, NMI and Lakeshore entered into five promissory notes for the principal amount of $80,000 each with zero interest rate. On December 7, 2023, January 8, 2024, and February 6, 2024, NMI and Lakeshore entered into three promissory notes pursuant to which Lakeshore borrowed the principal amount of $20,000 each with zero interest rate. As a result of the Merger, all loans to Lakeshore had been consolidated and eliminated on the Company’s unaudited condensed consolidated balance sheets. Interest income for loan receivable – related parties amounted to $0 and $0 during the three and six months ended June 30, 2024, respectively. Interest income for loan receivable – related parties amounted to $2,052 and $2,425 during the three and six months ended June 30, 2023, respectively. Short-term loans — related parties On November 29, 2022, Visiontech signed a loan with Zhiyi (Jonathan) Zhang, one of the stockholders of the Company, for the principal amount of $100,000 with 8% interest rate. This loan is originally required to be paid in full before May 29, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024 and subsequently further extended to August 15, 2024. During the year ended December 31, 2023, the Company paid $40,000 to Zhiyi Zhang. The loan balance as of June 30, 2024 and December 31, 2023 was $60,000 and $60,000. As of June 30, 2024 and December 31, 2023, the accrued interest of this loan was $9,619 and $7,186, respectively. In December 2022, the Company signed two loans with Tie (James) Li, the Company’s CEO, for the total principal amount of $610,000 with 8% interest rate. This loan is originally required to be paid in full before June 1, 2023, the Company initially extended it to November 15, 2023. The Company made $500,000 payments towards the loan on June 16, 2023. The $110,000 loan was further extended to February 15, 2024 and subsequently extended to August 15, 2024. The loan balance as of June 30, 2024 and December 31, 2023 was $110,000 and $110,000, respectively. The accrued interest of $110,000 loan as of June 30, 2024 and December 31, 2023 was $13,200 and $8,800, respectively. On July 11, 2023, Lakeshore signed one loan with Tie (James) Li for a principal amount of $125,000 with 8% interest rate. This loan was required to be paid in full before November 11, 2023. On December 8, 2023, Lakeshore entered into a side letter to this loan agreement to extend the repayment to March 11, 2024 and agree to waive any and all interest and penalties that may have accrued commencing on November 11, 2023. This loan was subsequently extended to September 15, 2024. As of June 30, 2024, accrued interest of this loan was $3,041. On January 17, 2023, the Company and NMCayman, one of the stockholders of the Company, entered into a loan agreement for the principal amount of $318,270 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, and subsequently extended to August 15, 2024. As of June 30, 2024 and December 31, 2023, accrued interest of this loan was $37,099 and $24,276. On January 17, 2023, the Company and NMCayman entered into a loan agreement for the principal amount of $294,985 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, and subsequently extended to August 15, 2024. As of June 30, 2024 and December 31, 2023, the accrued interest of this loan was $34,385 and $22,500. On April 1, 2023, NMI and NMCayman entered into a loan agreement for the principal amount of $160,000 with 8% interest rate. This loan had been paid in full on June 13, 2023. Interest expense for short-term loan - related parties amounted to $18,147 and $34,203 during the three and six months ended March 31, 2024, respectively. Interest expense for short-term loan - related parties amounted to $6,164 and $26,033 during the three and six months ended March 31, 2023, respectively.	Note 12 — Related party transactions UniNet Global Inc., a vendor whose stockholder is Zhiyi (Jonathan) Zhang who is also one of the stockholders and management of the Company, sold certain products to Visiontech. As of December 31, 2023 and 2022, the outstanding accounts payable amount due to UniNet Global Inc. was $2,758,074 and $3,235,546, respectively. From 2022 to April 2023, Jinlong (David) Du, the CEO of Megaphoton, was also the Director of the Company and will serve as Director of Nature’s Miracle following the Merger with Lakeshore. On April 17, 2023, Jinlong Du resigned from his position as a member of the Nature’s Miracle’s board of director and will not serve as Nature’s Miracle’s Holding Inc.’s director post merger. For the four months ended April 30, 2023 and for the year ended December 31, 2022, the purchases Visiontech made from Megaphoton was $92,416 and $3,332,739. As of December 31, 2022, the outstanding accounts payable amount due to Megaphoton was $1,151,534. For the four months ended April 30, 2023 and for the year ended December 31, 2022, the net purchases Hydroman made from Megaphoton were $0 and $3,997,810. As of December 31, 2022, the outstanding accounts payable amount due to Megaphoton was 5,218,444. On May 4, 2020, Hydroman entered into a Statement of Work with Megaphoton for Megaphoton to become its exclusive supplier of agricultural equipment. As part of the contract, Hydroman paid Megaphoton $500,000 of security deposit in 2020. The deposit was directly applied to purchase during February 2022. As of December 31, 2022, security deposit to Megaphoton from Hydroman was $0. Hydroman and Megaphoton ended the exclusive supplier agreement on May 4, 2023. On April 11, 2023, one of the Company’s customers, Iluminar Lighting LLC (“Iluminar”) entered into Debt Conversion Agreement with the Company pursuant to which it will convert $1,000,000 of accounts receivable to 1,033,333 shares of Iluminar which is 10% of Iluminar’s outstanding shares. As of December 31, 2023, the shares were issued to the Company. For year ended December 31, 2023, the sales revenue from Iluminar was $300,053 and the purchase from Iluminar was $56,671. As of December 31, 2023, the account receivable from Iluminar was $305,669. Prepayments — related party On September 30, 2020, Visiontech paid a total amount of $13,304 to Varto Levon Doudakian, one of the stockholders of the Company, for normal business operating expenses. On December 29, 2023, Visiontech and Varto Levon Doudakian entered into an agreement to offset his bonus payable due in 2023 with $13,304 prepayments to Varto Levon Doudakian. As of December 31, 2023 and 2022, the outstanding amount of prepayments to Varto Levon Doudakian was $0 and $13,304, respectively. Other payables — related parties For the year ended December 31, 2022, Nature’s Miracle Inc. (Cayman), one of the stockholders of the Company, paid a total amount of $345,000 of legal and audit fee for the Company. As of December 31, 2023 and 2022, the outstanding amount due to Nature’s Miracle Inc. (Cayman) was $170,000 and $170,000, respectively. For the year ended December 31, 2021, Yang Wei, one of the stockholders of the Visiontech, paid a total amount of $23,813 of normal business operating fee for the Company. As of December 31, 2023 and 2022, the outstanding amount due to Yang Wei was $23,813 and $23,813, respectively. For the year ended December 31, 2022, Zhiyi Zhang, one of the stockholders of the Visiontech, paid a total amount of $27,944 of normal business operating fee for the Company. On May 19, 2023 and September 4, 2023, Zhiyi Zhang paid another $1,000 and $557 for normal business operating expenses, respectively. On October 11, 2023, the Company paid off $28,501 of the balance. As of December 31, 2023 and 2022, the outstanding amount due to Zhiyi Zhang was $1,000 and $27,944. As of December 31, 2023 and 2022, accrued interest expense from related parties, were $63,141 and $4,317, respectively, which were included in other payable related parties on the Company’s balance sheets. (see Short-term loans — related parties for detail). Loan receivable — related parties consisted of the following as of the date indicated: December 31, December 31, Loan to Lakeshore Acquisition II Corp. $ 460,000 $ — Loan to Doudakian, Varto Levon* - — Total loan receivable – related parties $ 460,000 $ — * During 2023, Visiontech and Varto Levon Doudakian, one of the stockholders of the Company, entered into five loan agreements for total principal amount of $110,000 with 8% interest rate. On December 29, 2023, Visiontech and Varto Levon Doudakian entered into an agreement to offset bonus due to Varto Levon Doudakian with this loan and accrued interest. As of December 31, 2023, loan to Varto Levon Doudakian is $0. On June 8, 2023, the Company and Lakeshore entered into a promissory note for the principal amount of $40,000 with zero interest rate. This loan is due on demand. On July 7, 2023, August 10, 2023, September 11, 2023, Nature’s Miracle and Lakeshore entered into three promissory notes for the principal amount of $80,000 each with zero interest rate. All loans are due on demand. On October 11, 2023 and November 9, 2023, Nature’s Miracle and Lakeshore entered into two promissory notes pursuant to which Lakeshore borrowed a principal amount of $80,000 each with zero interest rate. Both loans are due on demand. On December 7, 2023, Nature’s Miracle and Lakeshore entered into a promissory note pursuant to which Lakeshore borrowed a principal amount of $20,000 with zero interest rate. This loan is due on demand. Interest income for loan receivable – related parties amounted to $6,861 and $0 for the years ended December 31, 2023 and 2022. Short-term loans — related parties On November 29, 2022, Visiontech signed a loan with Zhiyi Zhang, the stockholder of the Company, for the principal amount of $100,000 with 8% interest rate. This loan is originally required to be paid in full before May 29, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024 and subsequently further extended to August 15, 2024. The loan balance as of December 31, 2023 and 2022 was $60,000 and $100,000. During the year ended December 31, 2023, the Company paid $40,000 to Zhiyi Zhang. As of December 31, 2023 and 2022, the accrued interest of this loan was $7,186 and $723, respectively. In December 2022, the Company signed two loans with Tie Li, the stockholder of the Company, for the total principal amount of $610,000 with 8% interest rate. This loan is originally required to be paid in full before June 1, 2023, the Company initially extended it to November 15, 2023. During the nine months ended September 30, 2023, the Company made $500,000 payments towards the loan. The $110,000 loan was further extended to February 15, 2024 and subsequently extended to August 15, 2024. The loan balance as of December 31, 2023 and 2022 was $110,000 and $610,000, respectively. The accrued interest of $110,000 loan as of December 31, 2023 and 2022 was $8,800 and $3,594, respectively. On January 17, 2023, the Company and Nature’s Miracle Inc. (Cayman), one of the stockholders of the Company, entered into a loan agreement for the principal amount of $318,270 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, and subsequently extended to August 15, 2024. As of December 31, 2023, accrued interest of this loan was $24,276. On January 17, 2023, the Company and Nature’s Miracle Inc. (Cayman), one of the stockholders of the Company, entered into a loan agreement for the principal amount of $294,985 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, and subsequently extended to August 15, 2024. As of December 31, 2023, the accrued interest of this loan was $22,500. On April 1, 2023, Nature’s Miracle and Nature’s Miracle Inc. (Cayman), one of the stockholders of the Company, entered into a loan agreement for the principal amount of $160,000 with 8% interest rate. This loan had been paid in full on June 13, 2023. Interest expense for short-term loan - related parties amounted to $80,381 and $4,317 for the years ended December 31, 2023 and 2022.

Income Taxes

Income Taxes	6 Months Ended	12 Months Ended
Income Taxes	Jun. 30, 2024	Dec. 31, 2023
Income Taxes [Abstract]
Income taxes	Note 12 — Income taxes As of June 30, 2024 and December 31, 2023, the Company’s deferred tax asset had a full valuation allowance recorded against it. The effective tax rate for the three and six months ended June 30, 2024 were 0.0% and (0.1)%, respectively. The effective tax rate for the three and six months ended June 30, 2023 were 25.5% and 19.2%, respectively. The effective tax rate differs from the federal and state statutory tax rate of 21.0% primarily due to the valuation allowance on the deferred tax assets.	Note 13 — Income taxes The provision for income taxes for the years ended December 31, 2023 and 2022 consisted of the following: December 31, December 31, Income Tax Expense Current federal tax expense Federal $ - $ 53,687 State 2,421 22,600 Deferred tax Federal 162,048 (108,612 ) State 53,889 (36,119 ) Total $ 218,358 $ (68,444 ) The Company is subject to U.S. federal income tax as well as income tax of state tax jurisdictions. The following is a reconciliation of income tax expenses at the effective rate to income tax at the calculated statutory rates: December 31, December 31, Statutory tax rate Federal 21.00 % 21.00 % State of California 6.81 % 6.98 % Permanent difference (4.19 )% — % Change in valuation allowance (26.69 )% (25.27 )% Effective tax rate (3.07 )% 2.71 % As of December 31, 2023 and 2022 the income tax payable was $299,018 and $833,044, respectively, and the net deferred tax asset was $0 The significant components that comprised the Company’s net deferred taxes are as follows: As of As of Deferred tax assets/(liabilities) Property, plant and equipment (70,758 ) (70,759 ) Right of use asset 17,283 10,631 Allowance for credit loss 327,557 73,740 Inventory impairment 355,243 - Net operating loss – federal 1,243,813 681,949 Less: valuation allowance (1,873,138 ) (479,624 ) Total deferred tax assets/(liabilities) - 215,937 The Company’s cumulative net operating loss (“NOL”) of approximately $6.8 million as of December 31, 2023 was mainly from NOL of Nature’s Miracle and Hydroman. The Company evaluated the recoverable amounts of deferred tax assets and provided a valuation allowance to the extent that future taxable profits will be available against which the net operating loss and temporary difference can be utilized. The Company considers both positive and negative factors when assessing the future realization of the deferred tax assets and applied weigh to the relative impact of the evidence to the extent it could be objectively verified.

Equity

Equity	6 Months Ended	12 Months Ended
Equity	Jun. 30, 2024	Dec. 31, 2023
Equity [Abstract]
Equity	Note 13 — Equity The total number of shares which the Company shall have the authority to issue is one hundred and ten million (110,000,000) shares of two classes of capital stock to be designated respectively preferred stock (“Preferred Stock”) and common stock (“Common Stock”). The total number of shares of Common Stock the Corporation shall have authority to issue is 100,000,000 shares, par value $0.0001 per share. The total number of shares of Preferred Stock the Corporation shall have authority to issue is 10,000,000 shares, par value $0.0001 per share. The Preferred Stock authorized by this Certificate of Incorporation may be issued in series. As a result of the Merger as described in note 1, all share and per share data has been retroactively restated to reflect the current capital structure of the Company. Shares issued in connection with the Company’s Merger on March 11, 2024: Common Lakeshore’s shares outstanding prior to reverse recapitalization 2,241,500 Shares issued to private rights 35,150 Conversion of the Lakeshore’s public shares and rights 790,097 Shares issued to service providers 801,539 Bonus shares issued to in connection with Lakeshore loans * 66,000 Bonus shares issued to in connection with NMI loans * 100,000 Conversion of NMI’s shares into the Company’s ordinary shares 22,272,478 Total shares outstanding 26,306,764 * In connection with the Merger, the Company, Lakeshore and NMI further entered into a Letter Agreement on November 15, 2023, a total of 125,000 shares of the Company’s common stock will be issued upon closing of the Merger in connection with certain transactions relating to the Merger: (i) 50,000 shares to Tie (James) Li and 50,000 shares to Zhiyi (Jonathan) Zhang (or 100,000 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of NMI with the principal amount of $3,700,000; (ii) 12,500 shares to Tie (James) Li and 12,500 shares to Deyin (Bill) Chen (or 25,000 shares in the aggregate) in connection with their loans to Lakeshore, each with the principal amount of $125,000 under separate but similar loan agreements); At the Close of Merger, additional shares of 16,000 and 25,000 were issued to Tie (James) Li and Prosperity Spring International Investment Management in connection with their loans to Lakeshore. The shares were valued $10 per share, of which $1.0 million (100,000 shares awarded pertaining to loan guarantee for the Newtek loan) was expensed as finance expense in the Company unaudited condensed consolidated statements of operations during the three and six months ended June 30, 2024. $660,000 was expensed in Lakeshore’s statements of operations and carried over as retained deficit after the Merger. The shares in connection with the loans have been issued during the close of the Merger. 2024 Incentive Plan In connection with the Merger, the Company adopted the Equity Incentive Plan (the “2024 Incentive Plan”). The 2024 Incentive Plan will provide for grants of stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or equity-related cash-based awards. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing consulting or advisory services for the Company, will be eligible for grants under the 2024 Incentive Plan. The 2024 Incentive Plan provides for the future issuance of shares of the Company’s Common Stock, representing 10% of the number of shares of the Company’s Common Stock outstanding following the Business Combination (after giving effect to the Redemption). The 2024 Incentive Plan also provides for an annual increase on January 1 for each of the first ten (10) calendar years during the term of the 2024 Incentive Plan by the lesser of (a) Five percent (5%) of all classes of the Company’s common stock outstanding on each December 31 immediately prior to the date of increase or (b) such number of Shares determined by the Board. Shares award to Mr. Hausman and Mr. Carpenter per Letter Agreement stated above has a fair value of $1.1 million and were expensed as compensation expenses according to vesting terms. Pursuant to board resolution dated March 24, 2024, certain key employees were approved for stock incentives including George Yutuc (Chief Financial Officer), Kirk Collins (Director of Sales), and Amber Wang (Controller). Each can receive shares that vest over time of 100,000, 50,000 and 50,000 shares, respectively. Each of these employees have signed an employment agreement that reflects such shares and unique vesting schedules. The fair value of the shares to be issued was approximately $178,000 at $0.89 per share. On April 2, 2024, the Company entered into an investor relations consulting agreement with MZHCI LLC (“MZHCI”) pursuant to which MZHCI will provide investor relations services to the company and the agreement has a term of six months. The Company will pay $14,000 cash per month and to issue MZHCI 150,000 shares of restricted common stock, 75,000 shares will be vested immediately upon signing the agreement and 75,000 shares will vest on October 1, 2024. The fair value of the shares to be issued was approximately $143,000 at $0.95 per share. The 150,000 shares were issued on May 7, 2024. For the three and six months ended June 30, 2024, the Company recorded stock compensation expenses of $195,908 and $367,805, respectively. Those stock compensation expenses are included in the Company’s operating expenses. Warrants In connection with the reverse recapitalization, the Company has assumed 3,625,750 warrants outstanding, which consisted of 3,450,000 public warrants and 175,750 private warrants. Both of the public warrants and private warrant met the criteria for equity classification. Each whole warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as described below, commencing 30 days after the completion of its initial business combination, and expiring five years from after the completion of an initial business combination. No fractional warrant will be issued and only whole warrants will trade. The Company may redeem the warrants at a price of $0.01 per warrant upon 30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $18.00 (as adjusted for share sub-divisions, share dividends, reorganizations and recapitalizations) per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given, provided there is an effective registration statement and current prospectus in effect with respect to the ordinary shares underlying such warrants during the 30 day redemption period. If the Company redeems the warrants as described above, management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” If a registration statement is not effective within 90 days following the consummation of a business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their warrants on a cashless basis and in no event (whether in the case of a registration statement being effective or otherwise) will the Company be required to net cash settle the warrant exercise. If an initial business combination is not consummated, the warrants will expire and will be worthless. In addition, if (a) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at a newly issued price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our initial shareholders or their affiliates, without taking into account any founders’ shares held by the Company’s initial shareholders or such affiliates, as applicable, prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the Company’s initial business combination (net of redemptions), and (c) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business combination is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the market value and the newly issued price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the market value and the newly issued price.	Note 14 — Equity The total number of shares which the Company shall have the authority to issue is one hundred and ten million (110,000,000) shares of two classes of capital stock to be designated respectively preferred stock (“Preferred Stock”) and common stock (“Common Stock”). The total number of shares of Common Stock the Corporation shall have authority to issue is 100,000,000 shares, par value $0.0001 per share. The total number of shares of Preferred Stock the Corporation shall have authority to issue is 10,000,000 shares, par value $0.0001 per share. The Preferred Stock authorized by this Certificate of Incorporation may be issued in series. As a result of the Merger as described in note 1, all share and per share data has been retroactively restated to reflect the current capital structure of the Company. On April 15, 2022, Nature’s Miracle entered into a Subscription Agreement with Nature’s Miracle Incorporated, a company incorporated in Cayman. Pursuant to the Subscription Agreement, the company issued 6,904,468 shares of its common stock, raising net proceeds of $394,000. On June 1, 2022, Nature’s Miracle entered into share exchange agreements with Visiontech, Hydroman and their owners. Pursuant to Visiontech Share Exchange Agreement, the Company agreed to issue 8,908,991 shares of common stock to Visiontech owners in exchange for 100% of the equity interest of Visiontech. Pursuant to Hydroman Share Exchange Agreement, the Company agreed to issue 6,459,019 shares of common stock to Hydroman owners in exchange for 100% of the equity interest of Hydroman. The Company, Lakeshore and Nature’s Miracle further entered into a Letter Agreement on November 15, 2023, a total of 235,000 shares of the Company’s common stock will be issued upon closing of the Merger in connection with certain transactions relating to the Merger and Nature’s Miracle’s employment agreements: (i) 50,000 shares to Tie (James) Li and 50,000 shares to Zhiyi, Zhang (or 100,000 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of Natures Miracle with the principal amount of $3,700,000; (ii) 12,500 shares to Tie (James) Li and 12,500 shares to Deyin (Bill) Chen (or 25,000 shares in the aggregate) in connection with their loans to Lakeshore, each with the principal amount of $125,000 under separate but similar loan agreements); (iii) 10,000 shares to Charles Jourdan Hausman in connection with his appointment as a board member with Nature’s Miracle and (iv) 100,000 shares to Darin Carpenter in connection with an employment agreement with Nature’s Miracle. The shares were valued at approximately $2.35 million and will be expensed in the Company’s statements of operations after consummation of the Merger in accordance with the service period. 2024 Incentive Plan In connection with the Merger, the Company adopted the Equity Incentive Plan (the “2024 Incentive Plan”). The 2024 Incentive Plan will provide for grants of stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or equity-related cash-based awards. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing consulting or advisory services for the Company, will be eligible for grants under the 2024 Incentive Plan. The 2024 Incentive Plan provides for the future issuance of shares of the Company’s Common Stock, representing 10% of the number of shares of the Company’s Common Stock outstanding following the Business Combination (after giving effect to the Redemption). The 2024 Incentive Plan also provides for an annual increase on January 1 for each of the first ten (10) calendar years during the term of the 2024 Incentive Plan by the lesser of (a) Five percent (5%) of all classes of the Company’s common stock outstanding on each December 31 immediately prior to the date of increase or (b) such number of Shares determined by the Board. Pursuant to board resolution dated August 23, 2023, the Company is to grant a one-time award of 10,000 shares of common stock of the company to Charles Hausman, a Director of the Company; a one-time award of 50,000 shares of the company to Tie “James” Li and a one-time award of 50,000 shares of the company to Zhiyi Zhang, both executives of the Company. The above awards are vested immediately upon consummation of the business combination with Lakeshore. Pursuant to board resolution dated September 20, 2023, the Company approved a stock grant to Mr. Darin Carpenter, Chief Operating Officer of the Company, pursuant to which Mr. Carpenter will be issued 100,000 shares of the Company’s common stock over a two-year service period upon consummation of the business combination Lakeshore. As of December 31, 2023, no shares have been issued under the plan.

Concentration of Risk

Concentration of Risk	6 Months Ended	12 Months Ended
Concentration of Risk	Jun. 30, 2024	Dec. 31, 2023
Concentration of Risk [Abstract]
Concentration of risk	Note 14 — Concentration of risk Credit risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. As of June 30, 2024 and December 31, 2023, $28,725 and $219,553, respectively, were deposited with various major financial institutions in the United States. Accounts receivable is typically unsecured and derived from revenue earned from customers, thereby exposing the Company to credit risk. The risk is mitigated by the Company’s assessment of its customers’ creditworthiness and its ongoing monitoring of outstanding balances. The Company maintains reserves for estimated credit losses, and such losses have generally been within expectations. Customer and vendor concentration risk During the three and six months ended June 30, 2024 and during the three and six months ended June 30, 2023, the major customers of the Company are as below. Iluminar is a related party of the Company since April 11, 2023, as disclosed in Note 11— Related party transactions. For the For the As of Percentage of Percentage of Percentage of Customer A 39 % 24 % 49 % Customer C 15 % 11 % 15 % Iluminar 17 % 18 % 26 % For the For the As of Percentage of Percentage of Percentage of Customer C <10 % 15 % 13 % Customer G <10 % <10 % 31 % Customer H <10 % <10 % 12 % Customer I <10 % <10 % 10 % Iluminar <10 % <10 % 18 % Customer E <10 % 16 % <10 % Customer F 20 % <10 % <10 % During the three and six months ended June 30, 2024 and during the three and six months ended June 30, 2023, the major vendors of the Company are as below. Both Megaphoton and Uninet Global Inc. are related parties of the Company (Megaphoton is no longer a related party of the Company after April 2023), as disclosed in Note 11— Related party transactions, and all purchases from Uninet Global Inc. are products originally manufactured by Megaphoton Inc. For the For the As of Percentage of Percentage of Percentage of Megaphoton Inc. <10 % <10 % 53 % Uninet Global Inc. <10 % <10 % 23 % Vendor A 29 % 48 % <10 % Vendor E 57 % 38 % 11 % For the For the As of Percentage of Percentage of Percentage of Megaphoton 15 % 14 % 62 % Uninet Global Inc. <10 % <10 % 20 % Vendor A 68 % 55 % <10 % Vendor D <10 % 14 % <10 %	Note 15 — Concentration of risk Credit risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. As of December 31, 2023 and 2022, $219,553 and $629,355, respectively, were deposited with various major financial institutions in the United States. Accounts receivable is typically unsecured and derived from revenue earned from customers, thereby exposing the Company to credit risk. The risk is mitigated by the Company’s assessment of its customers’ creditworthiness and its ongoing monitoring of outstanding balances. The Company maintains reserves for estimated credit losses, and such losses have generally been within expectations. Customer and vendor concentration risk During the year ended December 31, 2023 and 2022, the major customers of the Company are as below. Iluminar is a related party of the Company since April 11, 2023, as disclosed in Note 12 — Related party transactions. For the As of Percentage of Percentage of Customer C 13% 13 Customer G <10% 31 Customer H <10% 12 Customer I <10% 10% Iluminar <10% 18 For the As of Percentage of Percentage of Iluminar <10% 39 Customer B <10% 12 Customer C <10% 12 Customer D <10% 11% Customer E 17% <10% Customer F 15 <10% During the year ended December 31, 2023 and 2022, the major vendors of the Company are as below. Both Megaphoton and Uninet Global Inc. are related parties of the Company (Megaphoton is no longer a related party of the Company after April 2023), as disclosed in Note 12 — Related party transactions, and all purchases from Uninet Global Inc. are products originally manufactured by Megaphoton Inc. For the As of Percentage of Percentage of Vendor A 52% <10% Vendor B 25% <10% Megaphoton Inc. <10% 62% Uninet Global Inc. <10% 20 For the As of Percentage of Percentage of Megaphoton 49 53 % Uninet Global Inc. <10% 27 Vendor A 20 14

Lease

Lease	6 Months Ended	12 Months Ended
Lease	Jun. 30, 2024	Dec. 31, 2023
Lease [Abstract]
Lease	Note 15 — Lease The Company follows ASC 842 Leases. The Company has entered into lease agreements for vehicle, offices and warehouses space in California, Pennsylvania and Texas. $578,179 and $503,089 of operating lease right-of-use assets and $644,458 and $517,356 of operating lease liabilities were reflected on the June 30, 2024 and December 31, 2023 financial statements, respectively. On January 28, 2021, Hydroman entered into a lease agreement of the warehouse in Texas. The lease term was from February 1, 2021 to February 29, 2024 and the month from February 1, 2021 to February 28, 2021 was free of charge. The lease payments are $6,750 per month for the period commencing March 1, 2021 and ending February 28, 2022, $6,920 per month for the period commencing March 1, 2022 and ending February 28, 2023, $7,100 per month for the period commencing March 1, 2023 and ending February 29, 2024. The lease was terminated in May 2023. On April 14, 2021, Hydroman entered into a lease agreement of the warehouse in Pennsylvania. The lease term was from May 1, 2021 to April 30, 2024 and the month from May 1, 2021 to May 31, 2021 was free of charge. The lease payments are $6,300 per month for the period commencing June 1, 2021 and ending May 31, 2022, $6,452 per month for the period commencing June 1, 2022 and ending May 31, 2023, $6,609 per month for the period commencing June 1, 2023 and ending May 31, 2024. The lease was terminated on March 2023. On May 15, 2021, Hydroman entered into a lease agreement of the warehouse in California. The lease term was from May 16, 2021 to May 15, 2022. The lease payments are $22,375 per month. On May 15, 2021, Hydroman entered into a sublease agreement of this warehouse with McLovin’s Pet Food Inc. The sublease term was from May 16, 2021 to May 15, 2022. The payments of the sublease are $2,885 per month. On May 16, 2022, Hydroman extended the lease of the warehouse in California. The new leasing term was from June 16, 2022 to June 15, 2025 and an extra month from May 16, 2022 to June 15, 2022 free of charge. The lease payments are $29,088 per month for the period commencing June 16, 2022 and ending June 15, 2023, $29,960 per month for the period commencing June 16, 2023 and ending June 15, 2024, $30,859 per month for the period commencing June 16, 2024 and ending June 15, 2025. The corresponding sublease with McLovin’s Pet Food Inc. was also extended from May 16, 2022 to May 15, 2025. The payments of the sublease are $3,751 per month for the period commencing May 16, 2022 and ending May 15, 2023, $3,863 per month for the period commencing May16, 2023 and ending May 15, 2024, $3,979 per month for the period commencing May 16, 2024 and ending May 15, 2025. The sublease was terminated in January 2023. On September 1, 2022, Photon Technology Ltd entered into a year-to-year lease agreement for an office located in Canada. The term of the lease commenced on September 1, 2022. The monthly payment was CAD 3,500 (USD $2,690). The lease was terminated in March 2023. On September 21, 2022, NMI entered into a month-to-month lease agreement for an office located in California. The term of the lease commenced on September 21, 2022. The monthly payment was $2,333. The lease was terminated in December 2023. On May 28, 2023, Visiontech entered into a lease agreement for a vehicle. The leasing term began on May 28, 2023 and will terminate on April 28, 2025 with a first installment of $15,000 and then continuously monthly payment of $1,550. On April 11, 2024, the Company entered into a lease agreement for an office located in California. The lease term was from May 1, 2024 to April 30, 2027. The lease payments are $8,528 per month for the period commencing May 1, 2024 and ending April 30, 2025, $8,784 per month for the period commencing May 1, 2025 and ending April 30, 2026, $9,047 per month for the period commencing May 1, 2026 and ending April 30, 2027. As of June 30, 2024 and December 31, 2023, the weighted-average remaining operating lease term of its existing leases is approximately 1.83 and 1.45 years, respectively. As of June 30, 2024 and December 31, 2023, the average discount rate of its existing leases is approximately 6.80% and 6.81%, respectively. For the For the June 30, June 30, June 30, June 30, Lease cost (Unaudited) (Unaudited) (Unaudited) (Unaudited) Operating lease cost (included in Cost of Revenue and Other Expense in the Company’s Statement of Operations) $ 105,112 $ 105,195 $ 168,245 $ 241,745 Other information Cash paid for amounts included in the measurement of lease liabilities 81,389 126,013 116,234 253,572 The supplemental balance sheet information related to leases for the period is as follows: As of As of Operating leases Right of use asset 578,179 503,089 Lease Liability – current portion 460,311 359,459 Lease Liability – net of current portion 184,147 157,897 Total operating lease liabilities $ 644,458 $ 517,356 Maturities of the Company’s lease liabilities are as follows: Twelve months ended June 30, Operating 2025 $ 486,748 2026 105,929 2027 90,470 Less: Imputed interest/present value discount (38,690 ) Present value of lease liabilities $ 644,458	Note 16 — Lease The Company follows ASC 842 Leases. The Company has entered into lease agreements for vehicle, offices and warehouses space in California, Pennsylvania and Texas. $503,089 and $973,147 of operating lease right-of-use assets and $517,356 and $1,011,134 of operating lease liabilities were reflected on the December 31, 2023 and 2022 financial statements, respectively. On January 28, 2021, Hydroman entered into a lease agreement of the warehouse in Texas. The lease term was from February 1, 2021 to February 29, 2024 and the month from February 1, 2021 to February 28, 2021 was free of charge. The lease payments are $6,750 per month for the period commencing March 1, 2021 and ending February 28, 2022, $6,920 per month for the period commencing March 1, 2022 and ending February 28, 2023, $7,100 per month for the period commencing March 1, 2023 and ending February 29, 2024. The lease was terminated in May 2023. On April 14, 2021, Hydroman entered into a lease agreement of the warehouse in Pennsylvania. The lease term was from May 1, 2021 to April 30, 2024 and the month from May 1, 2021 to May 31, 2021 was free of charge. The lease payments are $6,300 per month for the period commencing June 1, 2021 and ending May 31, 2022, $6,452 per month for the period commencing June 1, 2022 and ending May 31, 2023, $6,609 per month for the period commencing June 1, 2023 and ending May 31, 2024. The lease was terminated on March 2023. Total amount of ROU and lease liability derecognized amounted to $144,602 and $152,179, respectively. Loss on disposal of ROU amounted to $33,423 for the year ended December 31, 2023. On May 15, 2021, Hydroman entered into a lease agreement of the warehouse in California. The lease term was from May 16, 2021 to May 15, 2022. The lease payments are $22,375 per month. On May 15, 2021, Hydroman entered into a sublease agreement of this warehouse with McLovin’s Pet Food Inc. The sublease term was from May 16, 2021 to May 15, 2022. The payments of the sublease are $2,885 per month. On May 16, 2022, Hydroman extended the lease of the warehouse in California. The new leasing term was from June 16, 2022 to June 15, 2025 and an extra month from May 16, 2022 to June 15, 2022 free of charge. The lease payments are $29,088 per month for the period commencing June 16, 2022 and ending June 15, 2023, $29,960 per month for the period commencing June 16, 2023 and ending June 15, 2024, $30,859 per month for the period commencing June 16, 2024 and ending June 15, 2025. The corresponding sublease with McLovin’s Pet Food Inc. was also extended from May 16, 2022 to May 15, 2025. The payments of the sublease are $3,751 per month for the period commencing May 16, 2022 and ending May 15, 2023, $3,863 per month for the period commencing May16, 2023 and ending May 15, 2024, $3,979 per month for the period commencing May 16, 2024 and ending May 15, 2025. The sublease was terminated in January 2023. On September 1, 2022, Photon Technology Ltd entered into a year-to-year lease agreement for an office located in Canada. The term of the lease commenced on September 1, 2022. The monthly payment was CAD 3,500 (USD $2,690). The lease was terminated in March 2023. On September 21, 2022, Nature’s Miracle entered into a month-to-month lease agreement for an office located in California. The term of the lease commenced on September 21, 2022. The monthly payment was $2,333. The lease was terminated in December 2023. On May 28, 2023, Visiontech entered into a lease agreement for a vehicle. The leasing term began on May 28, 2023 and will terminate on April 28, 2025 with a first installment of $15,000 and then continuously monthly payment of $1,550. Year Ended December 31, 2023 and 2022: Lease cost December 31, December 31, Operating lease cost (included in Cost of Revenue and Other Expense in the Company’s Statement of Operations) $ 414,370 $ 303,157 Other information Cash paid for amounts included in the measurement of lease liabilities 442,252 327,091 Weighted average remaining term in years 1.45 2.22 Average discount rate – operating leases 6.81 % 6.05 % The supplemental balance sheet information related to leases for the period is as follows: As of As of Operating leases Right of use asset 503,089 973,147 Lease Liability – current portion 359,459 468,425 Lease Liability – net of current portion 157,897 542,709 Total operating lease liabilities $ 517,356 $ 1,011,134 Maturities of the Company’s lease liabilities are as follows: Twelve months ended December 31, Operating 2024 $ 383,236 2025 160,494 Less: Imputed interest/present value discount (26,374 ) Present value of lease liabilities $ 517,356

Contingencies

Contingencies	6 Months Ended	12 Months Ended
Contingencies	Jun. 30, 2024	Dec. 31, 2023
Contingencies [Abstract]
Contingencies	Note 16 — Contingencies The Company may, from time to time, be involved in legal matters arising in the ordinary course of its business. While the Company is not presently subject to any material legal proceedings, there can be no assurance that such matters will not arise in the future or that any such matters in which the Company is involved, or which may arise in the ordinary course of the Company’s business, will not at some point proceed to litigation or that such litigation will not have a material adverse effect on the business, financial condition or results of operations of the Company. On August 22, 2023, two separate lawsuits were filed against NMI and two of its wholly-owned subsidiaries: Visiontech Group Inc., a California corporation, and Hydroman Inc., a California corporation (collectively referred to as the “Defendants”) by Megaphoton. Megaphoton, a manufacturer and producer of artificial lighting equipment for use in agriculture and industrial applications, filed the lawsuits against the Defendants in Los Angeles Superior Court, asserting that the Defendants have breached a contract/guarantee agreement by failing to pay a total of $6,857,167, as per the terms of these agreements. NMI believes that there is no merit in the complaint and has filed a counter-suit against Megaphoton in Orange County Court, California, seeking affirmative relief on September 22, 2023. On March 5, 2024, Megaphoton filed requests to dismiss the cases against Hydroman and Visiontech in the Superior Court of Los Angeles. On March 1, 2024 NMI was notified of a complaint in San Bernardino Superior Court by Vien Le, its former CFO, who was employed approximately 2 months. The lawsuit claims wrongful discharge, untimely payment of wages and other related items. The Company has retained counsel and believes it will successfully defend against this lawsuit. Nasdaq Notification Letter On April 26, 2024, the “Company received a notification letter (the “Notification Letter on MVPHS”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with the minimum Market Value of Publicly Held Shares (the “MVPHS”) set forth in Nasdaq Listing Rule 5450(b)(2)(C) for continued listing on Nasdaq, which requires a minimum MVPHS of $15,000,000 (the “MVPHS Requirement”), since the Company failed to meet the MVPHS Requirement for a period of 30 consecutive business days from March 13, 2024 to April 25, 2024. The Notification Letter on MVPHS has no immediate effect on the listing or trading of the common stock, par value $0.0001 per share, of the Company (“Common Stock”) on Nasdaq and, as of April 26, 2024, the Common Stock will continue to trade on Nasdaq under the symbol “NMHI.” Additionally, on April 26, 2024, the Company received a separate notification letter (the “Notification Letter on MVLS”) from Nasdaq, indicating that the Company was no longer in compliance with the minimum Market Value of Listed Securities (“MVLS”) of $50,000,000 required for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”) since the Company failed to meet the MVLS Requirement for a period of 30 consecutive business days from March 13, 2024 to April 25, 2024. The Notification Letter on MVLS has no immediate effect on the listing or trading of the Common Stock on Nasdaq and, as of April 26, 2024, the Common Stock will continue to trade on Nasdaq under the symbol “NMHI.” The Company has a period of 180 calendar days, or until October 23, 2024, to regain compliance with the Requirements. On May 23, 2024, the Company received another notice from Nasdaq, notifying the Company that, because the closing bid price for the Common Stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Rule 5450(a)(1) of Nasdaq Listing Rules. Nasdaq’s notice has no immediate effect on the listing of the Company’s Common Stock on the Nasdaq Global Market. Pursuant to Nasdaq Marketplace Rule 5810(c)(3)(A), the Company has been provided an initial compliance period of 180 calendar days, or until November 20, 2024, to regain compliance with the minimum bid price requirement. The Company intends to monitor the MVPHS Requirement, MVLS Requirement, and minimum bid price requirement of its Common Stock and will consider implementing available options to regain compliance with the MVPHS Requirement, MVLS Requirement and minimum bid price requirement under the Nasdaq Listing Rules. The Company intends to monitor the MVPHS Requirement and MVLS Requirement of its Common Stock and will consider implementing available options to regain compliance with the MVPHS Requirement and MVLS Requirement under the Nasdaq Listing Rules.	Note 17 — Contingencies As of December 31, 2023, the Company is not a party to any material legal proceedings, investigation or claims. However, the Company may, from time to time, be involved in legal matters arising in the ordinary course of its business. While the Company is not presently subject to any material legal proceedings, there can be no assurance that such matters will not arise in the future or that any such matters in which the Company is involved, or which may arise in the ordinary course of the Company’s business, will not at some point proceed to litigation or that such litigation will not have a material adverse effect on the business, financial condition or results of operations of the Company. On August 22, 2023, two separate lawsuits were filed against Nature’s Miracle and two of its wholly-owned subsidiaries: Visiontech Group Inc., a California corporation, and Hydroman Inc., a California corporation (collectively referred to as the “Defendants”) by Megaphoton. Megaphoton, a manufacturer and producer of artificial lighting equipment for use in agriculture and industrial applications, filed the lawsuits against the Defendants in Los Angeles Superior Court, asserting that the Defendants have breached a contract/guarantee agreement by failing to pay a total of $6,857,167, as per the terms of these agreements. Nature’s Miracle believes that there is no merit in the complaint and has filed a counter-suit against Megaphoton in Orange County Court, California, seeking affirmative relief on September 22, 2023. On March 5, 2024, Megaphoton filed requests to dismiss the cases against Hydroman and Visiontech in the Superior Court of Los Angeles.

Subsequent Events

Subsequent Events	6 Months Ended	12 Months Ended
Subsequent Events	Jun. 30, 2024	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent events	Note 17— Subsequent events On July 3, 2024, the Company signed four convertible note investment agreements total of $410,000 from four investors. Each note bears 12% interest per annum and matures in 6 months. The Company shall repay the principal and accumulated interest after six months. If the investors choose to convert, the number of shares will be calculated by dividing the principal plus accumulated interest by $0.442. $410,000 had been deposited into the Company’s bank account in July 2024. On July 16, 2024, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a certain investor (the “Purchaser”) pursuant to which the Company sold, in a private placement (the “July 2024 Offering”), a $180,000 convertible note (the “July 2024 Note” and, the shares underlying the July 2024 Note, the “July 2024 Note Shares”) with an original issue discount of $27,500 and warrant (the “July 2024 Warrant”) to purchase up to 217,500 shares of common stock (the “July 2024 Warrant Shares”) at an exercise price of $0.87 per share. As consideration for entering into the Securities Purchase Agreement, the Company issued a total of 180,000 shares (the “Commitment Shares”) to the Purchaser on July 19, 2024. The July 2024 Warrant is exercisable on July 17, 2024 until five years from July 17, 2024. On July 30, 2024, the note was terminated as a result of the Company’s full payment of the note’s principal amount and accrued interest and other fees in the total amount of $212,400. As a result, all obligations under the note have been satisfied, and the note is no longer outstanding. On July 25, 2024, the Company entered into an underwriting agreement with EF Hutton LLC as the underwriter, relating to a firm commitment underwritten public offering of 5,000,000 units (the “Units”) consisting of (i) one share of common stock, par value $ 0.0001 per share (“Common Stock”) and (ii) one Series A Warrant to purchase one share of Common Stock (“Warrant”) at a public offering price of $0.24 per Unit, for aggregate gross proceeds of $1.2 million, prior to deducting underwriting discounts and other offering expenses. The closing of the offering occurred on July 29, 2024. On August 1, 2024, the Company and Darin Carpenter entered into the mutual termination of employment agreement and intent to transition to project-based work (the “Agreement”), in which it was agreed that Mr. Carpenter shall resign from his position as Chief Operating Officer of the Company effective as of July 31, 2024. Pursuant to the Agreement, the Company and Mr. Carpenter agreed that Mr. Carpenter will provide services as a consultant to the Company on a per project basis as needed. In addition, the Company agreed to fully vest 100,013 shares of common stock that was issuable to Mr. Carpenter pursuant to the Employment Agreement dated as of September 17, 2023, by and between the Company and Mr. Carpenter. The Company also agreed to pay Mr. Carpenter the equivalent of one month of salary payable in September 2024. On August 13, 2024, the Company entered a securities purchase agreement with 1800 Diagonal Lending LLC (“Diagonal”), in connection with the issuance of a promissory note in the aggregate principal amount of $181,700, including an original issue discount of $23,700, closing expenses of $8,000 deducted from funding amount; with additional tranches of financing of up to $1.0 million in the aggregate during the next twelve months subject to further agreement by and between Diagonal and the Company. The initial funding shall be payable in 10 equal monthly installments of $20,350. In the event of default, the note has convertibility provisions.	Note 18 — Subsequent events On January 8, 2024 and February 6, 2024, Nature’s Miracle and Lakeshore entered into two promissory notes pursuant to which Lakeshore borrowed a principal amount of $20,000 each with zero interest rate. Both loans are due on demand. On March 1, 2024 the Company was notified of a complaint in San Bernardino Superior Court by Vien Le, its former CFO, who was employed approximately 2 months. The lawsuit claims wrongful discharge, untimely payment of wages and other related items. The Company has retained counsel and believes it will successfully defend against this lawsuit. On March 7, 2024, the Company’s subsidiary Nature’s Miracles entered into a loan agreement with Peng Zhang, a shareholder of the Company. The amount of the loan is $1,405,000 with 10% interest and is due on March 7, 2025. Pursuant to board resolution dated March 24, 2024, certain key employees were approved for stock incentives including George Yutuc (Chief Financial Officer), Kirk Collins (Director of Sales), and Amber Wang (Controller). Each can receive shares that vest over time of 100,000, 50,000 and 50,000 shares, respectively. Each of these employees have signed an employment agreement that reflects such shares and unique vesting schedules. On March 11, 2024, Lakeshore merged with and into the Company for the sole purpose of reincorporating Lakeshore into the State of Delaware. Immediately after the Reincorporation, the Company consummated the merger between the Company and Nature’s Miracle, resulting in the stockholders of Nature’s Miracle becoming 84.7% stockholders of the Company and the Company becoming the 100% stockholder of Nature’s Miracle. As of December 31, 2023, approximately $15.0 million remained in the trust account of Lakeshore, approximately $13.9 million was subsequently redeemed by public shareholders, leaving approximately $1.1 million for payment of offering costs. The following table presents the number of the Company’s common stock issued and outstanding immediately following the Reverse Recapitalization: Common Stock The Company’s shares outstanding prior to Reverse Recapitalization 2,241,500 Shares issued to private rights 35,150 Conversion of the Company’s public shares and rights 790,097 Shares issued to service providers 801,539 Bonus shares issued to investors 166,000 Conversion of Nature’s Miracle’s shares into the Company’s ordinary shares 22,272,478 Total shares outstanding 26,306,764 On April 2, 2024, the Company entered into an investor relations consulting agreement with MZHCI LLC (“MZHCI”) pursuant to which MZHCI will provide investor relations services to the company and the agreement has a term of six months. The Company will pay $14,000 cash per month and to issue MZHCI 150,000 shares of restricted common stock, 75,000 shares will be vested immediately upon signing the agreement and 75,000 shares will vest on October 1, 2024. The fair value of the shares to be issued was approximately $143,000 at $0.95 per share.

Reverse Recapitalization

Reverse Recapitalization	6 Months Ended
Reverse Recapitalization	Jun. 30, 2024
Reverse Recapitalization [Abstract]
Reverse recapitalization	Note 5 — Reverse recapitalization On March 11, 2024, Lakeshore merged with and into the Company for the sole purpose of reincorporating Lakeshore into the State of Delaware. Immediately after the Reincorporation, the Company consummated the merger between the Company and NMI, resulting in the stockholders of NMI becoming 84.7% stockholders of the Company and the Company becoming the 100% stockholder of Nature’s Miracle. Lakeshore was treated as the “acquired” company for financial reporting purposes. Accordingly, the financial statements of the Company represent the continuation of the financial statements of NMI, with the Merger reflected as the equivalent of NMI issuing ordinary shares for the net assets of Lakeshore, accompanied by a recapitalization. The net assets of Lakeshore were recognized as of the closing date at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger are those of NMI. The shares and corresponding capital amounts and all per share data related to NMI outstanding shares prior to the reverse recapitalization have been retroactively adjusted. The following table presents the number of the Company’s common stock issued and outstanding immediately following the reverse recapitalization: Common Lakeshore’s shares outstanding prior to reverse recapitalization 2,241,500 Shares issued to private rights 35,150 Conversion of the Lakeshore’s public shares and rights 790,097 Shares issued to service providers 801,539 Bonus shares issued to investors 166,000 Conversion of NMI’s shares into the Company’s ordinary shares 22,272,478 Total shares outstanding 26,306,764 In connection with the reverse recapitalization, the Company has assumed 3,625,750 warrants outstanding, which consisted of 3,450,000 public warrants and 175,750 private warrants. Both of the public warrants and private warrants met the criteria for equity classification. (see Note 13 Equity for details) In connection with the reverse recapitalization, the Company raised approximately $1.1 million of proceeds, presented as cash flows from activities, which included the contribution of approximately $15.1 million of funds held in Lakeshore’s trust account, net of approximately $13.9 million paid to redeem 1,246,563 public shares of Lakeshore’s ordinary shares, approximately $1.0 million in transaction costs incurred by Lakeshore, and repayments of a promissory note in the amount of $75,000 issued to Lakeshore’s related party. NMI incurred approximately $1.1 million of transaction costs, which consisted of direct incremental legal and accounting fees in connection with the Merger and were reclassified to additional paid-in capital. The net effect of the above with the net liabilities assumed from Lakeshore of approximately $1.6 million was recorded to the Company’s retained deficit. The following table reconcile the elements of the reverse recapitalization to the consolidated statements of cash flows and the changes in shareholders’ equity (deficit): As of Funds held in Lakeshore’s trust account $ 15,067,702 Funds held in Lakeshore’s operating cash account 198 Less: amount paid to redeem public shares of Lakeshore’s ordinary shares (13,947,723 ) Proceeds from the reverse recapitalization 1,120,177 Less: payments of transaction costs incurred by Lakeshore (1,044,980 ) Less: repayments of promissory note – related party of Lakeshore’ (75,000 ) Less: notes assumed from Lakeshore (555,000 ) Less: liability assumed from Lakeshore (1,547,814 ) Less: transaction costs paid by NMI (1,100,857 ) Add: receivable assumed from Lakeshore 500,000 Net liabilities assumed from issuance of common stock upon the Merger, balance classified to retained deficit $ (2,703,474 )

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended	12 Months Ended
Accounting Policies, by Policy (Policies)	Jun. 30, 2024	Dec. 31, 2023
Basis of Presentation and Summary of Significant Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The unaudited condensed consolidated financial statements include the accounts of the Company and its variable interest entities and have been prepared in accordance with U.S. GAAP and the requirements of the U.S. Securities and Exchange Commission (“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These unaudited condensed consolidated financial statements have been prepared on the same basis as its annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2024, or for any other interim period or for any other future year. All intercompany balances and transactions have been eliminated in consolidation.	Basis of presentation The accompanying financial statements have been prepared in accordance with the generally accepted accounting principles in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”). The Company’s fiscal year end date is December 31.
Principles of consolidation	Principles of consolidation The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiaries, which include its wholly owned subsidiaries and VIE over which the Company exercises control and, when applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company and its subsidiaries and VIE have been eliminated upon consolidation.	Principles of consolidation The consolidated financial statements include the financial statements of the Company and its subsidiaries, which include its wholly owned subsidiaries and VIE over which the Company exercises control and, when applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company and its subsidiaries and VIE have been eliminated upon consolidation.
Use of estimates and assumptions	Use of estimates and assumptions The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities reported and disclosures of contingent assets and liabilities as of the date of the unaudited financial statements and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates.	Use of estimates and assumptions The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities reported and disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates.
Cash and cash equivalents	Cash and cash equivalents Cash and cash equivalents consist of amounts held as cash on hand and bank deposits. From time to time, the Company may maintain bank balances in interest bearing accounts in excess of the $250,000 currently insured by the Federal Deposit Insurance Corporation for interest bearing accounts (there is currently no insurance limit for deposits in noninterest bearing accounts). The Company has not experienced any losses with respect to cash. Management believes our Company is not exposed to any significant credit risk with respect to its cash.	Cash and cash equivalents Cash and cash equivalents consist of amounts held as cash on hand and bank deposits. From time to time, the Company may maintain bank balances in interest bearing accounts in excess of the $250,000 currently insured by the Federal Deposit Insurance Corporation for interest bearing accounts (there is currently no insurance limit for deposits in noninterest bearing accounts). The Company has not experienced any losses with respect to cash. Management believes our Company is not exposed to any significant credit risk with respect to its cash.
Short-term investments		Short-term investments Short-term investments are investment in marketable equity securities that are measured and recorded at fair value based on quoted prices in active markets on reporting dates with changes in fair value, whether realized or unrealized, recorded through the income statement.
Prepayments and other current assets	Prepayments and other current assets Prepaid expenses and other current assets primarily include prepaid expenses paid to product providers, and other deposits. Management regularly reviews the aging of such balances and changes in payment and realization trends and records allowances when management believes collection or realization of amounts due are at risk. Accounts considered uncollectable are written off against allowances after exhaustive efforts at collection are made. As of June 30, 2024 and December 31, 2023, no allowance for doubtful account was recorded.	Prepayments and other current assets Prepaid expenses and other current assets primarily include prepaid expenses paid to product providers, and other deposits. Management regularly reviews the aging of such balances and changes in payment and realization trends and records allowances when management believes collection or realization of amounts due are at risk. Accounts considered uncollectable are written off against allowances after exhaustive efforts at collection are made. As of December 31, 2023 and 2022, no allowance for doubtful account was recorded.
Accounts receivable, net	Accounts receivable, net During the ordinary course of business, the Company extends unsecured credit to its customers. Accounts receivable are stated at the amount the Company expects to collect from customers. Management reviews its accounts receivable balances each reporting period to determine if an allowance for doubtful accounts is required. An allowance for doubtful accounts is recorded in the period in which loss is determined to be probable based on assessment of specific evidence indicating likelihood of collection, historical experience, account balance aging and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased. Starting from January 1, 2023, the Company adopted ASU No.2016-13 “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASC Topic 326”). The Company used a modified retrospective approach, and the adoption does not have an impact on our unaudited condensed consolidated financial statements. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary.	Accounts receivable During the ordinary course of business, the Company extends unsecured credit to its customers. Accounts receivable are stated at the amount the Company expects to collect from customers. Management reviews its accounts receivable balances each reporting period to determine if an allowance for doubtful accounts is required. An allowance for doubtful accounts is recorded in the period in which loss is determined to be probable based on assessment of specific evidence indicating likelihood of collection, historical experience, account balance aging and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased. Starting from January 1, 2023, the Company adopted ASU No.2016-13 “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASC Topic 326”). The Company used a modified retrospective approach, and the adoption does not have an impact on our consolidated financial statements. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary.
Inventory	Inventory Inventory consists of finished goods ready for sale and is stated at the lower of cost or market. The Company values its inventory using the weighted average costing method. The Company’s policy is to include as a part of cost of goods sold any freight incurred to ship the product from its vendors to warehouses. Outbound freight costs related to shipping costs to customers are considered periodic costs and are reflected in cost of revenue. The Company regularly reviews inventory and considers forecasts of future demand, market conditions and product obsolescence. If the estimated realizable value of the inventory is less than cost, the Company makes provisions in order to reduce its carrying value to its estimated market value. The Company also reviews inventory for slow moving inventory and obsolescence and records impairment for obsolescence. During the three and six months ended June 30, 2024, there was no inventory impairment loss recorded. During the three and six months ended June 30, 2023, there was no inventory impairment loss recorded.	Inventory Inventory consists of finished goods ready for sale and is stated at the lower of cost or market. The Company values its inventory using the weighted average costing method. The Company’s policy is to include as a part of cost of goods sold any freight incurred to ship the product from its vendors to warehouses. Outbound freight costs related to shipping costs to customers are considered periodic costs and are reflected in cost of revenue. The Company regularly reviews inventory and considers forecasts of future demand, market conditions and product obsolescence. If the estimated realizable value of the inventory is less than cost, the Company makes provisions in order to reduce its carrying value to its estimated market value. The Company also reviews inventory for slow moving inventory and obsolescence and records impairment for obsolescence. For the year ended December 31, 2023 and 2022, inventory impairment loss amounted to $1,269,469 and $0, respectively.
Cost method investment	Cost method investment The Company accounts for investments with less than 20% of the voting shares and does not have the ability to exercise significant influence over operating and financial policies of the investee using the cost method. The Company records cost method investment at the historical cost in its unaudited condensed consolidated financial statements and subsequently records any dividends received from the net accumulated earrings of the investee as income. Dividends received in excess of earnings are considered a return of investment and are recorded as reduction in the cost of the investments. Cost method investment is evaluated for impairment when facts or circumstances indicate that the fair value of the long-term investments is less than its carrying value. An impairment is recognized when a decline in fair value is determined to be other-than-temporary. The Company reviews several factors to determine whether a loss is other-than-temporary. These factors include, but are not limited to, the: (i) nature of the investment; (ii) cause and duration of the impairment; (iii) extent to which fair value is less than cost; (iv) financial condition and near-term prospects of the investments; and (v) ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. No event had occurred and indicated that other-than-temporary impairment existed and therefore during the three and six months ended June 30, 2024, the Company did not record any impairment charges for its investments. During the three and six months ended June 30, 2023, the Company did not record any impairment charges for its investments.	Cost method investment The Company accounts for investments with less than 20% of the voting shares and does not have the ability to exercise significant influence over operating and financial policies of the investee using the cost method. The Company records cost method investment at the historical cost in its consolidated financial statements and subsequently records any dividends received from the net accumulated earrings of the investee as income. Dividends received in excess of earnings are considered a return of investment and are recorded as reduction in the cost of the investments. Cost method investment is evaluated for impairment when facts or circumstances indicate that the fair value of the long-term investments is less than its carrying value. An impairment is recognized when a decline in fair value is determined to be other-than-temporary. The Company reviews several factors to determine whether a loss is other-than-temporary. These factors include, but are not limited to, the: (i) nature of the investment; (ii) cause and duration of the impairment; (iii) extent to which fair value is less than cost; (iv) financial condition and near term prospects of the investments; and (v) ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. No event had occurred and indicated that other-than-temporary impairment existed and therefore the Company did not record any impairment charges for its investments for the years ended December 31, 2023 and 2022.
Security deposits	Security deposits To maintain a stable supply for goods and build a long-term relationship, the Company may pay certain amount of funds to its vendors as security deposits which are recorded as non-current assets on the balance sheet depending on its return date.	Security deposits To maintain a stable supply for goods and build a long-term relationship, the Company may pay certain amount of funds to its vendors as security deposits which are recorded as non-current assets on the balance sheet depending on its return date.
Property and equipment	Property and equipment Property and equipment are stated at historical cost. Depreciation is provided over the estimated useful life of each class of depreciable assets and is computed using the straight-line method over the useful lives of the assets are as follows: Useful Life Machinery and equipment 5 years Computer and peripherals 3 years Trucks and automobiles 5 years Buildings 39 years The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statements of operations. Expenditures for maintenance and repairs are expensed as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized.	Property and equipment Property and equipment are stated at historical cost. Depreciation is provided over the estimated useful life of each class of depreciable assets and is computed using the straight-line method over the useful lives of the assets are as follows: Useful Life Machinery and equipment 5 years Computer and peripherals 3 years Trucks and automobiles 5 years Buildings 39 years The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statements of operations. Expenditures for maintenance and repairs are expensed as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized.
Deferred offering costs	Deferred offering costs Deferred offering costs consist primarily of expenses paid to attorneys, consultants, underwriters, and etc. related to its merger transaction. The balance has been offset with the proceeds received after the close of the offering.	Deferred offering costs Deferred offering costs consist primarily of expenses paid to attorneys, consultants, underwriters, and etc. related to its merger transaction. The balance will be offset with the proceeds received after the close of the offering.
Business combination		Business combination The purchase price of an acquired company is allocated between tangible and intangible assets acquired and liabilities assumed from the acquired business based on their estimated fair values, with the residual of the purchase price recorded as goodwill. Transaction costs associated with business combinations are expensed as incurred and are included in general and administrative expenses in the Company’s consolidated statements of operations. The results of operations of the acquired business are included in the Company’s operating results from the date of acquisition.
Goodwill		Goodwill Goodwill represents the excess of the consideration paid of an acquisition over the fair value of the net identifiable assets of the acquired subsidiaries at the date of acquisition. Goodwill is not amortized and is tested for impairment at least annually, more often when circumstances indicate impairment may have occurred. Goodwill is carried at cost less accumulated impairment losses. If impairment exists, goodwill is immediately written off to its fair value and the loss is recognized in the consolidated statements of operations and comprehensive loss. Impairment losses on goodwill are not reversed. The Company reviews the carrying value of intangible assets not subject to amortization, including goodwill, to determine whether impairment may exist annually or more frequently if events and circumstances indicate that it is more likely than not that an impairment has occurred. The Company has the option to assess qualitative factors to determine whether it is necessary to perform further impairment testing in accordance with ASC 350-20, as amended by ASU 2017-04. If the Company believes, as a result of the qualitative assessment, that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, then the impairment test described below is required. The Company compares the fair values of each reporting unit to its carrying amount, including goodwill. If the fair value of each reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. If the carrying amount of a reporting unit exceeds its fair value, impairment is recognized for the difference, limited to the amount of goodwill recognized for the reporting unit. Estimating fair value is performed by utilizing various valuation techniques, with the primary technique being a discounted cash flow. For the year ended December 31, 2023 and 2022, goodwill impairment loss amounted $1,023,533 and $0
Fair value measurement	Fair value measurement The Company adopted ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability. ASC Topic 820 specifies a hierarchy of valuation techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows: Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. When available, the Company uses quoted market prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest rates and currency rates.	Fair value measurement The Company adopted ASC Topic 820, Fair Value Measurements and Disclosures ASC Topic 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability. ASC Topic 820 specifies a hierarchy of valuation techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows: Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. When available, the Company uses quoted market prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest rates and currency rates.
Fair values of financial instruments	Fair values of financial instruments Financial instruments include cash and cash equivalents, accounts receivable, prepayments, loan receivable, and other current assets, other payable and accrued liabilities, accounts payable — related parties, short term loans and taxes payable. The Company considers the carrying amount of short-term financial instruments to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization. The Company’s long-term debts are measured at amortized cost, no fair value option is elected.	Fair values of financial instruments Financial instruments include cash and cash equivalents, accounts receivable, prepayments, loan receivable, and other current assets, other payable and accrued liabilities, accounts payable — related parties, short term loans and taxes payable. The Company considers the carrying amount of short-term financial instrument to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization. The Company’s long term debts are measured at amortized cost, no fair value option is elected.
Revenue recognition	Revenue recognition The Company follows Accounting Standards Codification (“ASC”) 606 Revenue Recognition and recognizes revenue from product sales revenues, net of promotional discounts and return allowances, when the following revenue recognition criteria are met: a contract has been identified, separate performance obligations are identified, the transaction price is determined, the transaction price is allocated to separate performance obligations and revenue is recognized upon satisfying each performance obligation. The Company is a growing agriculture technology company providing CEA hardware products to growers in the controlled environment agriculture industry setting in North America. Majority of the Company’s products were grow lights and related products for the indoor growing settings. Starting from first quarter of 2024, the Company also provides indoor grow containers to its customers. The Company’s contracts with customers where the amounts charged per product is fixed and determinable, the specific terms of the contracts were agreed on by the Company including payment terms which are typically 30 to 60 days for existing customers and prepaid for most new customers. In certain contracts involving customers that entered into rebate programs with utility companies for using LED lighting, payment term ranges from 60 to 120 days. The Company’s performance obligation is to deliver the products to customers. For indoor grow container products, the Company also involved in customization of the products to suit customer’s specific needs. The provision of customization and configuration to meet certain technical specification per US market and delivery of product is considered one performance obligation as the as the services provided are not distinct within the context of the contract whereas the customers can only obtain benefit when the services and products are provided together. Transaction prices are mostly fixed. In some contracts, when determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customers and the transfer of the promised goods or services to the licensees will be one year or less. The Company had one contract with customer with installment payment terms of up to 16 months. The difference between the contract price and the Company’s cash selling price of the same products are recognized as interest income over the term of the payments. Interest income amounted to $44,239 and $78,385 during the three and six months ended June 30, 2023, respectively. This contract was terminated on July 12, 2023. The Company transfers the risk of loss or damage upon shipment, therefore, revenue from product sales is recognized at a point in time when control of product transfer to customer and the Company has no further obligation to provide services related to such product evidenced by customer signing acceptances upon receipt of goods. Return allowances, which reduce product revenue by the Company’s best estimate of expected product returns, are estimated using historical experience. The Company evaluates the criteria of ASC 606 — Revenue Recognition Principal-Agent Considerations in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Company ships the products according to shipping terms on the purchase order or sales order. Once delivery is complete, the Company then sends an invoice to the customer according to the quantity and price of shipment. The Company evaluates the indicators of control in accordance with ASU 2016-08: 1) the Company is the most visible entity to customers and assumes fulfilment risk and risks related to the acceptability of products, including addressing customer inquiries directly and handling of product returns or refunds directly if any. For grow light products, the Company has its own brand for marketing. For indoor grow containers products, the Company is also involved in the design and technical specification of the products to meet requirement in the US market 2) The Company assumes inventory risk either through storing the products in its own warehouses; or for drop shipments directly from vendors, the Company takes the title from vendors through inspection and acceptance and is responsible for product damage during shipment period prior to acceptance of its customers and is also responsible for product return if the customer is not satisfied with the products. 3) The Company determines the resale price of the products. 4) The Company is the party that directs the use of the inventory and can prevent the vendor from transferring the product to a customer or to redirect the products to a different customer, after evaluating the above scenario, the Company considers itself the principal of these arrangements and records revenue on a gross basis. The Company’s disaggregate revenue stream by products are summarized below: For the For the June 30, June 30, June 30, June 30, (Unaudited) (Unaudited) (Unaudited) (Unaudited) Grow light $ 3,404,967 $ 1,943,528 $ 5,465,906 $ 4,910,200 Indoor grow containers - - 143,781 - Total revenues $ 3,404,967 $ 1,943,528 $ 5,609,687 $ 4,910,200 Prepayments received from customers prior to the delivery of goods to customers or picked up by the customers are recorded as contract liability under the account Deferred income — contract liabilities. Movements of Deferred income — contract liabilities consisted of the following as of the date indicated: As of As of Beginning balance $ 118,909 $ 808,118 Prepayments from customers 470,967 1,370,836 Recognized as revenues (525,807 ) (2,060,045 ) Ending balance $ 64,069 $ 118,909 The Company periodically provides incentive offers to its customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases and other similar offers. Current discount offers, when accepted by the Company’s customers, are treated as a reduction to the transaction price of the related transaction. Sales discounts are recorded in the period in which the related sale is recognized. Sales return allowances are recorded and estimated based on historical returns which were generally immaterial to the Company. Estimated warranty are immaterial because suppliers provide a warranty period of 1-5 years for all products, varying depending on the product type. After customers provide their purchase invoices and serial numbers for the return products, the factories will issue the replacement products. Additionally, the factories will also bear the corresponding shipping costs, making the company’s warranty expenses negligible.	Revenue recognition The Company follows Accounting Standards Codification (“ASC”) 606 Revenue Recognition and recognizes revenue from product sales revenues, net of promotional discounts and return allowances, when the following revenue recognition criteria are met: a contract has been identified, separate performance obligations are identified, the transaction price is determined, the transaction price is allocated to separate performance obligations and revenue is recognized upon satisfying each performance obligation. The Company’s contracts with customers where the amounts charged per product is fixed and determinable, the specific terms of the contracts were agreed on by the Company including payment terms which are typically 30 to 60 days. In certain contracts involving customers that entered into rebate programs with Utility companies for using LED lighting, payment term ranges from 60 to 120 days. In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customers and the transfer of the promised goods or services to the licensees will be one year or less. The Company had one contract with customer with installment payment terms of up to 16 months. The difference between the contract price and the Company’s cash selling price of the same products are recognized as interest income over the term of the payments. Interest income amounted to $78,385 and $22,764 for the years ended December 31, 2023 and 2022, respectively. This contract was terminated on July 12, 2023 and the Company recognized provision for credit loss of approximately $0.2 million. The Company transfers the risk of loss or damage upon shipment, therefore, revenue from product sales is recognized at a point in time when control of product transfer to customer and the Company has no further obligation to provide services related to such product evidenced by customer signing acceptances upon receipt of goods. Return allowances, which reduce product revenue by the Company’s best estimate of expected product returns, are estimated using historical experience. The Company evaluates the criteria of ASC 606 — Revenue Recognition Principal Agent Considerations in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Company has only one performance obligation which is the delivery of products. The Company ships the products according to shipping terms on the purchase order or sales order. Once delivery is complete, the Company then sends an invoice to the customer according to the quantity and price of shipment. If the timing of payments agreed to by the parties to the contract (either explicitly or implicitly) provides the customer or the entity with a significant benefit of financing the transfer of goods or services to the customer, the entity will need to adjust the promised amount of consideration for the effects of the time value of money when determining the transaction price. Generally, when the Company is primarily responsible for fulfilling the promise to provide a specified good or service, the Company is subject to inventory risk before control of the good or service has been transferred to a customer and the Company has discretion in establishing the price, revenue is recorded at gross. Prepayments received from customers prior to the delivery of goods to customers or picked up by the customers are recorded as contract liability under the account Deferred income — contract liabilities. Movements of Deferred income — contract liabilities consisted of the following as of the date indicated: As of As of Beginning balance $ 808,118 $ 997,732 Prepayments from customers 1,370,836 1,352,698 Recognized as revenues (2,060,045 ) (1,542,312 ) Ending balance $ 118,909 $ 808,118 The Company periodically provides incentive offers to its customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases and other similar offers. Current discount offers, when accepted by the Company’s customers, are treated as a reduction to the transaction price of the related transaction. Sales discounts are recorded in the period in which the related sale is recognized. Sales return allowances are recorded and estimated based on historical returns which were generally immaterial to the Company. Estimated warranty are immaterial because suppliers provide a warranty period of 1-5 years for all products, varying depending on the product type. After customers provide their purchase invoices and serial numbers for the return products, the factories will issue the replacement products. Additionally, the factories will also bear the corresponding shipping costs, making the company’s warranty expenses negligible.
Cost of revenue	Cost of revenue Cost of revenue mainly consist of costs for purchases of products and related storage, warehouse rent, outbound freight, delivery fees and payroll related expenses.	Cost of revenue Cost of revenue mainly consist of costs for purchases of products and related storage, warehouse rent, outbound freight, delivery fees and payroll related expenses.
Segment reporting	Segment reporting The Company follows ASC 280, Segment Reporting. The Company’s chief operating decision maker, the Chief Executive Officer, reviews the results of operations when making decisions about allocating resources and assessing the performance of the Company as a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. The Company’s long-lived assets are all located in California, United States, and substantially all the Company’s revenues are derived from within the USA. Therefore, no geographical segments are presented.	Segment reporting The Company follows ASC 280, Segment Reporting. The Company’s chief operating decision maker, the Chief Executive Officer, reviews the results of operations when making decisions about allocating resources and assessing the performance of the Company as a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. The Company’s long-lived assets are all located in California, United States, and substantially all of the Company’s revenues are derived from within the USA. Therefore, no geographical segments are presented.
Leases	Leases The Company follows ASC 842 — Leases (“ASC 842”), which requires lessees to record right-of-use (“ROU”) assets and related lease obligations on the balance sheet, as well as disclose key information regarding leasing arrangements. ROU assets represent our right to use an underlying asset for the lease terms and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term.	Leases The Company follows ASC 842 — Leases (“ASC 842”), which requires lessees to record right-of-use (“ROU”) assets and related lease obligations on the balance sheet, as well as disclose key information regarding leasing arrangements. ROU assets represent our right to use an underlying asset for the lease terms and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
Income taxes	Income taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their perspective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized. As a result of the implementation of certain provisions of ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting and disclosure for uncertainty in tax position, as defined, ASC 740 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes. The Company follows the provisions of ASC 740 and has analyzed filing positions in each of the federal and state jurisdictions where the Company is required to file income tax returns, as well as open tax years in such jurisdictions. The Company has identified the U.S. federal jurisdiction, and the states of Delaware, as its “major” tax jurisdictions. The Company believes that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. The Company’s policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes.	Income taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their perspective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized. As a result of the implementation of certain provisions of ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting and disclosure for uncertainty in tax position, as defined, ASC 740 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes. The Company follows the provisions of ASC 740, and has analyzed filing positions in each of the federal and state jurisdictions where the Company is required to file income tax returns, as well as open tax years in such jurisdictions. The Company has identified the U.S. federal jurisdiction, and the states of Delaware, as its “major” tax jurisdictions. The Company believes that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. The Company’s policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes.
Commitments and Contingencies	Commitments and Contingencies In the ordinary course of business, the Company is subject to certain contingencies, including legal proceedings and claims arising out of the business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable that a loss has occurred, and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and specific facts and circumstances of each matter.	Commitments and Contingencies In the ordinary course of business, the Company is subject to certain contingencies, including legal proceedings and claims arising out of the business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable that a loss has occurred and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and specific facts and circumstances of each matter.
Loss per share	Loss per share Basic loss per share is computed by dividing net loss attributable to holders of common stock by the weighted average number of common stock outstanding during the year. During the three and six months ended June 30, 2024, basic and diluted loss per share are the same because the Company had net loss for the periods. During the three and six months ended June 30, 2023, basic and diluted loss per share are the same because the Company had net loss for the periods.	Loss per share Basic loss per share is computed by dividing net loss attributable to holders of common stock by the weighted average number of common stock outstanding during the year. For the years ended December 31, 2023 and 2022, basic and diluted earnings/ (loss) per share are the same because the Company has no common stock equivalents outstanding during these periods.
Recently adopted accounting pronouncements		Recently adopted accounting pronouncements In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments — Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments — Credit Losses — Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-02 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. The Company adopted the ASU on January 1, 2023 and the adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.
Recently issued accounting pronouncements	Recently issued accounting pronouncements In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its unaudited condensed consolidated financial statements and related disclosures. Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated balance sheets, statements of income and comprehensive income and statements of cash flows.	Recently issued accounting pronouncements In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures. Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s consolidated balance sheets, statements of income and comprehensive income and statements of cash flows.
Stock-based compensation	Stock-based compensation The Company accounts for stock-based compensation awards to employees in accordance with FASB ASC Topic 718, “Compensation – Stock Compensation”, which requires that stock-based payment transactions with employees be measured based on the grant-date fair value of the equity instrument issued and recognized as compensation expense over the requisite service period. The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 718 amended by ASU 2018-07. Under FASB ASC Topic 718, stock compensation granted to non-employees has been determined as the fair value of the consideration received or the fair value of equity instrument issued, whichever is more reliably measured and is recognized as an expense as the goods or services are received.
Warrants	Warrants The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Basis of Presentation and Summary of Significant Accounting Policies [Abstract]
Schedule of Straight-Line Method Over the Useful Lives	Property and equipment are stated at historical cost. Depreciation is provided over the estimated useful life of each class of depreciable assets and is computed using the straight-line method over the useful lives of the assets are as follows: Useful Life Machinery and equipment 5 years Computer and peripherals 3 years Trucks and automobiles 5 years Buildings 39 years	Property and equipment are stated at historical cost. Depreciation is provided over the estimated useful life of each class of depreciable assets and is computed using the straight-line method over the useful lives of the assets are as follows: Useful Life Machinery and equipment 5 years Computer and peripherals 3 years Trucks and automobiles 5 years Buildings 39 years
Schedule of Deferred income and Contract Liabilities	Movements of Deferred income — contract liabilities consisted of the following as of the date indicated: As of As of Beginning balance $ 118,909 $ 808,118 Prepayments from customers 470,967 1,370,836 Recognized as revenues (525,807 ) (2,060,045 ) Ending balance $ 64,069 $ 118,909	Movements of Deferred income — contract liabilities consisted of the following as of the date indicated: As of As of Beginning balance $ 808,118 $ 997,732 Prepayments from customers 1,370,836 1,352,698 Recognized as revenues (2,060,045 ) (1,542,312 ) Ending balance $ 118,909 $ 808,118
Schedule of Disaggregate Revenue	The Company’s disaggregate revenue stream by products are summarized below: For the For the June 30, June 30, June 30, June 30, (Unaudited) (Unaudited) (Unaudited) (Unaudited) Grow light $ 3,404,967 $ 1,943,528 $ 5,465,906 $ 4,910,200 Indoor grow containers - - 143,781 - Total revenues $ 3,404,967 $ 1,943,528 $ 5,609,687 $ 4,910,200

Variable Interest Entity (Table

Variable Interest Entity (Tables) - Variable Interest Entity, Primary Beneficiary [Member]	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Variable Interest Entity [Line Items]
Schedule of Carrying Amount of Assets and Liabilities	The carrying amount of the assets and liabilities are as follows: As of Cash $ 1,046 Prepaid expense 1,800 Property and equipment, net 4,180,504 Total assets $ 4,183,350 Current portion of long-term debt $ 82,374 Long-term debt, net of current portion 2,730,266 Accrued expenses 398 Intercompany payable to Visiontech 1,367,078 Total liabilities $ 4,180,116	The carrying amount of the assets and liabilities are as follows: As of Cash $ 8,889 Prepaid expense 1,800 Property and equipment, net 4,224,930 Total assets $ 4,235,619 Current portion of long-term debt $ 80,638 Long-term debt, net of current portion 2,771,959 Intercompany payable to Visiontech (2) 1,411,025 Total liabilities $ 4,263,622
Schedule of Operating Results of VIE	The operating results of VIE included in the unaudited condensed consolidated statements of operations are as follows for the period indicated: For the For the Revenue * $ 83,211 $ 166,421 Selling, general and administrative (27,840 ) (82,450 ) Interest expense (25,414 ) (51,034 ) Income tax - (1,700 ) Net income $ 29,957 $ 31,237 * Upland generated its revenue from leasing the warehouse to Visiontech. Revenue of Upland was fully eliminated on the unaudited condensed consolidated statements of operations.	The operating results of VIE included in the consolidated statements of operations are as follows for the period indicated: For the Revenue (1) $ 332,842 Selling, general and administrative (169,563.00 ) Interest expense (2) (259,713.00 ) Income tax (800.00 ) Net loss $ (97,234.00 ) (1) Upland generated its revenue from leasing the warehouse to Visiontech. Revenue of Upland was fully eliminated on the consolidated statements of operations. (2) Upland generated interest expense of $155,806 from the intercompany payable to Visiontech of $1,411,025, both amounts were eliminated on the consolidated statements of operations.

Business Combination (Tables)

Business Combination (Tables)	12 Months Ended
Business Combination (Tables)	Dec. 31, 2023
Business Combination [Abstract]
Schedule of Fair Value of the Identifiable Assets Acquired and Liabilities	The following table summarizes the fair value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of Hydroman on June 1, 2022. Fair value Cash $ 97,650 Inventories, net 3,538,989 Other current assets 163,009 Right-of-use assets 1,227,673 Deferred tax assets 115,562 Other non-current assets 120,538 Accounts payable – related parties (3,752,571 ) Other current liabilities (780,423 ) Other non-current liabilities (828,960 ) Net assets acquired (98,533 ) Goodwill on acquisition 1,023,533 Total consideration $ 925,000

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
Goodwill (Tables)	Dec. 31, 2023
Goodwill [Abstract]
Schedule of Changes in Carrying Amount pf Goodwill	Changes in the carrying amount pf goodwill for the year ended December 31, 2023 and 2022 were as follows: December 31, December 31, Beginning balance $ 1,023,533 $ - Acquisitions - 1,023,533 Goodwill impairment (1,023,533 ) - Ending balance $ - $ 1,023,533

Accounts Receivable, Net (Table

Accounts Receivable, Net (Tables)	6 Months Ended	12 Months Ended
Accounts Receivable, Net (Tables)	Jun. 30, 2024	Dec. 31, 2023
Accounts Receivable, Net [Abstract]
Schedule of Accounts Receivable	Accounts receivable consisted of the following as of the date indicated: As of As of Accounts receivable $ 2,737,042 $ 1,906,222 Less: allowance for credit losses (683,364 ) (669,974 ) Subtotal accounts receivable, net 2,053,678 1,236,248 Accounts receivable - related parties 717,835 305,669 Total accounts receivable, net $ 2,771,513 $ 1,541,917	Accounts receivable consisted of the following as of the date indicated: As of As of Accounts receivable $ 1,906,222 $ 3,953,635 Accounts receivable - related parties 305,669 - Less: allowance for credit losses (669,974 ) (259,690 ) Total accounts receivable, net 1,541,917 3,693,945 Accounts receivable – non-current * — 138,613 Accounts receivable – current $ 1,541,917 $ 3,555,332 * On November 11, 2022, the Company had one contract with customer with installment payment terms of up to 16 months. The difference between the contract price and the Company’s cash selling price of the same products are recognized as interest income over the term of the payments. As of December 31, 2023 and 2022, the account receivable of this client was $0 and $462,114, of which account receivable -non-current was $0
Schedule of Allowance for Credit Losses	Movement of allowance for credit losses consisted of the following as of the date indicated: June 30, December 31, Beginning balance $ 669,974 $ 259,690 Addition 24,391 907,021 Recovery/write-off (11,001 ) (496,737 ) Ending balance $ 683,364 $ 669,974	Movement of allowance for credit losses consisted of the following as of the date indicated: December 31, December 31, Beginning balance $ 259,690 $ 15,898 Allowance from acquisition of Hydroman — 4,964 Addition 907,021 322,395 Write-off (496,737 ) (83,567 ) Ending balance $ 669,974 $ 259,690

Loans Receivable (Tables)

Loans Receivable (Tables)	12 Months Ended
Loans Receivable (Tables)	Dec. 31, 2023
Loans Receivable [Abstract]
Schedule of Loans Receivable	Loans receivable consisted of the following as of the date indicated: As of As of Loan to CGGP, LLC $ — $ 62,383 Loan to NewCo Vision, LLC — 70,530 Total loan receivable $ — $ 132,913

Cost Method Investment (Tables)

Cost Method Investment (Tables)	6 Months Ended	12 Months Ended
Cost Method Investment (Tables)	Jun. 30, 2024	Dec. 31, 2023
Cost Method Investment [Abstract]
Schedule of Cost Method Investment	Cost method investment consist of the following: As of As of 10% Investment of Iluminar $ 1,000,000 $ 1,000,000 Total $ 1,000,000 $ 1,000,000	Cost method investment consist of the following: As of As of 10% Investment of Iluminar $ 1,000,000 $ — Total $ 1,000,000 $ —

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	6 Months Ended	12 Months Ended
Property and Equipment, Net (Tables)	Jun. 30, 2024	Dec. 31, 2023
Property and Equipment, Net [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consist of the following: As of As of Trucks & Automobiles $ 285,099 $ 285,099 Machinery & Equipment 67,847 67,847 Building 3,465,230 3,465,230 Land 930,000 930,000 Subtotal 4,748,176 4,748,176 Less: accumulated depreciation (421,624 ) (341,904 ) Total $ 4,326,552 $ 4,406,272	Property and equipment, net consist of the following: As of As of Computers & Peripherals $ — $ 7,167 Trucks & Automobiles 285,099 293,599 Machinery & Equipment 67,847 84,085 Building 3,465,230 3,465,230 Land 930,000 930,000 Subtotal 4,748,176 4,780,081 Less: accumulated depreciation (341,904 ) (191,648 ) Total $ 4,406,272 $ 4,588,433

Loans Payable (Tables)

Loans Payable (Tables)	6 Months Ended	12 Months Ended
Loans Payable (Tables)	Jun. 30, 2024	Dec. 31, 2023
Loans Payable [Abstract]
Schedule of Minimum Required Principal Payments	Minimum required principal payments towards the Company’s auto loans as of June 30, 2024 are as follows: Twelve months ended June 30, Repayment 2025 $ 35,240 2026 32,944 2027 26,172 Thereafter 3,285 Total $ 97,641 Twelve months ended June 30, Repayment 2025 $ 82,374 2026 85,380 2027 88,495 Thereafter 2,556,392 Total $ 2,812,641 Twelve months ended June 30, Repayment 2025 $ 166,879 2026 196,507 2027 231,396 Thereafter 2,612,991 Total $ 3,207,773	Minimum required principal payments towards the Company’s auto loans as of December 31, 2023 are as follows: Twelve months ended December 31, Repayment 2024 $ 34,383 2025 36,120 2026 27,656 2027 16,462 Total $ 114,621 Minimum required principal payments towards the Company’s building loan as of December 31, 2023 are as follows: Twelve months ended December 31, Repayment 2024 $ 80,638 2025 83,868 2026 86,928 2027 90,100 Thereafter 2,511,063 Total $ 2,852,597 Minimum required principal payments towards the Company’s secured business loan as of December 31, 2023 are as follows: Twelve months ended December 31, Repayment 2024 $ 153,784 2025 181,088 2026 213,239 2027 251,099 Thereafter 2,482,316 Total $ 3,281,526

Related Party Transactions (Tab

Related Party Transactions (Tables)	6 Months Ended	12 Months Ended
Related Party Transactions (Tables)	Jun. 30, 2024	Dec. 31, 2023
Related Party Transactions [Abstract]
Schedule of Loan Receivable Related Parties	Loan receivable — related parties: As of As of December 31, Loan to Lakeshore Acquisition II Corp. $ - $ 460,000 Total loan receivable – related parties $ - $ 460,000	Loan receivable — related parties consisted of the following as of the date indicated: December 31, December 31, Loan to Lakeshore Acquisition II Corp. $ 460,000 $ — Loan to Doudakian, Varto Levon* - — Total loan receivable – related parties $ 460,000 $ — * During 2023, Visiontech and Varto Levon Doudakian, one of the stockholders of the Company, entered into five loan agreements for total principal amount of $110,000 with 8% interest rate. On December 29, 2023, Visiontech and Varto Levon Doudakian entered into an agreement to offset bonus due to Varto Levon Doudakian with this loan and accrued interest. As of December 31, 2023, loan to Varto Levon Doudakian is $0.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2023
Income Taxes [Abstract]
Schedule of Provision for Income Taxes	The provision for income taxes for the years ended December 31, 2023 and 2022 consisted of the following: December 31, December 31, Income Tax Expense Current federal tax expense Federal $ - $ 53,687 State 2,421 22,600 Deferred tax Federal 162,048 (108,612 ) State 53,889 (36,119 ) Total $ 218,358 $ (68,444 )
Schedule of Reconciliation of Income Tax Expenses	The following is a reconciliation of income tax expenses at the effective rate to income tax at the calculated statutory rates: December 31, December 31, Statutory tax rate Federal 21.00 % 21.00 % State of California 6.81 % 6.98 % Permanent difference (4.19 )% — % Change in valuation allowance (26.69 )% (25.27 )% Effective tax rate (3.07 )% 2.71 %
Schedule of Net Deferred Taxes	The significant components that comprised the Company’s net deferred taxes are as follows: As of As of Deferred tax assets/(liabilities) Property, plant and equipment (70,758 ) (70,759 ) Right of use asset 17,283 10,631 Allowance for credit loss 327,557 73,740 Inventory impairment 355,243 - Net operating loss – federal 1,243,813 681,949 Less: valuation allowance (1,873,138 ) (479,624 ) Total deferred tax assets/(liabilities) - 215,937

Equity (Tables)

Equity (Tables)	6 Months Ended
Equity (Tables)	Jun. 30, 2024
Equity [Abstract]
Schedule of Merger	Shares issued in connection with the Company’s Merger on March 11, 2024: Common Lakeshore’s shares outstanding prior to reverse recapitalization 2,241,500 Shares issued to private rights 35,150 Conversion of the Lakeshore’s public shares and rights 790,097 Shares issued to service providers 801,539 Bonus shares issued to in connection with Lakeshore loans * 66,000 Bonus shares issued to in connection with NMI loans * 100,000 Conversion of NMI’s shares into the Company’s ordinary shares 22,272,478 Total shares outstanding 26,306,764 * In connection with the Merger, the Company, Lakeshore and NMI further entered into a Letter Agreement on November 15, 2023, a total of 125,000 shares of the Company’s common stock will be issued upon closing of the Merger in connection with certain transactions relating to the Merger: (i) 50,000 shares to Tie (James) Li and 50,000 shares to Zhiyi (Jonathan) Zhang (or 100,000 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of NMI with the principal amount of $3,700,000; (ii) 12,500 shares to Tie (James) Li and 12,500 shares to Deyin (Bill) Chen (or 25,000 shares in the aggregate) in connection with their loans to Lakeshore, each with the principal amount of $125,000 under separate but similar loan agreements); At the Close of Merger, additional shares of 16,000 and 25,000 were issued to Tie (James) Li and Prosperity Spring International Investment Management in connection with their loans to Lakeshore.

Concentration of Risk (Tables)

Concentration of Risk (Tables)	6 Months Ended	12 Months Ended
Concentration of Risk (Tables)	Jun. 30, 2024	Dec. 31, 2023
Concentration of Risk [Abstract]
Schedule of Major Customers	During the three and six months ended June 30, 2024 and during the three and six months ended June 30, 2023, the major customers of the Company are as below. For the For the As of Percentage of Percentage of Percentage of Customer A 39 % 24 % 49 % Customer C 15 % 11 % 15 % Iluminar 17 % 18 % 26 % For the For the As of Percentage of Percentage of Percentage of Customer C <10 % 15 % 13 % Customer G <10 % <10 % 31 % Customer H <10 % <10 % 12 % Customer I <10 % <10 % 10 % Iluminar <10 % <10 % 18 % Customer E <10 % 16 % <10 % Customer F 20 % <10 % <10 %	During the year ended December 31, 2023 and 2022, the major customers of the Company are as below. For the As of Percentage of Percentage of Customer C 13% 13 Customer G <10% 31 Customer H <10% 12 Customer I <10% 10% Iluminar <10% 18 For the As of Percentage of Percentage of Iluminar <10% 39 Customer B <10% 12 Customer C <10% 12 Customer D <10% 11% Customer E 17% <10% Customer F 15 <10%
Schedule of Major Vendors	During the three and six months ended June 30, 2024 and during the three and six months ended June 30, 2023, the major vendors of the Company are as below. For the For the As of Percentage of Percentage of Percentage of Megaphoton Inc. <10 % <10 % 53 % Uninet Global Inc. <10 % <10 % 23 % Vendor A 29 % 48 % <10 % Vendor E 57 % 38 % 11 % For the For the As of Percentage of Percentage of Percentage of Megaphoton 15 % 14 % 62 % Uninet Global Inc. <10 % <10 % 20 % Vendor A 68 % 55 % <10 % Vendor D <10 % 14 % <10 %	During the year ended December 31, 2023 and 2022, the major vendors of the Company are as below. For the As of Percentage of Percentage of Vendor A 52% <10% Vendor B 25% <10% Megaphoton Inc. <10% 62% Uninet Global Inc. <10% 20 For the As of Percentage of Percentage of Megaphoton 49 53 % Uninet Global Inc. <10% 27 Vendor A 20 14

Lease (Tables)

Lease (Tables)	6 Months Ended	12 Months Ended
Lease (Tables)	Jun. 30, 2024	Dec. 31, 2023
Lease [Abstract]
Schedule of Lease Cost	As of June 30, 2024 and December 31, 2023, the average discount rate of its existing leases is approximately 6.80% and 6.81%, respectively. For the For the June 30, June 30, June 30, June 30, Lease cost (Unaudited) (Unaudited) (Unaudited) (Unaudited) Operating lease cost (included in Cost of Revenue and Other Expense in the Company’s Statement of Operations) $ 105,112 $ 105,195 $ 168,245 $ 241,745 Other information Cash paid for amounts included in the measurement of lease liabilities 81,389 126,013 116,234 253,572	Year Ended December 31, 2023 and 2022: Lease cost December 31, December 31, Operating lease cost (included in Cost of Revenue and Other Expense in the Company’s Statement of Operations) $ 414,370 $ 303,157 Other information Cash paid for amounts included in the measurement of lease liabilities 442,252 327,091 Weighted average remaining term in years 1.45 2.22 Average discount rate – operating leases 6.81 % 6.05 %
Schedule of Balance Sheet Information Related to Leases	The supplemental balance sheet information related to leases for the period is as follows: As of As of Operating leases Right of use asset 578,179 503,089 Lease Liability – current portion 460,311 359,459 Lease Liability – net of current portion 184,147 157,897 Total operating lease liabilities $ 644,458 $ 517,356	The supplemental balance sheet information related to leases for the period is as follows: As of As of Operating leases Right of use asset 503,089 973,147 Lease Liability – current portion 359,459 468,425 Lease Liability – net of current portion 157,897 542,709 Total operating lease liabilities $ 517,356 $ 1,011,134
Schedule of Maturities of Lease Liabilities	Maturities of the Company’s lease liabilities are as follows: Twelve months ended June 30, Operating 2025 $ 486,748 2026 105,929 2027 90,470 Less: Imputed interest/present value discount (38,690 ) Present value of lease liabilities $ 644,458	Maturities of the Company’s lease liabilities are as follows: Twelve months ended December 31, Operating 2024 $ 383,236 2025 160,494 Less: Imputed interest/present value discount (26,374 ) Present value of lease liabilities $ 517,356

Subsequent Events (Tables)

Subsequent Events (Tables)	6 Months Ended	12 Months Ended
Subsequent Events (Tables)	Jun. 30, 2024	Dec. 31, 2023
Subsequent Events [Abstract]
Schedule of Common Stock Issued and Outstanding	The following table presents the number of the Company’s common stock issued and outstanding immediately following the reverse recapitalization: Common Lakeshore’s shares outstanding prior to reverse recapitalization 2,241,500 Shares issued to private rights 35,150 Conversion of the Lakeshore’s public shares and rights 790,097 Shares issued to service providers 801,539 Bonus shares issued to investors 166,000 Conversion of NMI’s shares into the Company’s ordinary shares 22,272,478 Total shares outstanding 26,306,764	The following table presents the number of the Company’s common stock issued and outstanding immediately following the Reverse Recapitalization: Common Stock The Company’s shares outstanding prior to Reverse Recapitalization 2,241,500 Shares issued to private rights 35,150 Conversion of the Company’s public shares and rights 790,097 Shares issued to service providers 801,539 Bonus shares issued to investors 166,000 Conversion of Nature’s Miracle’s shares into the Company’s ordinary shares 22,272,478 Total shares outstanding 26,306,764

Reverse Recapitalization (Table

Reverse Recapitalization (Tables)	6 Months Ended	12 Months Ended
Reverse Recapitalization (Tables)	Jun. 30, 2024	Dec. 31, 2023
Reverse Recapitalization [Abstract]
Schedule of Common Stock Issued and Outstanding Reverse Recapitalization	The following table presents the number of the Company’s common stock issued and outstanding immediately following the reverse recapitalization: Common Lakeshore’s shares outstanding prior to reverse recapitalization 2,241,500 Shares issued to private rights 35,150 Conversion of the Lakeshore’s public shares and rights 790,097 Shares issued to service providers 801,539 Bonus shares issued to investors 166,000 Conversion of NMI’s shares into the Company’s ordinary shares 22,272,478 Total shares outstanding 26,306,764	The following table presents the number of the Company’s common stock issued and outstanding immediately following the Reverse Recapitalization: Common Stock The Company’s shares outstanding prior to Reverse Recapitalization 2,241,500 Shares issued to private rights 35,150 Conversion of the Company’s public shares and rights 790,097 Shares issued to service providers 801,539 Bonus shares issued to investors 166,000 Conversion of Nature’s Miracle’s shares into the Company’s ordinary shares 22,272,478 Total shares outstanding 26,306,764
Schedule of Reverse Recapitalization	The following table reconcile the elements of the reverse recapitalization to the consolidated statements of cash flows and the changes in shareholders’ equity (deficit): As of Funds held in Lakeshore’s trust account $ 15,067,702 Funds held in Lakeshore’s operating cash account 198 Less: amount paid to redeem public shares of Lakeshore’s ordinary shares (13,947,723 ) Proceeds from the reverse recapitalization 1,120,177 Less: payments of transaction costs incurred by Lakeshore (1,044,980 ) Less: repayments of promissory note – related party of Lakeshore’ (75,000 ) Less: notes assumed from Lakeshore (555,000 ) Less: liability assumed from Lakeshore (1,547,814 ) Less: transaction costs paid by NMI (1,100,857 ) Add: receivable assumed from Lakeshore 500,000 Net liabilities assumed from issuance of common stock upon the Merger, balance classified to retained deficit $ (2,703,474 )

Nature of Business and Organi_2

Nature of Business and Organization (Details)

12 Months Ended

May 07, 2024 shares

Aug. 18, 2022 USD ($)

Aug. 18, 2022 CAD ($)

Jun. 01, 2022 shares

Apr. 15, 2022 shares

Jan. 10, 2022 USD ($)

Aug. 27, 2021 USD ($)

Dec. 31, 2023 USD ($)

Dec. 31, 2022 USD ($)

Aug. 13, 2024 USD ($)

Jun. 30, 2024 USD ($)

Mar. 11, 2024

Jun. 14, 2023 USD ($)

Jan. 17, 2023 USD ($)

Aug. 27, 2022 USD ($)

Nature of Business and Organization [Line Items]

Aggregate value (in Dollars)

$ 230,000,000

Shares issued (in Shares) | shares

150,000

Equivalent (in Dollars)

$ 45,500

221,760

$ 810,371

$ 30,532

Payment cost (in Dollars)

$ 1,574,079

Commercial loan fixed rate (in Dollars)

$ 3,000,000

Fixed rate percentage

3.79%

Upland promised to pay (in Dollars)

$ 4,395,230

$ 1,574,079

Original principal amount (in Dollars)

110,000

$ 181,700

$ 3,700,000

$ 294,985

$ 1,574,079

Upland purchased warehouse (in Dollars)

$ 4,395,230

Visiontech Group, Inc [Member]

Nature of Business and Organization [Line Items]

Interest rate percentage

4.90%

Nature’s Miracle, Inc [Member]

Nature of Business and Organization [Line Items]

Ownership, percentage

100%

84.70%

Merger Agreement [Member]

Nature of Business and Organization [Line Items]

Ownership, percentage

100%

Visiontech Group, Inc [Member]

Nature of Business and Organization [Line Items]

Ownership, percentage

56.30%

Share Exchange Agreement [Member]

Nature of Business and Organization [Line Items]

Ownership, percentage

100%

Nature’s Miracle, Inc [Member]

Nature of Business and Organization [Line Items]

Voting percentage

50%

Visiontech [Member]

Nature of Business and Organization [Line Items]

Voting percentage

100%

Hydroman [Member]

Nature of Business and Organization [Line Items]

Voting percentage

100%

Photon Technology (Canada) Ltd [Member]

Nature of Business and Organization [Line Items]

Voting percentage

100%

Total consideration

$ 62,571

Director [Member] | Nature’s Miracle, Inc [Member]

Nature of Business and Organization [Line Items]

Voting percentage

84.70%

Common Stock [Member]

Nature of Business and Organization [Line Items]

Shares issued (in Shares) | shares

6,904,468

Issuing shares (in Shares) | shares

6,844,000

Common Stock [Member] | Hydroman [Member]

Nature of Business and Organization [Line Items]

Shares issued (in Shares) | shares

6,844,000

Going Concern (Details)

Going Concern (Details) - USD ($)

6 Months Ended

Aug. 13, 2024

Jul. 30, 2024

Jul. 25, 2024

Jul. 16, 2024

Jul. 03, 2024

May 07, 2024

May 02, 2024

Mar. 07, 2024

Apr. 15, 2022

Jun. 30, 2024

Jul. 19, 2024

Dec. 31, 2023

Jul. 11, 2023

Jun. 14, 2023

Jan. 17, 2023

Dec. 31, 2022

Aug. 27, 2022

Going Concern [Line Items]

Bank deposits

$ 31,000,000,000

$ 200,000

$ 800,000

Working capital deficit

$ 13,000,000

$ 7,400,000

$ 3,300,000

Convertible note investment

$ 125,000

Deposited

$ 410,000

Original issue discount

$ 27,500

Exercise price per share (in Dollars per share)

$ 9.2

Other fees

$ 212,400

$ 42,500

Commitment underwritten public offering (in Shares)

150,000

Common stock, par value (in Dollars per share)

[1]

$ 0.0001

Gross proceeds

$ 1,200,000

Principal amount

$ 181,700

$ 110,000

$ 3,700,000

$ 294,985

$ 1,574,079

Original issue discount

23,700

Closing expenses

8,000

$ 660,000

Aggregate financing

$ 230,000,000

Monthly installments

20,350

July 2024 Warrant [Member]

Going Concern [Line Items]

Warrant to purchase (in Shares)

217,500

July 2024 Warrant Shares [Member]

Going Concern [Line Items]

Exercise price per share (in Dollars per share)

$ 0.87

Warrant [Member]

Going Concern [Line Items]

Exercise price per share (in Dollars per share)

$ 0.24

$ 0.01

Nature's Miracle Holding Inc [Member]

Going Concern [Line Items]

Convertible note investment

$ 1,405,000

Interest rate

10%

Purchase Commitment [Member]

Going Concern [Line Items]

Issued shares (in Shares)

180,000

Diagonal Lending LLC [Member]

Going Concern [Line Items]

Aggregate financing

1,000,000

Subsequent Event [Member]

Going Concern [Line Items]

Convertible note investment

$ 410,000

Interest rate

12%

Accumulated interest (in Dollars per share)

$ 0.442

Convertible note

$ 180,000

Original issue discount

23,700

Exercise price per share (in Dollars per share)

$ 0.24

$ 0.87

Commitment underwritten public offering (in Shares)

180,000

Closing expenses

8,000

Monthly installments

$ 20,350

EF Hutton LLC [Member]

Going Concern [Line Items]

Commitment underwritten public offering (in Shares)

5,000,000

Common Stock [Member]

Going Concern [Line Items]

Commitment underwritten public offering (in Shares)

6,904,468

Common stock, par value (in Dollars per share)

$ 0.0001

Private Placement [Member]

Going Concern [Line Items]

Convertible note

$ 180,000

[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Federal Deposit Insurance		$ 250,000		$ 250,000
Inventory impairment loss				$ 1,269,469	$ 0
Percentage of investments voting shares		20%		20%
Goodwill impairment loss				$ 1,023,533
Interest income				78,385	$ 22,764
Credit loss				$ 200,000
Reportable segment				1
Interest income amount	$ 44,239		$ 78,385

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Straight-Line Method Over the Useful Lives	Dec. 31, 2023
Machinery and equipment [Member]
Schedule of Straight-Line Method Over the Useful Lives [Line Items]
Property Plant And Equipment Useful Life	5 years
Computer and peripherals [Member]
Schedule of Straight-Line Method Over the Useful Lives [Line Items]
Property Plant And Equipment Useful Life	3 years
Trucks And Automobiles [Member]
Schedule of Straight-Line Method Over the Useful Lives [Line Items]
Property Plant And Equipment Useful Life	5 years
Buildings [Member]
Schedule of Straight-Line Method Over the Useful Lives [Line Items]
Property Plant And Equipment Useful Life	39 years

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Deferred Income and Contract Liabilities - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Deferred Income and Contract Liabilities [Abstract]
Beginning balance	$ 118,909	$ 808,118	$ 997,732
Prepayments from customers	470,967	1,370,836	1,352,698
Recognized as revenues	(525,807)	(2,060,045)	(1,542,312)
Ending balance	$ 64,069	$ 118,909	$ 808,118

Variable Interest Entity (Detai

Variable Interest Entity (Details)	12 Months Ended
Variable Interest Entity (Details)	Dec. 31, 2023 USD ($)
Variable Interest Entity [Abstract]
Interest expense	$ 155,806
Intercompany payable to Visiontech	$ 1,411,025

Variable Interest Entity (Det_2

Variable Interest Entity (Details) - Schedule of Carrying Amount of Assets and Liabilities - Variable Interest Entity, Primary Beneficiary [Member] - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Schedule of Carrying Amount of Assets and Liabilities [Line Items]
Cash	$ 1,046	$ 8,889
Prepaid expense	1,800	1,800
Property and equipment, net	4,180,504	4,224,930
Total assets	4,183,350	4,235,619
Current portion of long-term debt	82,374	80,638
Long-term debt, net of current portion	2,730,266	2,771,959
Intercompany payable to Visiontech	1,367,078	1,411,025
Total liabilities	$ 4,180,116	$ 4,263,622

Variable Interest Entity (Det_3

Variable Interest Entity (Details) - Schedule of Operating Results of VIE - Variable Interest Entity, Primary Beneficiary [Member]	12 Months Ended
	Dec. 31, 2023 USD ($)
Schedule of Operating Results of VIE [Line Items]
Revenue	$ 332,842	[1]
Selling, general and administrative	(169,563)
Interest expense	(259,713)	[2]
Income tax	(800)
Net loss	$ (97,234)

[1] Upland generated its revenue from leasing the warehouse to Visiontech. Revenue of Upland was fully eliminated on the consolidated statements of operations. Upland generated interest expense of $155,806 from the intercompany payable to Visiontech of $1,411,025, both amounts were eliminated on the consolidated statements of operations.

Business Combination (Details)

Business Combination (Details) - USD ($) $ in Millions		12 Months Ended
Business Combination (Details) - USD ($) $ in Millions	Jun. 01, 2022	Dec. 31, 2023
Business Combination [Line Items]
Goodwill arising from the acquisition		$ 1
Nature’s Miracle’s [Member]
Business Combination [Line Items]
Business combination acquired percentage	100%
Common Stock [Member]
Business Combination [Line Items]
Shares issued	6,459,019
Nature’s Miracle’s [Member] \| Common Stock [Member]
Business Combination [Line Items]
Shares issued	6,844,000

Business Combination (Details)

Business Combination (Details) - Schedule of Fair Value of the Identifiable Assets Acquired and Liabilities	Dec. 31, 2023 USD ($)
Schedule of Fair Value of the Identifiable Assets Acquired and Liabilities [Abstract]
Cash	$ 97,650
Inventories, net	3,538,989
Other current assets	163,009
Right-of-use assets	1,227,673
Deferred tax assets	115,562
Other non-current assets	120,538
Accounts payable – related parties	(3,752,571)
Other current liabilities	(780,423)
Other non-current liabilities	(828,960)
Net assets acquired	(98,533)
Goodwill on acquisition	1,023,533
Total consideration	$ 925,000

Goodwill (Details)

Goodwill (Details) - USD ($)	12 Months Ended
Goodwill (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Goodwill [Abstract]
Goodwill impairment loss	$ 1,023,533	$ 0

Goodwill (Details) - Schedule o

Goodwill (Details) - Schedule of Changes in Carrying Amount of Goodwill - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Changes in Carrying Amount of Goodwill [Abstract]
Beginning balance	$ 1,023,533
Acquisitions		1,023,533
Goodwill impairment	(1,023,533)
Ending balance		$ 1,023,533

Accounts Receivable, Net (Detai

Accounts Receivable, Net (Details) - USD ($)	3 Months Ended		6 Months Ended
Accounts Receivable, Net (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Jul. 12, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounts receivable, Net [Line Items]
Account receivable non current							$ 138,613
Credit loss termination						$ 193,795
Credit losses	$ 683,364	$ 259,690	$ 683,364	$ 259,690	669,974		259,690	$ 15,898
Provision for credit losses	$ 14,176	$ (23,401)	$ 24,391	$ 789
Related Party [Member]
Accounts receivable, Net [Line Items]
Account receivable current					0		462,114
Credit losses					$ 907,021		$ 322,395

Accounts Receivable, Net (Det_2

Accounts Receivable, Net (Details) - Schedule of Accounts Receivable - Accounts Receivable [Member] - USD ($)		Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable		$ 2,737,042	$ 1,906,222	$ 3,953,635
Less: allowance for credit losses			(669,974)	(259,690)
Total accounts receivable, net		$ 2,771,513	1,541,917	3,693,945
Accounts receivable – non-current	[1]			138,613
Accounts receivable – current			1,541,917	3,555,332
Related Party [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable			$ 305,669

[1] On November 11, 2022, the Company had one contract with customer with installment payment terms of up to 16 months. The difference between the contract price and the Company’s cash selling price of the same products are recognized as interest income over the term of the payments. As of December 31, 2023 and 2022, the account receivable of this client was $0 and $462,114, of which account receivable -non-current was $0

Accounts Receivable, Net (Det_3

Accounts Receivable, Net (Details) - Schedule of Allowance for Credit Losses - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Schedule Of Allowance For Credit Losses Abstract
Beginning balance	$ 669,974	$ 259,690	$ 259,690	$ 15,898
Allowance from acquisition of Hydroman				4,964
Addition	24,391	907,021	907,021	322,395
Write-off	(11,001)	(496,737)	(496,737)	(83,567)
Ending balance	$ 683,364	$ 669,974	$ 669,974	$ 259,690

Loans Receivable (Details)

Loans Receivable (Details) - USD ($)	3 Months Ended		6 Months Ended
Loans Receivable (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2022
Visiontech and CGGP, LLC (“CGGP”) [Member]
Loans Receivable (Details) [Line Items]
Total amount					$ 123,688
Annual rate percentage					7%		7%
Iinstallment payments					$ 21,038	$ 62,383	$ 21,038
Amount of notes							$ 123,688
Loans payable	$ 0		$ 62,383
Visiontech and NewCo Vision, LLC (“NewCo”) [Member]
Loans Receivable (Details) [Line Items]
Total amount					$ 139,840
Annual rate percentage					7%		7%
Iinstallment payments					$ 23,785	$ 70,530	$ 23,785
Amount of notes							$ 139,840
Loans payable		$ 0		$ 70,530

Loans Receivable (Details) - Sc

Loans Receivable (Details) - Schedule of Loans Receivable - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Schedule of Loans Receivable [Line Items]
Total loan receivable		$ 132,913
Loan to CGGP, LLC [Member]
Schedule of Loans Receivable [Line Items]
Total loan receivable		62,383
Loan to NewCo Vision, LLC [Member]
Schedule of Loans Receivable [Line Items]
Total loan receivable		$ 70,530

Cost Method Investment (Details

Cost Method Investment (Details) - Iluminar Lighting LLC [Member]	Apr. 11, 2023 USD ($) shares
Cost Method Investment (Details) [Line Items]
Accounts receivable \| $	$ 1,000,000
Shares of iluminar \| shares	1,033,333
Outstanding shares	10%
Accounts receivable \| $	$ 1,000,000
Shares of illuminar \| shares	1,033,333
Shares outstanding percent	10%

Cost Method Investment (Detai_2

Cost Method Investment (Details) - Schedule of Cost Method Investment - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Cost Method Investment [Abstract]
10% Investment of Iluminar	$ 1,000,000	$ 1,000,000
Total	$ 1,000,000	$ 1,000,000

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Property and Equipment, Net (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Property and Equipment, Net [Line Items]
Depreciation expense	$ 39,860	$ 41,694	$ 79,720	$ 83,388	$ 164,942	$ 141,342
Disposals of property and equipment					$ 17,219	$ 0

Property and Equipment, Net (_2

Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	$ 4,748,176	$ 4,748,176	$ 4,780,081
Less: accumulated depreciation	(421,624)	(341,904)	(191,648)
Property, Plant and Equipment, Net	4,326,552	4,406,272	4,588,433
Computers & Peripherals [Member]
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross			7,167
Trucks & Automobiles [Member]
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	285,099	285,099	293,599
Machinery & Equipment [Member]
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	67,847	67,847	84,085
Building [Member]
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	3,465,230	3,465,230	3,465,230
Land [Member]
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	$ 930,000	$ 930,000	$ 930,000

Loans Payable (Details)

Loans Payable (Details)																									3 Months Ended		6 Months Ended		12 Months Ended
Loans Payable (Details)	Dec. 11, 2024 USD ($)	Aug. 13, 2024 USD ($)	Jul. 30, 2024 USD ($)	Jun. 06, 2024 USD ($)	Jun. 06, 2024 AFN (؋)	May 02, 2024 USD ($)	Mar. 11, 2024 USD ($)	Mar. 07, 2024 USD ($)	Oct. 30, 2023 USD ($)	Oct. 23, 2023 USD ($)	Jun. 14, 2023 USD ($)	Feb. 13, 2023 USD ($)	Nov. 18, 2022 USD ($)	Nov. 02, 2022 USD ($)	Oct. 31, 2022 USD ($)	Sep. 28, 2022 USD ($)	Sep. 21, 2022 USD ($)	Sep. 18, 2022 USD ($)	Sep. 01, 2022 USD ($)	Aug. 31, 2022 USD ($)	Jan. 10, 2022 USD ($)	Aug. 27, 2021 USD ($)	Jun. 08, 2021 USD ($)	Feb. 27, 2021 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jul. 11, 2023 USD ($)	May 28, 2023 USD ($)	May 19, 2023	Jan. 17, 2023 USD ($)	Aug. 27, 2022 USD ($)
Loans Payable [Line Items]
Short-term loans paid																									$ 2,928,183		$ 2,928,183		$ 509,443	$ 1,453,464
Debt extinguishment																													200,000
Accounts receivable						$ 1,240,150																							305,669
Purchase price						807,500															$ 3,000,000
Total fees			$ 212,400			42,500
Weekly installment																	$ 2,244.38
Number of weekly installment																	364 days
Effective interest rate												16.85%					31.22%	10.80%							16.85%		16.85%						10.80%
Borrowing amount																													$ 503,500	$ 317,857
Weighted average effective interest rate																													85.36%	92.64%
Outstanding balance																											$ 737,375		$ 409,443	$ 1,435,285
Principal amount					؋ 288,750												$ 100,000
Bank loan balance																													0	76,064
Gross policy premium and related fees												$ 4,812						$ 35,508
Financed cost												4,461						26,387
Monthly installments payable												$ 481						$ 3,065							$ 15,165		15,165		15,165			$ 15,000
Premium financing loan																													0	14,922
Borrowed principal amount									$ 100,000
Annual interest rate							8%		12%																									8%
Loan balance																													100,000
Interest expenses short term loan																									304,302	$ 5,364	428,215	$ 381,814	428,159	635,296
Outstanding amount																									97,641		97,641		114,621	147,354
Purchase amount																					$ 4,395,230	$ 1,574,079
Principal of the loan																											73,752		32,733	24,333
Outstanding amount of building loan																											3,207,773
Secured business loan																													3,281,526	0
Principal sum		$ 181,700									$ 3,700,000																		110,000					$ 294,985	$ 1,574,079
Net proceed amount																													3,300,000
Debt issuance cost																													360,000
Interest expenses long term																									159,385	28,870	320,304	56,594	406,442	102,854
Weekly installment		$ 20,350
Pay a weekly installment				$ 15,056		$ 41,000
Loan balance																													0
Principal amount																															$ 125,000
Total payments of loan							$ 75,000
Short-Term Loans [Member]
Loans Payable [Line Items]
Short-term loans paid																													1,900,000
Purchase amount																													78,077	69,326
Auto Loans [Member]
Loans Payable [Line Items]
Maturity date																								Feb. 28, 2026
Principal of the loan																									8,541	8,130	16,980	16,168
Secured business loan [Member]
Loans Payable [Line Items]
Maturity date											Jul. 01, 2033
Principal of the loan																									37,629	0		0
Outstanding amount of building loan																													3,281,526
Principal sum											$ 3,700,000
Factor H [Member]
Loans Payable [Line Items]
Accounts receivable										$ 768,500
Purchase price										503,500
Total fees										26,500
Final payment										38,500
Principal of the loan																									70,125		70,125
Weekly installment										$ 22,814.84
Effective interest rate										85.36%
Loan balance																									175,315		$ 175,315
Merchants [Member]
Loans Payable [Line Items]
Effective interest rate																											93.05%
Seven Promissory Notes [Member]
Loans Payable [Line Items]
Borrowed principal amount																									380,000		$ 380,000
Interest rate																											0%
Agile Capital Funding LLC [Member]
Loans Payable [Line Items]
Effective interest rate																											99.88%
Factor A [Member]
Loans Payable [Line Items]
Purchase price																				$ 712,500
Total fees																				37,500
Weekly installment																				$ 26,625
Principal of the loan																										181,461		326,233
Effective interest rate																				105.19%
Factor B [Member]
Loans Payable [Line Items]
Accounts receivable																			$ 458,500
Purchase price																			339,465
Total fees																			10,500
Weekly installment																			$ 8,817.31
Effective interest rate																			55.79%
Principal of the loan																										178,874		262,157
Factor C [Member]
Loans Payable [Line Items]
Accounts receivable															$ 675,000
Purchase price															485,000
Total fees															15,000
Weekly installment															$ 16,071
Principal of the loan																										247,619		367,632
Effective interest rate															106.56%
Capital Management Institution D [Member]
Loans Payable [Line Items]
Principal of the loan																										0		68,868
Factor E [Member]
Loans Payable [Line Items]
Accounts receivable														$ 374,750
Purchase price														225,000
Weekly installment														$ 15,615
Effective interest rate														84.67%
Final payment														$ 25,000
Principal of the loan																										129,673		188,441
Factor F [Member]
Loans Payable [Line Items]
Accounts receivable													$ 206,113
Purchase price													123,750
Total fees													13,750
Weekly installment													$ 8,588
Effective interest rate													89.96%
Principal of the loan																										75,112		110,977
Factor G [Member]
Loans Payable [Line Items]
Accounts receivable													$ 206,113
Purchase price													123,750
Total fees													13,750
Weekly installment													$ 8,588
Effective interest rate													89.96%
Principal of the loan																										69,112		110,977
WebBank [Member]
Loans Payable [Line Items]
Principal of the loan																										57,696		76,064
Long Term Debts Auto Loans [Member]
Loans Payable [Line Items]
Maturity date																								Feb. 28, 2026
Building Loan [Member]
Loans Payable [Line Items]
Principal of the loan																									$ 19,930	19,218	$ 39,957	38,831
Business Loan [Member]
Loans Payable [Line Items]
Maturity date											Jul. 01, 2033
Nature’s Miracles [Member]
Loans Payable [Line Items]
Amount of loan percent																									10%		10%
Factor A [Member]
Loans Payable [Line Items]
Accounts receivable																				$ 1,065,000
Purchase price																				712,500
Total fees																				37,500
Weekly installment																				$ 26,625
Number of weekly installment																				280 days
Effective interest rate																				105.19%
Factor B [Member]
Loans Payable [Line Items]
Accounts receivable																			$ 458,500
Purchase price																			339,465
Total fees																			10,500
Weekly installment																			$ 8,817.31
Number of weekly installment																			364 days
Effective interest rate																			55.79%
Factor C [Member]
Loans Payable [Line Items]
Accounts receivable															$ 675,000
Purchase price															485,000
Total fees															15,000
Weekly installment															$ 16,071
Number of weekly installment															294 days
Effective interest rate															106.56%
Capital Management Institution D [Member]
Loans Payable [Line Items]
Accounts receivable															$ 100,000
Purchase price															149,000
Total fees															$ 10,000
Number of weekly installment															140 days
Effective interest rate															85.25%
Purchase percentage															20%
Estimated daily payment amount															$ 1,490
Factor E [Member]
Loans Payable [Line Items]
Accounts receivable														374,750
Purchase price														225,000
Weekly installment														$ 15,615
Number of weekly installment														168 days
Effective interest rate														84.67%
Final payment														$ 25,000
Factor F [Member]
Loans Payable [Line Items]
Accounts receivable													$ 206,113
Purchase price													123,750
Total fees													13,750
Weekly installment													$ 8,588
Number of weekly installment													168 days
Effective interest rate													89.96%
Factor G [Member]
Loans Payable [Line Items]
Accounts receivable													$ 206,113
Purchase price													123,750
Total fees													13,750
Weekly installment													$ 8,588
Number of weekly installment													168 days
Effective interest rate													89.96%
Factor H [Member]
Loans Payable [Line Items]
Accounts receivable										$ 768,500
Purchase price										503,500
Total fees										26,500
Weekly installment										$ 22,814.84
Number of weekly installment										224 days
Effective interest rate										85.36%
Final payment										$ 38,500
Redone and Deyin Chen [Member]
Loans Payable [Line Items]
Accounts receivable																				$ 1,065,000
Visiontech And Hydroman [Member]
Loans Payable [Line Items]
Short-term loans paid																													822,610
Principal of the loan																									$ 227,493		$ 409,443
Nature’s Miracles [Member]
Loans Payable [Line Items]
Principal amount																									1,405,000		1,405,000
Redone and Deyin Chen (Bill) [Member]
Loans Payable [Line Items]
Effective interest rate							8%
Loan balance							$ 430,000
Principal amount							50,000
Periodic payment							$ 150,000
Interest expenses																											7,595
Agile Capital Funding LLC [Member]
Loans Payable [Line Items]
Principal of the loan																									19,192		19,192
Hydroman and ClassicPlan Premium Financing Inc [Member]
Loans Payable [Line Items]
Principal of the loan																										11,965		14,922
Hydroman and First Insurance Funding [Member]
Loans Payable [Line Items]
Principal of the loan																										$ 4,393		$ 4,812
Vehicles [Member]
Loans Payable [Line Items]
Purchase price																								$ 55,202
Monthly installments payable																								1,014
Purchase amount																								$ 68,802
Second Vehicle [Member]
Loans Payable [Line Items]
Purchase price																							$ 73,814
Monthly installments payable																							1,172
Purchase amount																							$ 86,114
Third Vehicle [Member]
Loans Payable [Line Items]
Purchase price																$ 56,440
Monthly installments payable																1,107
Purchase amount																$ 62,230
Building [Member]
Loans Payable [Line Items]
Outstanding amount of building loan																											2,812,641		2,852,597	$ 2,930,674
Independent Third Party [Member]
Loans Payable [Line Items]
Outstanding balance																											$ 100,000		$ 100,000
Borrowed principal amount									$ 100,000
Interest rate									12%
Administrative Agent Fee [Member]
Loans Payable [Line Items]
Total fees \| ؋					؋ 13,750
Forecast [Member]
Loans Payable [Line Items]
Principal of the loan								$ 1,405,000
Interest rate								10%
Forecast [Member] \| Redone and Deyin Chen (Bill) [Member]
Loans Payable [Line Items]
Periodic payment	$ 230,000																								$ 5,695

Loans Payable (Details) - Sched

Loans Payable (Details) - Schedule of Minimum Required Principal Payments - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Auto Loans [Member]
Schedule of Minimum Required Principal Payments [Line Items]
2024	$ 35,240	$ 34,383
2025	32,944	36,120
2026	26,172	27,656
2027		16,462
Thereafter	3,285
Total	97,641	114,621
Building Loan [Member]
Schedule of Minimum Required Principal Payments [Line Items]
2024	82,374	80,638
2025	85,380	83,868
2026	88,495	86,928
2027		90,100
Thereafter	2,556,392	2,511,063
Total	2,812,641	2,852,597
Business Loan [Member]
Schedule of Minimum Required Principal Payments [Line Items]
2024	166,879	153,784
2025	196,507	181,088
2026	231,396	213,239
2027		251,099
Thereafter	2,612,991	2,482,316
Total	$ 3,207,773	$ 3,281,526

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)								3 Months Ended		4 Months Ended	6 Months Ended		9 Months Ended	12 Months Ended
Related Party Transactions (Details) - USD ($)	May 02, 2024	Feb. 15, 2024	Oct. 11, 2023	Sep. 04, 2023	Jun. 16, 2023	May 19, 2023	Apr. 11, 2023	Jun. 30, 2024	Jun. 30, 2023	Apr. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Aug. 13, 2024	Mar. 11, 2024	Feb. 06, 2024	Jan. 08, 2024	Dec. 29, 2023	Dec. 07, 2023	Nov. 09, 2023	Oct. 30, 2023	Sep. 11, 2023	Aug. 10, 2023	Jul. 11, 2023	Jul. 07, 2023	Jun. 14, 2023	Jun. 08, 2023	Apr. 01, 2023	Jan. 17, 2023	Nov. 29, 2022	Aug. 27, 2022	Jun. 01, 2022	Jan. 10, 2022	Sep. 30, 2020	May 04, 2020
Related Party Transactions [Line Items]
Accounts payable amount								$ 2,713,074			$ 2,713,074			$ 2,758,074	$ 3,235,546
Purchases										$ 92,416					3,332,739
Outstanding accounts payable															5,218,444
Security deposit								27,633			27,633			47,633	66,720																							$ 500,000
Shares of Iluminar (in Shares)							1,033,333																												8,908,991
Percentage of outstanding shares							10%
Sales revenue														300,053
Cost of goods purchase														56,671
Account receivable	$ 1,240,150													305,669
Paid amount																																					$ 13,304
Bonus payable due																					$ 13,304
Outstanding amount of prepayments														0	13,304
Legal and audit fee															345,000
Outstanding amount											170,000			170,000	170,000
Principal amount														110,000			$ 181,700												$ 3,700,000			$ 294,985		$ 1,574,079
Interest rate																		8%						12%								8%
Loan amount														0
Interest income for loan receivable								0	$ 2,052		0	$ 2,425
Accrued interest								34,385			34,385			22,500
Loan Interest																																				$ 3,000,000
Interest expense for short-term loan								304,302	5,364		428,215	381,814		428,159	635,296
Sales revenue								588,720	25,097		994,098	25,097
Related Party [Member]
Related Party Transactions [Line Items]
Accrued interest expense from related parties														63,141	4,317
Interest income for loan receivable														6,861	0
Interest expense for short-term loan														80,381	4,317
Megaphoton [Member]
Related Party Transactions [Line Items]
Accounts payable amount															1,151,534
Purchases								137,974	0		230,390	0			3,997,810
Hydroman [Member]
Related Party Transactions [Line Items]
Purchases										$ 0
Yang Wei [Member]
Related Party Transactions [Line Items]
Outstanding amount											23,813			23,813	23,813
Business operating fee																$ 23,813
Zhiyi Zhang [Member]
Related Party Transactions [Line Items]
Outstanding amount											1,000			1,000	27,944
Business operating fee				$ 557		$ 1,000									27,944
Paid off balance			$ 28,501											40,000
Principal amount																																	$ 100,000
Interest rate																																	8%
Loan amount								60,000			60,000			60,000	100,000
Accrued interest								9,619			9,619			$ 7,186	723
Varto Levon Doudakian [Member]
Related Party Transactions [Line Items]
Interest rate														8%
Tie Li [Member]
Related Party Transactions [Line Items]
Principal amount															$ 610,000
Interest rate															8%
Loan amount								110,000			110,000			$ 110,000	$ 610,000
Accrued interest								110,000			110,000			110,000
Payments towards					$ 500,000								$ 500,000
Loan extended		$ 110,000												110,000
Loan Interest								13,200			13,200			8,800	3,594
Nature's Miracle Holding Inc [Member]
Related Party Transactions [Line Items]
Principal amount																															$ 160,000	$ 318,270
Interest rate																															8%	8%
Accrued interest								37,099			37,099			24,276
Iluminar Lighting LLC [Member]
Related Party Transactions [Line Items]
Purchases								1,160	0		1,160	0
Related Party [Member]
Related Party Transactions [Line Items]
Accounts receivable								717,835			717,835			305,669
Accrued interest expense from related parties											97,344			$ 63,141
Interest expense for short-term loan								18,147	$ 6,164		34,203	$ 26,033
TieJamesLi [Member]
Related Party Transactions [Line Items]
Principal amount																											$ 125,000
Interest rate																											8%
Accrued interest								$ 3,041			$ 3,041
NMCayman [Member]
Related Party Transactions [Line Items]
Principal amount																																$ 294,985
Interest rate																																8%
Promissory Note [Member]
Related Party Transactions [Line Items]
Principal amount																						$ 20,000								$ 40,000	$ 160,000
Interest rate																						0%								0%	8%
One Promissory Note [Member]
Related Party Transactions [Line Items]
Principal amount			$ 80,000																			$ 20,000						$ 80,000
Interest rate			0%																			0%						0%
Two Promissory Note [Member]
Related Party Transactions [Line Items]
Principal amount																				$ 20,000			$ 80,000			$ 80,000
Interest rate																				0%			0%			0%
Three Promissory Note [Member]
Related Party Transactions [Line Items]
Principal amount																			$ 20,000						$ 80,000
Interest rate																			0%						0%
Four Promissory Notes [Member]
Related Party Transactions [Line Items]
Principal amount			$ 80,000
Interest rate			0%
Five Promissory Note [Member]
Related Party Transactions [Line Items]
Principal amount																							$ 80,000
Interest rate																							0%
Iluminar Lighting LLC [Member]
Related Party Transactions [Line Items]
Accounts receivable							$ 1,000,000
Percentage of outstanding shares							10%
Megaphoton from Hydroman [Member]
Related Party Transactions [Line Items]
Security deposit															$ 0

Related Party Transactions (D_2

Related Party Transactions (Details) - Schedule of Loan Receivable Related Parties - USD ($)		Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Loan Receivable Related Parties [Line Items]
Loan receivable			$ 460,000
Loan to Lakeshore Acquisition II Corp. [Member]
Schedule of Loan Receivable Related Parties [Line Items]
Loan receivable			460,000
Loan to Doudakian, Varto Levon [Member]
Schedule of Loan Receivable Related Parties [Line Items]
Loan receivable	[1]

[1] During 2023, Visiontech and Varto Levon Doudakian, one of the stockholders of the Company, entered into five loan agreements for total principal amount of $110,000 with 8% interest rate. On December 29, 2023, Visiontech and Varto Levon Doudakian entered into an agreement to offset bonus due to Varto Levon Doudakian with this loan and accrued interest. As of December 31, 2023, loan to Varto Levon Doudakian is $0.

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Income Taxes [Abstract]
Income tax payable (in Dollars)					$ 299,018	$ 833,044
Deferred tax asset, net (in Dollars)						$ 215,937
Net operating loss (in Dollars)					$ 6,800,000
Effective tax rate	0%	25.50%	(0.10%)	19.20%	(3.07%)	2.71%
Federal statutory tax rate			21%		21%	21%
State statutory tax rate			21%		6.81%	6.98%

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of Provision for Income Taxes - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Current federal tax expense
Federal		$ 53,687
State	2,421	22,600
Deferred tax
Federal	162,048	(108,612)
State	53,889	(36,119)
Total	$ 218,358	$ (68,444)

Income Taxes (Details) - Sche_2

Income Taxes (Details) - Schedule of Reconciliation of Income Tax Expenses	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Schedule of Reconciliations of Statutory Income Tax Rate [Abstract]
Federal			21%		21%	21%
State of California			21%		6.81%	6.98%
Permanent difference					(4.19%)
Change in valuation allowance					(26.69%)	(25.27%)
Effective tax rate	0%	25.50%	(0.10%)	19.20%	(3.07%)	2.71%

Income Taxes (Details) - Sche_3

Income Taxes (Details) - Schedule of Net Deferred Taxes - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets/(liabilities)
Property, plant and equipment	$ (70,758)	$ (70,759)
Right of use asset	17,283	10,631
Allowance for credit loss	327,557	73,740
Inventory impairment	355,243
Net operating loss – federal	1,243,813	681,949
Less: valuation allowance	(1,873,138)	(479,624)
Total deferred tax assets/(liabilities)		$ 215,937

Equity (Details)

Equity (Details) - USD ($)								3 Months Ended	6 Months Ended		12 Months Ended
Equity (Details) - USD ($)		Oct. 01, 2024	Aug. 13, 2024	May 07, 2024	Apr. 02, 2024	Jun. 01, 2022	Apr. 15, 2022	Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2024	Jul. 25, 2024	May 23, 2024	Mar. 31, 2024	Nov. 15, 2023	Apr. 11, 2023	Mar. 31, 2023	Dec. 31, 2021
Equity [Line Items]
Common stock, shares authorized	[1]							100,000,000	100,000,000		100,000,000	100,000,000
Common stock par value per share (in Dollars per share)	[1]							$ 0.0001	$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock shares authorized								1,000,000	1,000,000		1,000,000	1,000,000
Preferred stock per share (in Dollars per share)								$ 0.0001	$ 0.0001		$ 0.0001	$ 0.0001
Shares to issue				150,000
Raising net proceeds (in Dollars)							$ 394,000					$ 394,000
Shares outstanding						8,908,991												1,033,333
Equity interest						100%
Shares issued	[1]							26,456,764	26,456,764		22,272,478	22,272,478
Related party, description									(i) 50,000 shares to Tie (James) Li and 50,000 shares to Zhiyi (Jonathan) Zhang (or 100,000 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of NMI with the principal amount of $3,700,000; (ii) 12,500 shares to Tie (James) Li and 12,500 shares to Deyin (Bill) Chen (or 25,000 shares in the aggregate) in connection with their loans to Lakeshore, each with the principal amount of $125,000 under separate but similar loan agreements); At the Close of Merger, additional shares of 16,000 and 25,000 were issued to Tie (James) Li and Prosperity Spring International Investment Management in connection with their loans to Lakeshore		(i) 50,000 shares to Tie (James) Li and 50,000 shares to Zhiyi, Zhang (or 100,000 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of Natures Miracle with the principal amount of $3,700,000; (ii) 12,500 shares to Tie (James) Li and 12,500 shares to Deyin (Bill) Chen (or 25,000 shares in the aggregate) in connection with their loans to Lakeshore, each with the principal amount of $125,000 under separate but similar loan agreements); (iii) 10,000 shares to Charles Jourdan Hausman in connection with his appointment as a board member with Nature’s Miracle and (iv) 100,000 shares to Darin Carpenter in connection with an employment agreement with Nature’s Miracle.
Shares value (in Dollars)											$ 2,350,000
Number of share rate											10%
Incentive plan											5%
Price per share (in Dollars per share)															$ 1
Shares value (in Dollars)									$ 1,000,000
Shares awarded									100,000
Expenses (in Dollars)			$ 8,000						$ 660,000
Compensation expenses (in Dollars)								$ 195,908	367,805
Fair value of shares (in Dollars)					$ 143,000			$ 178,000	$ 178,000
Fair value per share (in Dollars per share)					$ 0.95			$ 0.89	$ 0.89
Cash payment (in Dollars)					$ 14,000				$ 266,925	$ 533,929	$ 438,932	$ 395,000
Warrants outstanding								3,625,750	3,625,750
Exercise price per share (in Dollars per share)								$ 9.2	$ 9.2
Sale price of ordinary share (in Dollars per share)									$ 18
Trading days									20
Threshold consecutive trading days for redemption of warrants									30
Redemption period									30 days
Consummation of business									90
Market value rate									115%
Trigger price (in Dollars per share)								$ 18	$ 18
Issued price rate								180%	180%
Warrant [Member]
Equity [Line Items]
Warrants outstanding								3,625,750	3,625,750
Ordinary price per share (in Dollars per share)								$ 11.5	$ 11.5
Exercise price per share (in Dollars per share)								$ 0.01	$ 0.01					$ 0.24
Public Warrants [Member]
Equity [Line Items]
Warrants outstanding								3,450,000	3,450,000
Private Warrants [Member]
Equity [Line Items]
Warrants outstanding								175,750	175,750
Incentive Plan 2024 [Member]
Equity [Line Items]
Number of share rate									10%
Incentive plan									5%
Compensation expenses (in Dollars)									$ 1,100,000
Common Stock [Member]
Equity [Line Items]
Common stock par value per share (in Dollars per share)											$ 0.0001
Shares to issue	[2]											6,904,468
Shares outstanding	[2]							26,456,764	26,456,764	22,272,478	22,272,478	22,272,478				26,306,764			22,272,478	8,908,991
Shares issued	[2]											6,459,019
Common stock share vested					75,000
Preferred Stock [Member]
Equity [Line Items]
Preferred stock shares authorized											10,000,000
Preferred stock per share (in Dollars per share)											$ 0.0001
Business Combination [Member]
Equity [Line Items]
Ordinary price per share (in Dollars per share)								$ 9.2	$ 9.2
MZHCI LLC [Member]
Equity [Line Items]
Shares to issue					150,000
Visiontech [Member]
Equity [Line Items]
Equity interest						100%			60%
James [Member]
Equity [Line Items]
Shares issued											50,000
Zhiyi Zhang [Member]
Equity [Line Items]
Shares issued											50,000
George Yutuc [Member]
Equity [Line Items]
Vest over time shares									100,000
Kirk Collins [Member]
Equity [Line Items]
Vest over time shares									50,000
Amber Wang [Member]
Equity [Line Items]
Vest over time shares									50,000
Director [Member] \| Charles Hausman [Member]
Equity [Line Items]
Shares issued											10,000
Chief Operating Officer [Member] \| Common Stock [Member]
Equity [Line Items]
Shares issued											100,000
Common Stock [Member]
Equity [Line Items]
Common stock, shares authorized								100,000,000	100,000,000		100,000,000
Common stock par value per share (in Dollars per share)								$ 0.0001	$ 0.0001					$ 0.0001
Shares to issue							6,904,468
Shares outstanding													26,306,764
Shares issued						6,459,019
Shares issued											235,000
Shares issued						6,844,000
Price per share (in Dollars per share)								$ 10	$ 10
Common Stock [Member] \| Letter Agreement [Member]
Equity [Line Items]
Shares issued																	125,000
Preferred Stock [Member]
Equity [Line Items]
Capital stock								110,000,000	110,000,000
Preferred stock shares authorized								10,000,000	10,000,000
Preferred stock per share (in Dollars per share)								$ 0.0001	$ 0.0001
Forecast [Member]
Equity [Line Items]
Fair value per share (in Dollars per share)					$ 0.95
Common stock share vested		75,000
Preferred Stock [Member]
Equity [Line Items]
Capital stock											110,000,000

[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024 Giving retroactive effect to reverse recapitalization effected on March 11, 2024

Concentration of Risk (Details)

Concentration of Risk (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Concentration of Risk [Line Items]
Cash deposited with financial institutions	$ 28,725	$ 219,553	$ 629,355

Concentration of Risk (Detail_2

Concentration of Risk (Details) - Schedule of Major Customers - Customer Concentration Risk [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Customer C [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage	15%	10%	11%	15%	13%	10%
Customer C [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage			15%	13%	13%	12%
Customer G [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage		10%		10%	10%
Customer G [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage				31%	31%
Customer H [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage		10%		10%	10%
Customer H [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage				12%	12%
Customer I [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage		10%		10%	10%
Customer I [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage				10%	10%
Iluminar [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage					10%
Iluminar [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage					18%
Iluminar [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage						10%
Iluminar [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage						39%
Customer B [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage						10%
Customer B [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage						12%
Customer D [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage						10%
Customer D [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage						11%
Customer E [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage		10%		16%		17%
Customer E [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage				10%		10%
Customer F [Member] \| Percentage of Revenue [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage		20%		10%		15%
Customer F [Member] \| Percentage of Account Receivable [Member]
Revenue, Major Customer [Line Items]
Major Customers Risk Percentage				10%		10%

Concentration of Risk (Detail_3

Concentration of Risk (Details) - Schedule of Major Vendors - Supplier Concentration Risk [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Purchase [Member] \| Vendor A [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage	29%	68%	48%	55%	52%	20%
Purchase [Member] \| Vendor B [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage					25%
Purchase [Member] \| Megaphoton Inc [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage					10%
Purchase [Member] \| Uninet Global Inc [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage	10%	10%	10%	10%	10%	10%
Purchase [Member] \| Megaphoton [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage	10%	15%	10%	14%		49%
Accounts Payable [Member] \| Vendor A [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage			10%		10%	14%
Accounts Payable [Member] \| Vendor B [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage					10%
Accounts Payable [Member] \| Megaphoton Inc [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage					62%
Accounts Payable [Member] \| Uninet Global Inc [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage			23%		20%	27%
Accounts Payable [Member] \| Megaphoton [Member]
Schedule of Major Vendors [Line Items]
Major Vendors Percentage			53%		62%	53%

Lease (Details)

6 Months Ended

12 Months Ended

May 15, 2021 USD ($)

Jun. 30, 2024 USD ($)

Jun. 30, 2023 USD ($)

Apr. 30, 2027 USD ($)

Apr. 30, 2026 USD ($)

Jun. 15, 2025 USD ($)

May 15, 2025 USD ($)

Apr. 30, 2025 USD ($)

Jun. 15, 2024 USD ($)

May 31, 2024 USD ($)

May 15, 2024 USD ($)

Feb. 29, 2024 USD ($)

Feb. 28, 2024 USD ($)

Dec. 31, 2023 USD ($)

Jun. 15, 2023 USD ($)

May 31, 2023 USD ($)

May 15, 2023 USD ($)

Feb. 28, 2023 USD ($)

Dec. 31, 2022 USD ($)

May 31, 2022 USD ($)

Feb. 28, 2022 USD ($)

May 28, 2023 USD ($)

Feb. 13, 2023 USD ($)

Sep. 21, 2022 USD ($)

Sep. 18, 2022 USD ($)

Sep. 01, 2022 USD ($)

Sep. 01, 2022 CAD ($)

Apr. 14, 2021

Jan. 28, 2021

Lease [Line Items]

Operating lease right-of-use assets

$ 578,179

$ 503,089

$ 973,147

Operating lease liabilities

644,458

$ 517,356

1,011,134

Description of lease term

February 1, 2021
to February 29, 2024

Lease payments

$ 22,375

$ 29,960

$ 3,863

$ 7,100

$ 442,252

$ 29,088

$ 6,452

$ 3,751

$ 6,920

327,091

$ 6,300

$ 6,750

Description of lease term

May 1, 2021
to April 30, 2024

Operating lease right-of-use assets

$ 144,602

Operating lease liabilities

$ 152,179

152,179

Loss on disposal of ROU

33,423

Sublease payments

$ 2,885

Description of lease term

June 16, 2022 to June 15,
2025

June 16, 2022 to June 15, 2025

Monthly payment

$ 1,550

First installment amount

$ 15,165

$ 15,000

$ 481

$ 3,065

Lease term

1 year 9 months 29 days

1 year 5 months 12 days

2 years 2 months 19 days

Weighted-average lease percentage

6.80%

6.81%

6.05%

Lease Agreements [Member]

Lease [Line Items]

Operating lease right-of-use assets

$ 578,179

$ 503,089

$ 973,147

Operating lease liabilities

$ 644,458

$ 517,356

$ 1,011,134

Lease payments

$ 3,751

McLovin’s Pet Food Inc. [Member]

Lease [Line Items]

Lease payments

$ 29,088

Description of sublease term

May 1, 2024 to April 30, 2027

McLovin’s Pet Food Inc. [Member]

Lease [Line Items]

Description of sublease term

May 16, 2021
to May 15, 2022

Photon Technology Ltd [Member]

Lease [Line Items]

Monthly payment

$ 2,690

$ 3,500

Nature’s Miracle [Member]

Lease [Line Items]

Monthly payment

$ 2,333

TEXAS

Lease [Line Items]

Description of lease term

February 1, 2021 to February 29, 2024

Lease payments

$ 7,100

$ 6,920

$ 6,750

PENNSYLVANIA

Lease [Line Items]

Lease payments

$ 6,609

$ 6,452

$ 6,300

Description of lease term

May 1, 2021 to April 30, 2024

CALIFORNIA

Lease [Line Items]

Description of lease term

May 16, 2021 to May 15, 2022

Lease payments

$ 22,375

Forecast [Member]

Lease [Line Items]

Lease payments

$ 9,047

$ 8,784

$ 30,859

$ 3,979

$ 8,528

$ 29,960

$ 6,609

$ 3,863

Forecast [Member] | McLovin’s Pet Food Inc. [Member] | Lease Agreements [Member]

Lease [Line Items]

Lease payments

$ 3,979

Lease (Details) - Schedule of L

Lease (Details) - Schedule of Lease Cost - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
Lease (Details) - Schedule of Lease Cost - USD ($)	May 15, 2021	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 15, 2024	May 15, 2024	Feb. 28, 2024	Dec. 31, 2023	Jun. 15, 2023	May 31, 2023	May 15, 2023	Feb. 28, 2023	Dec. 31, 2022	May 31, 2022	Feb. 28, 2022
Schedule of Lease Cost [Abstract]
Operating lease cost (included in Cost of Revenue and Other Expense in the Company’s Statement of Operations)		$ 105,112	$ 105,195	$ 168,245	$ 241,745				$ 414,370					$ 303,157
Other information
Cash paid for amounts included in the measurement of lease liabilities	$ 22,375					$ 29,960	$ 3,863	$ 7,100	$ 442,252	$ 29,088	$ 6,452	$ 3,751	$ 6,920	$ 327,091	$ 6,300	$ 6,750
Weighted average remaining term in years		1 year 9 months 29 days		1 year 9 months 29 days					1 year 5 months 12 days					2 years 2 months 19 days
Average discount rate – operating leases		6.80%		6.80%					6.81%					6.05%

Lease (Details) - Schedule of B

Lease (Details) - Schedule of Balance Sheet Information Related to Leases - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating leases
Right of use asset	$ 578,179	$ 503,089	$ 973,147
Lease Liability – current portion	460,311	359,459	468,425
Lease Liability – net of current portion	184,147	157,897	542,709
Total operating lease liabilities	$ 644,458	$ 517,356	$ 1,011,134

Lease (Details) - Schedule of M

Lease (Details) - Schedule of Maturities of Lease Liabilities - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Maturities of Lease Liabilities [Abstract]
2024	$ 486,748	$ 383,236
2025	105,929	160,494
Less: Imputed interest/present value discount	(38,690)	(26,374)
Present value of lease liabilities	$ 644,458	$ 517,356	$ 1,011,134

Contingencies (Details)

Contingencies (Details) - USD ($)	May 23, 2024	Apr. 26, 2024	Aug. 22, 2023
Contingencies (Details) [Line Items]
Guarantee agreement			$ 6,857,167
Minimum requirement		$ 15,000,000
Minimum market value		$ 50,000,000
Price per share (in Dollars per share)	$ 1
Common Stock [Member]
Contingencies (Details) [Line Items]
Common stock, par value (in Dollars per share)		$ 0.0001

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)

6 Months Ended

12 Months Ended

Aug. 13, 2024

Jul. 25, 2024

Jul. 16, 2024

Jul. 03, 2024

May 07, 2024

Mar. 07, 2024

Feb. 06, 2024

Jan. 08, 2024

Jun. 30, 2024

Dec. 31, 2023

Dec. 31, 2022

Oct. 01, 2024

Apr. 02, 2024

Mar. 11, 2024

Oct. 30, 2023

Sep. 17, 2023

Jul. 11, 2023

Jan. 17, 2023

Subsequent Event [Line Items]

Loan amount

$ 73,752

$ 32,733

$ 24,333

Trust account amount

15,000,000

Redeemed during period, by public shareholders

13,900,000

Offering cost expense

1,100,000

Cash Payed

$ 31,000,000,000

200,000

800,000

Fair value per share (in Dollars per share)

$ 0.89

$ 0.95

Investor investment

$ 1,000,000

Investment rate

12%

Deposited bank account

$ 410,000

Warrant purchase (in Shares)

3,625,750

Exercise price (in Dollars per share)

$ 9.2

Public offering units (in Shares)

150,000

Fully vest shares of common stock (in Shares)

100,013

Aggregate principal amount

$ 125,000

Original issue discount

$ 27,500

Closing expenses

$ 8,000

$ 660,000

Installment amount

20,350

Subsequent Event [Member]

Subsequent Event [Line Items]

Interest rate

12%

Investor investment

$ 410,000

Investment rate

12%

Accumulated interest (in Dollars per share)

$ 0.442

Convertible notes payable

180,000

Original issue discount

$ 27,500

Warrant purchase (in Shares)

217,500

Exercise price (in Dollars per share)

$ 0.24

$ 0.87

Public offering units (in Shares)

180,000

Accrued interest and other fees

$ 212,400

Aggregate gross proceeds

$ 1.2

Aggregate principal amount

$ 410,000

Original issue discount

23,700

Closing expenses

8,000

Additional tranches

1,000,000

Installment amount

20,350

Subsequent Event [Member] | Nature’s Miracle [Member]

Subsequent Event [Line Items]

Principal amount

$ 20,000

Interest rate

Subsequent Event [Member] | Lakeshore [Member]

Subsequent Event [Line Items]

Principal amount

$ 20,000

Interest rate

Subsequent Event [Member] | August 2024 Diagonal Lending LLC [Member]

Subsequent Event [Line Items]

Aggregate principal amount

$ 181,700

George Yutuc [Member]

Subsequent Event [Line Items]

Employment agreement shares (in Shares)

100,000

Kirk Collins [Member]

Subsequent Event [Line Items]

Employment agreement shares (in Shares)

50,000

Amber Wang [Member]

Subsequent Event [Line Items]

Employment agreement shares (in Shares)

50,000

Public Offering [Member] | Subsequent Event [Member]

Subsequent Event [Line Items]

Public offering units (in Shares)

5,000,000

Forecast [Member]

Subsequent Event [Line Items]

Interest rate

10%

Loan amount

$ 1,405,000

Stockholders percentage

100%

Cash Payed

$ 14,000

Vested agreement shares (in Shares)

75,000

Fair value amount

$ 143,000

Fair value per share (in Dollars per share)

$ 0.95

Forecast [Member] | Restricted Stock [Member]

Subsequent Event [Line Items]

Restricted common stock shares (in Shares)

150,000

Forecast [Member] | Nature’s Miracle [Member]

Subsequent Event [Line Items]

Stockholders percentage

84.70%

Subsequent Events (Details) - S

Subsequent Events (Details) - Schedule of Common Stock Issued and Outstanding - Common Stock [Member] - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2024
Schedule of Common Stock Issued and Outstanding [Line Items]
The Company’s shares outstanding prior to Reverse Recapitalization	2,241,500	2,241,500
Shares issued to private rights	35,150	35,150
Conversion of the Company’s public shares and rights	790,097
Shares issued to service providers	801,539	801,539
Bonus shares issued to investors	166,000
Conversion of Nature’s Miracle’s shares into the Company’s ordinary shares	22,272,478
Total shares outstanding	26,306,764

Basis of Presentation and Sum_6

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Straight-Line Method Over the Useful Lives	Dec. 31, 2023
Machinery and Equipment [Member]
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Straight-Line Method Over the Useful Lives [Line Items]
Property Plant And Equipment Useful Life	5 years
Computer Equipment [Member]
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Straight-Line Method Over the Useful Lives [Line Items]
Property Plant And Equipment Useful Life	3 years
Trucks And Automobiles [Member]
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Straight-Line Method Over the Useful Lives [Line Items]
Property Plant And Equipment Useful Life	5 years
Building [Member]
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Straight-Line Method Over the Useful Lives [Line Items]
Property Plant And Equipment Useful Life	39 years

Basis of Presentation and Sum_7

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Disaggregate Revenue - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenues	$ 3,404,967	$ 1,943,528	$ 5,609,687	$ 4,910,200	$ 8,932,751	$ 18,621,344
Grow light [Member]
Disaggregation of Revenue [Line Items]
Total revenues	3,404,967	1,943,528	5,465,906	4,910,200
Indoor grow containers [Member]
Disaggregation of Revenue [Line Items]
Total revenues			$ 143,781

Basis of Presentation and Sum_8

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Deferred Income and Contract Liabilities - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule Of Deferred Income And Contract Liabilities Abstract
Beginning balance	$ 118,909	$ 808,118	$ 997,732
Prepayments from customers	470,967	1,370,836	1,352,698
Recognized as revenues	(525,807)	(2,060,045)	(1,542,312)
Ending balance	$ 64,069	$ 118,909	$ 808,118

Variable Interest Entity (Det_4

Variable Interest Entity (Details) - Schedule of Carrying Amount of Assets and Liabilities - Variable Interest Entity, Primary Beneficiary [Member] - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Schedule of Carrying Amount of Assets and Liabilities [Line Items]
Cash	$ 1,046	$ 8,889
Prepaid expense	1,800	1,800
Property and equipment, net	4,180,504	4,224,930
Total assets	4,183,350	4,235,619
Current portion of long-term debt	82,374	80,638
Long-term debt, net of current portion	2,730,266	2,771,959
Accrued expenses	398
Intercompany payable to Visiontech	1,367,078	1,411,025
Total liabilities	$ 4,180,116	$ 4,263,622

Variable Interest Entity (Det_5

Variable Interest Entity (Details) - Schedule of Operating Results of VIE - USD ($)		3 Months Ended	6 Months Ended
		Jun. 30, 2024	Jun. 30, 2024
Schedule of Operating Results of VIE [Line Items]
Revenue	[1]		$ 166,421
Selling, general and administrative			(82,450)
Interest expense			(51,034)
Income tax			(1,700)
Net loss			$ 31,237
Variable Interest Entity, Primary Beneficiary [Member]
Schedule of Operating Results of VIE [Line Items]
Revenue	[1]	$ 83,211
Selling, general and administrative		(27,840)
Interest expense		(25,414)
Net loss		$ 29,957

[1] Upland generated its revenue from leasing the warehouse to Visiontech. Revenue of Upland was fully eliminated on the unaudited condensed consolidated statements of operations.

Reverse Recapitalization (Detai

Reverse Recapitalization (Details) - USD ($)	6 Months Ended
Reverse Recapitalization (Details) - USD ($)	Jun. 30, 2024	Mar. 11, 2024
Reverse Recapitalization [Line Items]
Warrants outstanding (in Shares)	3,625,750
Redeem public shares (in Shares)	1,246,563
Repayments of promissory note	$ 75,000
Net liabilities	1,600,000
NMI [Member]
Reverse Recapitalization [Line Items]
NMI stockholders percentage		84.70%
Contribution of funds held in trust account	13,900,000
Incurred transaction costs	1,100,000
Nature’s Miracle’s [Member]
Reverse Recapitalization [Line Items]
NMI stockholders percentage		100%
Reverse recapitalization of proceeds	1,100,000
Lakeshore’s shares [Member]
Reverse Recapitalization [Line Items]
Incurred transaction costs	$ 1,000,000
Public Warrants [Member]
Reverse Recapitalization [Line Items]
Warrants outstanding (in Shares)	3,450,000
Private Warrants [Member]
Reverse Recapitalization [Line Items]
Warrants outstanding (in Shares)	175,750
Nature’s Miracle’s [Member]
Reverse Recapitalization [Line Items]
Contribution of funds held in trust account	$ 15,100,000

Reverse Recapitalization (Det_2

Reverse Recapitalization (Details) - Schedule of Common Stock Issued and Outstanding Reverse Recapitalization	6 Months Ended
	Jun. 30, 2024 shares
Schedule of Common Stock Issued and Outstanding Reverse Recapitalization [Line Items]
Reverse recapitalization	26,306,764
Lakeshore’s shares [Member]
Schedule of Common Stock Issued and Outstanding Reverse Recapitalization [Line Items]
Reverse recapitalization	2,241,500
Shares Issued To Private Rights [Member]
Schedule of Common Stock Issued and Outstanding Reverse Recapitalization [Line Items]
Reverse recapitalization	35,150
Conversion of Lakeshore’s Public Shares and Rights [Member]
Schedule of Common Stock Issued and Outstanding Reverse Recapitalization [Line Items]
Reverse recapitalization	790,097
Shares Issued to Service Providers [Member]
Schedule of Common Stock Issued and Outstanding Reverse Recapitalization [Line Items]
Reverse recapitalization	801,539
Bonus Shares Issued To Investors [Member]
Schedule of Common Stock Issued and Outstanding Reverse Recapitalization [Line Items]
Reverse recapitalization	166,000
Conversion of NMI’s Shares [Member]
Schedule of Common Stock Issued and Outstanding Reverse Recapitalization [Line Items]
Reverse recapitalization	22,272,478

Reverse Recapitalization (Det_3

Reverse Recapitalization (Details) - Schedule of Reverse Recapitalization - USD ($)		6 Months Ended
	Mar. 11, 2024	Jun. 30, 2024	Jun. 30, 2023
Schedule of Reverse Recapitalization [Abstract]
Funds held in Lakeshore’s trust account	$ 15,067,702
Funds held in Lakeshore’s operating cash account	198
Less: amount paid to redeem public shares of Lakeshore’s ordinary shares	(13,947,723)
Proceeds from the reverse recapitalization	1,120,177
Less: payments of transaction costs incurred by Lakeshore	(1,044,980)	$ 1,044,980
Less: repayments of promissory note – related party of Lakeshore’	(75,000)	$ 75,000
Less: notes assumed from Lakeshore	(555,000)
Less: liability assumed from Lakeshore	(1,547,814)
Less: transaction costs paid by NMI	(1,100,857)
Add: receivable assumed from Lakeshore	500,000
Net liabilities assumed from issuance of common stock upon the Merger, balance classified to retained deficit	$ (2,703,474)

Accounts Receivable, Net (Det_4

Accounts Receivable, Net (Details) - Schedule of Accounts Receivable - Accounts Receivable [Member] - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Accounts Receivable [Line Items]
Accounts receivable	$ 2,737,042	$ 1,906,222	$ 3,953,635
Less: allowance for credit losses	(683,364)	(669,974)
Subtotal accounts receivable, net	2,053,678	1,236,248
Accounts receivable - related parties		1,541,917	3,555,332
Total accounts receivable, net	2,771,513	1,541,917	$ 3,693,945
Related Party [Member]
Schedule of Accounts Receivable [Line Items]
Accounts receivable - related parties	$ 717,835	$ 305,669

Accounts Receivable, Net (Det_5

Accounts Receivable, Net (Details) - Schedule of Allowance for Credit Losses - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Schedule Of Allowance For Credit Losses Abstract
Beginning balance	$ 669,974	$ 259,690	$ 259,690	$ 15,898
Addition	24,391	907,021	907,021	322,395
Recovery/write-off	(11,001)	(496,737)	(496,737)	(83,567)
Ending balance	$ 683,364	$ 669,974	$ 669,974	$ 259,690

Cost Method Investment (Detai_3

Cost Method Investment (Details) - Schedule of Cost Method Investment - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Cost Method Investment [Abstract]
10% Investment of Iluminar	$ 1,000,000	$ 1,000,000
Total	$ 1,000,000	$ 1,000,000

Cost Method Investment (Detai_4

Cost Method Investment (Details) - Schedule of Cost Method Investment (Parentheticals)	Jun. 30, 2024	Dec. 31, 2023
Schedule of Cost Method Investment [Abstract]
Investment	10%	10%

Property and Equipment, Net (_3

Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	$ 4,748,176	$ 4,748,176	$ 4,780,081
Less: accumulated depreciation	(421,624)	(341,904)	(191,648)
Property, Plant and Equipment, Net	4,326,552	4,406,272	4,588,433
Trucks & Automobiles [Member]
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	285,099	285,099	293,599
Machinery & Equipment [Member]
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	67,847	67,847	84,085
Building [Member]
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	3,465,230	3,465,230	3,465,230
Land [Member]
Schedule of Property and Equipment, Net [Line Items]
Property, Plant and Equipment, Gross	$ 930,000	$ 930,000	$ 930,000

Loans Payable (Details) - Sch_2

Loans Payable (Details) - Schedule of Minimum Required Principal Payments - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Auto Loans [Member]
Schedule of Minimum Required Principal Payments [Line Items]
2025	$ 35,240	$ 34,383
2026	32,944	36,120
2027	26,172	27,656
Thereafter	3,285
Total	97,641	114,621
Building Loan [Member]
Schedule of Minimum Required Principal Payments [Line Items]
2025	82,374	80,638
2026	85,380	83,868
2027	88,495	86,928
Thereafter	2,556,392	2,511,063
Total	2,812,641	2,852,597
Business Loan [Member]
Schedule of Minimum Required Principal Payments [Line Items]
2025	166,879	153,784
2026	196,507	181,088
2027	231,396	213,239
Thereafter	2,612,991	2,482,316
Total	$ 3,207,773	$ 3,281,526

Related Party Transactions (D_3

Related Party Transactions (Details) - Schedule of Loan Receivable Related Parties - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Loan to Lakeshore Acquisition II Corp [Member]
Schedule of Loan Receivable Related Parties [Line Items]
Loan receivable		$ 460,000
Total loan receivable – related parties [Member
Schedule of Loan Receivable Related Parties [Line Items]
Loan receivable		$ 460,000

Equity (Details) - Schedule of

Equity (Details) - Schedule of Merger - Common Stock [Member] - shares		Dec. 31, 2024	Dec. 31, 2023
Schedule of Merger [Line Items]
Lakeshore’s shares outstanding prior to reverse recapitalization		2,241,500	2,241,500
Shares issued to private rights		35,150	35,150
Conversion of the Lakeshore’s public shares and rights		790,097
Shares issued to service providers		801,539	801,539
Bonus shares issued to in connection with Lakeshore loans	[1]	66,000
Bonus shares issued to in connection with NMI loans	[1]	100,000
Conversion of NMI’s shares into the Company’s ordinary shares		22,272,478
Total shares outstanding		26,306,764

[1] In connection with the Merger, the Company, Lakeshore and NMI further entered into a Letter Agreement on November 15, 2023, a total of 125,000 shares of the Company’s common stock will be issued upon closing of the Merger in connection with certain transactions relating to the Merger: (i) 50,000 shares to Tie (James) Li and 50,000 shares to Zhiyi (Jonathan) Zhang (or 100,000 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of NMI with the principal amount of $3,700,000; (ii) 12,500 shares to Tie (James) Li and 12,500 shares to Deyin (Bill) Chen (or 25,000 shares in the aggregate) in connection with their loans to Lakeshore, each with the principal amount of $125,000 under separate but similar loan agreements); At the Close of Merger, additional shares of 16,000 and 25,000 were issued to Tie (James) Li and Prosperity Spring International Investment Management in connection with their loans to Lakeshore.

Concentration of Risk (Detail_4

Concentration of Risk (Details) - Schedule of Major Customers - Customer Concentration Risk [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Customer A [Member] \| Percentage of Revenue [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage	39%		24%
Customer A [Member] \| Percentage of Account Receivable [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage			49%
Customer C [Member] \| Percentage of Revenue [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage	15%	10%	11%	15%	13%	10%
Customer C [Member] \| Percentage of Account Receivable [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage			15%	13%	13%	12%
Iluminar [Member] \| Percentage of Revenue [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage	17%	10%	18%	10%
Iluminar [Member] \| Percentage of Account Receivable [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage			26%	18%
Customer G [Member] \| Percentage of Revenue [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage		10%		10%	10%
Customer G [Member] \| Percentage of Account Receivable [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage				31%	31%
Customer H [Member] \| Percentage of Revenue [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage		10%		10%	10%
Customer H [Member] \| Percentage of Account Receivable [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage				12%	12%
Customer I [Member] \| Percentage of Revenue [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage		10%		10%	10%
Customer I [Member] \| Percentage of Account Receivable [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage				10%	10%
Customer E [Member] \| Percentage of Revenue [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage		10%		16%		17%
Customer E [Member] \| Percentage of Account Receivable [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage				10%		10%
Customer F [Member] \| Percentage of Revenue [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage		20%		10%		15%
Customer F [Member] \| Percentage of Account Receivable [Member]
Schedule of Major Customers [Line Items]
Major Customers Risk Percentage				10%		10%

Concentration of Risk (Detail_5

Concentration of Risk (Details) - Schedule of Major Vendors - Supplier Concentration Risk [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Percentage of Purchase [Member] \| Megaphoton [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage	10%	15%	10%	14%		49%
Percentage of Purchase [Member] \| Uninet Global Inc [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage	10%	10%	10%	10%	10%	10%
Percentage of Purchase [Member] \| Vendor A [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage	29%	68%	48%	55%	52%	20%
Percentage of Purchase [Member] \| Vendor E [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage	57%		38%
Percentage of Purchase [Member] \| Vendor D [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage		10%		14%
Percentage of Account Payable [Member] \| Megaphoton [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage			53%		62%	53%
Percentage of Account Payable [Member] \| Uninet Global Inc [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage			23%		20%	27%
Percentage of Account Payable [Member] \| Vendor A [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage			10%		10%	14%
Percentage of Account Payable [Member] \| Vendor E [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage			11%
Percentage of Account Payable [Member] \| Vendor D [Member]
Schedule of Major Vendor [Line Items]
Major Vendors Percentage					10%

Lease (Details) - Schedule of_2

Lease (Details) - Schedule of Lease Cost - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Lease (Details) - Schedule of Lease Cost - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Schedule of Lease Cost [Abstract]
Operating lease cost (included in Cost of Revenue and Other Expense in the Company’s Statement of Operations)	$ 105,112	$ 105,195	$ 168,245	$ 241,745	$ 414,370	$ 303,157
Cash paid for amounts included in the measurement of lease liabilities	$ 81,389	$ 126,013	$ 116,234	$ 253,572

Lease (Details) - Schedule of_3

Lease (Details) - Schedule of Balance Sheet Information Related to Leases - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Balance Sheet Information Related to Leases [Abstract]
Right of use asset	$ 578,179	$ 503,089	$ 973,147
Lease Liability – current portion	460,311	359,459	468,425
Lease Liability – net of current portion	184,147	157,897	542,709
Total operating lease liabilities	$ 644,458	$ 517,356	$ 1,011,134

Lease (Details) - Schedule of_4

Lease (Details) - Schedule of Maturities of Lease Liabilities - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Maturities of Lease Liabilities [Abstract]
2025	$ 486,748	$ 383,236
2026	105,929	160,494
2027	90,470
Less: Imputed interest/present value discount	(38,690)	(26,374)
Present value of lease liabilities	$ 644,458	$ 517,356	$ 1,011,134